Patent Publication Number: US-8541343-B2

Title: Chemical compounds and their use as pesticides

Description:
This application is a 371 of International Application No. PCT/EP2010/068401 filed Nov. 29, 2010, which claims priority to GB 0921346.3 filed Dec. 4, 2009, the contents of which are incorporated herein by reference. 
     The present invention relates to new spiroheterocyclic dione derivatives, to processes for preparing them, to pesticidal, in particular insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests. 
     Spiroheterocyclic pyrrolidine dione derivatives are disclosed for example in WO 09/049,851. 
     It has now surprisingly been found that certain new spiroheterocyclic dione derivatives containing hydrazine groups have good insecticidal properties. 
     The present invention therefore provides compounds of the formula I 
                         
wherein
 
     X, Y and Z independently of each other are C 1-4 alkyl, C 3-6 cycloalkyl, C 1-4 alkoxy, halogen, phenyl or phenyl substituted by C 1-4 alkyl, C 1-4 haloalkyl, halogen or cyano; 
     m and n, independently of each other, are 0, 1, 2 or 3 and m+n is 0, 1, 2 or 3; 
     G is hydrogen, a metal, ammonium, sulfonium or a latentiating group; 
     R 1  and R 2 , independently of each other, are hydrogen, C 1-4 alkyl, benzyl, C 1-4 alkylcarbonyl or C 1-4 alkoxycarbonyl; or 
     R 1  and R 2  together with the nitrogen atom to which they are attached form a 5- to 7-membered ring optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur; 
     R 3  and R 4 , independently of each other, are hydrogen, C 1-4 alkyl, benzyl, C 1-4 alkylcarbonyl or C 1-4 alkoxycarbonyl; or 
     R 3  and R 4  together with the nitrogen atom to which they are attached form a 5- to 7-membered ring optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur; and 
     an agrochemically acceptable salt or an N-oxide thereof. 
     In the compounds of the formula I, each alkyl moiety either alone or as part of a larger group is a straight or branched chain and is, for example, methyl, ethyl, n-propyl, n-butyl, iso-propyl, sec-butyl, iso-butyl or tert-butyl. 
     Alkoxy groups preferably have a preferred chain length of from 1 to 4 carbon atoms. Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy or tert-butoxy. Such groups can be part of a larger group such as alkoxyalkyl and alkoxyalkoxyalkyl. Alkoxyalkyl groups preferably have a chain length of 1 to 4 carbon atoms. Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-propoxymethyl, n-propoxyethyl or isopropoxymethyl. 
     Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl. 
     Haloalkyl groups preferably have a chain length of from 1 to 4 carbon atoms. Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl and 2,2,2-trichloroethyl; preferably trichloromethyl, difluorochloromethyl, difluoromethyl, trifluoromethyl and dichlorofluoromethyl. 
     The cycloalkyl groups preferably have from 3 to 6 ring carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. 
     Phenyl, also as part of a substituent such as benzyl, may be substituted, preferably by alkyl, haloalkyl, halogen or cyano groups. In this case, the substituents can be in ortho, meta and/or para position. The preferred substituent positions are the ortho and para positions, especially the ortho position to the ring attachment point. 
     The rings formed by R 1  and R 2  together with the nitrogen atom to which they are attached and the rings formed by R 3  and R 4  together with the nitrogen atom to which they are attached are 5-, 6- or 7-membered and include aromatic and non-aromatic ring systems, which optionally contain a further heteroatom selected from nitrogen, oxygen or sulphur. Examples of such rings include pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,2,3-thiadiazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl, 1,2,4-triazinyl, and 1,3,5-triazinyl; and 1,3-dioxolane, oxetane, tetrahydrofuran, tetrahydropyran, morpholine, thiomorpholine, thiomorpholine 1,1-dioxide, pyrrolidine, piperidine and piperazine. When present, the optional substituents on these aromatic and non-aromatic rings are C 1 -C 6 alkyl and C 1 -C 6 haloalkyl as well as those optional substituents given above for an alkyl moiety. 
     The latentiating groups G are selected to allow its removal by one or a combination of biochemical, chemical or physical processes to afford compounds of formula I where G is hydrogen before, during or following application to the treated area or plants. Examples of these processes include enzymatic cleavage, chemical hydrolysis and photoloysis. Compounds bearing such groups G may offer certain advantages, such as improved penetration of the cuticula of the plants treated, increased tolerance of crops, improved compatibility or stability in formulated mixtures containing other insecticides, herbicide safeners, plant growth regulators, herbicides or fungicides, or reduced leaching in soils. 
     The latentiating group G is preferably selected from the groups C 1 -C 8 alkyl, C 2 -C 3 haloalkyl, phenylC 1 -C 8 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano or by nitro), heteroarylC 1 -C 8 alkyl (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3  alkylsulfonyl, halogen, cyano or by nitro), C 3 -C 8 alkenyl, C 3 -C 8 haloalkenyl, C 3 -C 8 alkynyl, C(X a )—R a , C(X b )—X c —R b , C(X d )—N(R c )—R d , —SO 2 —R e , —P(X e )(R f )—R g  or CH 2 —X f —R h  wherein X a , X b , X c , X d , X e  and X f  are independently of each other oxygen or sulfur; 
     R a  is H, C 2 -C 18 alkenyl, C 2 -C 18 alkynyl, C 1 -C 10 haloalkyl, C 1 -C 10 cyanoalkyl, C 1 -C 10 nitroalkyl, C 1 -C 10 aminoalkyl, C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 2 -C 8 dialkylaminoC 1 -C 5 alkyl, C 3 -C 7 cycloalkylC 1 -C 5 alkyl, C 1 -C 5 alkoxyC 1 -C 5 alkyl, C 3 -C 5 alkenyloxyC 1 -C 5 alkyl, C 3 -C 5 alkynylC 1 -C 5 oxyalkyl, C 1 -C 5 alkylthioC 1 -C 5 alkyl, C 1 -C 5 alkylsulfinylC 1 -C 5 alkyl, C 1 -C 5 alkylsulfonylC 1 -C 5 alkyl, C 2 -C 8 alkylideneaminoxyC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylC 1 -C 5 alkyl, C 1 -C 5 alkoxycarbonylC 1 -C 5 alkyl, aminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylaminocarbonylC 1 -C 5 alkyl, C 2 -C 8 dialkylaminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylaminoC 1 -C 5 alkyl, N—C 1 -C 5 alkylcarbonyl-N—C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 3 -C 6 -trialkylsilylC 1 -C 5 alkyl, phenylC 1 -C 5 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), heteroarylC 1 -C 5 alkyl, (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), C 2 -C 5 haloalkenyl, C 3 -C 8 cycloalkyl, phenyl or phenyl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, heteroaryl or heteroaryl substituted by C 1 -C 3  alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, 
     R b  is C 1 -C 18 alkyl, C 3 -C 18 alkenyl, C 3 -C 18 alkynyl, C 2 -C 10 haloalkyl, C 1 -C 10 cyanoalkyl, C 1 -C 10 nitroalkyl, C 2 -C 10 aminoalkyl, C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 2 -C 8 dialkylaminoC 1 -C 5 alkyl, C 3 -C 7 cycloalkylC 1 -C 5 alkyl, C 1 -C 5 alkoxyC 1 -C 5 alkyl, C 3 -C 5 alkenyloxyC 1 -C 5 alkyl, C 3 -C 5 alkynyloxyC 1 -C 5 alkyl, C 1 -C 5 alkylthioC 1 -C 5 alkyl, C 1 -C 5 alkylsulfinylC 1 -C 5 alkyl, C 1 -C 5 alkylsulfonylC 1 -C 5 alkyl, C 2 -C 8 alkylideneaminoxyC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylC 1 -C 5 alkyl, C 1 -C 5 alkoxycarbonylC 1 -C 5 alkyl, aminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylaminocarbonylC 1 -C 5 alkyl, C 2 -C 8 dialkylaminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylaminoC 1 -C 5 alkyl, N—C 1 -C 5 alkylcarbonyl-N—C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 3 -C 6 trialkylsilylC 1 -C 5 alkyl, phenylC 1 -C 5 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), heteroarylC 1 -C 5 alkyl, (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkyl-thio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), C 3 -C 5 haloalkenyl, C 3 -C 8 cycloalkyl, phenyl or phenyl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 halo-alkoxy, halogen, cyano or nitro, heteroaryl or heteroaryl substituted by C 1 -C 3  alkyl, C 1-3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, 
     R c  and R d  are each independently of each other hydrogen, C 1 -C 10 alkyl, C 3 -C 10 alkenyl, C 3 -C 10 alkynyl, C 2 -C 10 haloalkyl, C 1 -C 10 cyanoalkyl, C 1 -C 10 nitroalkyl, C 1 -C 10 aminoalkyl, C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 2 -C 8 dialkylaminoC 1 -C 5 alkyl, C 3 -C 7 cycloalkylC 1 -C 5 alkyl, C 1 -C 5 alkoxyC 1 -C 5 alkyl, C 3 -C 5 alkenyloxyC 1 -C 5 alkyl, C 3 -C 5 alkynyloxyC 1 -C 5 alkyl, C 1 -C 5 alkylthioC 1 -C 5 alkyl, C 1 -C 5 alkylsulfinylC 1 -C 5 alkyl, C 1 -C 5 alkylsulfonylC 1 -C 5 alkyl, C 2 -C 8 alkylideneaminoxyC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylC 1 -C 5 alkyl, C 1 -C 5 alkoxycarbonylC 1 -C 5 alkyl, aminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylaminocarbonylC 1 -C 5 alkyl, C 2 -C 8 dialkylaminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylaminoC 1 -C 5 alkyl, N—C 1 -C 5 alkylcarbonyl-N—C 2 -C 5 alkylaminoalkyl, phenylC 1 -C 5 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), heteroarylC 1 -C 5 alkyl, (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), C 2 -C 5 haloalkenyl, C 3 -C 8 cycloalkyl, phenyl or phenyl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, heteroaryl or heteroaryl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, heteroarylamino or heteroarylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, diheteroarylamino or diheteroarylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, phenylamino or phenylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or by nitro, diphenylamino or diphenylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or by nitro or C 3 -C 7 cycloalkylamino, di-C 3 -C 7 cycloalkylamino or C 3 -C 7 cycloalkoxy or R c  and R d  may join together to form a 3-7 membered ring, optionally containing one heteroatom selected from O or S, 
     R e  is C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 1 -C 10 haloalkyl, C 1 -C 10 cyanoalkyl, C 1 -C 10 nitroalkyl, C 1 -C 10 aminoalkyl, C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 2 -C 8 dialkylaminoC 1 -C 5 alkyl, C 3 -C 7 cycloalkylC 1 -C 5 alkyl, C 1 -C 5 alkoxyC 1 -C 5 alkyl, C 3 -C 5 alkenyloxyC 1 -C 5 alkyl, C 3 -C 5 alkynyloxyC 1 -C 5 alkyl, C 1 -C 5 alkylthioC 1 -C 5 alkyl, C 1 -C 5 alkylsulfinylC 1 -C 5 alkyl, C 3 -C 5 alkylsulfonylC 1 -C 5 alkyl, C 2 -C 8 alkylideneaminoxyC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylC 1 -C 5 alkyl, C 1 -C 5 alkoxycarbonylC 1 -C 5 alkyl, aminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylaminocarbonylC 1 -C 5 alkyl, C 2 -C 8 dialkylaminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylaminoC 1 -C 5 alkyl, N—C 1 -C 5 alkylcarbonyl-N—C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 3 -C 6 -trialkylsilylC 1 -C 5 alkyl, phenylC 1 -C 5 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), heteroarylC 1 -C 5 alkyl (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), C 2 -C 5 haloalkenyl, C 3 -C 8 cycloalkyl, phenyl or phenyl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, heteroaryl or heteroaryl substituted by C 1 -C 3  alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or by nitro, heteroarylamino or heteroarylamino substituted by C 1 -C 3  alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or by nitro, diheteroarylamino or diheteroarylamino substituted by C 1 -C 3  alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, phenylamino or phenylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, diphenylamino, or diphenylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, or C 3 -C 7 cycloalkylamino, diC 3 -C 7 cycloalkylamino or C 3 -C 7 cycloalkoxy, C 1 -C 10 alkoxy, C 1 -C 10 haloalkoxy, C 1 -C 5 alkylamino or C 2 -C 8 dialkylamino 
     R f  and R g  are each independently of each other C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 1 -C 10 alkoxy, C 1 -C 10 haloalkyl, C 1 -C 10 cyanoalkyl, C 1 -C 10 nitroalkyl, C 1 -C 10 aminoalkyl, C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 2 -C 8 dialkylaminoC 1 -C 5 alkyl, C 3 -C 7 cycloalkylC 1 -C 5 alkyl, C 1 -C 5 alkoxyC 1 -C 5 alkyl, C 3 -C 5 alkenyloxyC 1 -C 5 alkyl, C 3 -C 5 alkynyloxyC 1 -C 5 alkyl, C 1 -C 5 alkylthioC 1 -C 5 alkyl, C 1 -C 5 alkylsulfinylC 1 -C 5 alkyl, C 1 -C 5 alkylsulfonylC 1 -C 5 alkyl, C 2 -C 8 alkylideneaminoxyC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylC 1 -C 5 alkyl, C 1 -C 5 alkoxycarbonylC 1 -C 5 alkyl, aminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylaminocarbonylC 1 -C 5 alkyl, C 2 -C 8 dialkylaminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylaminoC 1 -C 5 alkyl, N—C 1 -C 5 alkylcarbonyl-N—C 2 -C 5 alkylaminoalkyl, C 3 -C 6 trialkylsilylC 1 -C 5 alkyl, phenylC 1 -C 5 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), heteroarylC 1 -C 5 alkyl (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, halogen, cyano, or by nitro), C 2 -C 5 haloalkenyl, C 3 -C 8 cycloalkyl, phenyl or phenyl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, heteroaryl or heteroaryl substituted by C 1 -C 3  alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or by nitro, heteroarylamino or heteroarylamino substituted by C 1 -C 3  alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or by nitro, diheteroarylamino or diheteroarylamino substituted by C 1 -C 3  alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, phenylamino or phenylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, diphenylamino, or diphenylamino substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, or C 3 -C 7 cycloalkylamino, diC 3 -C 7 cycloalkylamino or C 3 -C 7 cycloalkoxy, C 1 -C 10 haloalkoxy, C 1 -C 5 alkylamino or C 2 -C 8 dialkylamino, benzyloxy or phenoxy, wherein the benzyl and phenyl groups may in turn be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or nitro, and 
     R h  is C 1 -C 10 alkyl, C 3 -C 10 alkenyl, C 3 -C 10 alkynyl, C 1 -C 10 haloalkyl, C 1 -C 10 cyanoalkyl, C 1 -C 10 nitroalkyl, C 2 -C 10 aminoalkyl, C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 2 -C 8 dialkylaminoC 1 -C 5 alkyl, C 3 -C 7 cycloalkylC 1 -C 5 alkyl, C 1 -C 5 alkoxyC 1 -C 5 alkyl, C 3 -C 5 alkenyloxyC 1 -C 5 alkyl, C 3 -C 5 alkynyloxyC 1 -C 5 alkyl, C 1 -C 5 alkylthioC 1 -C 5 alkyl, C 1 -C 5 alkylsulfinylC 1 -C 5 alkyl, C 3 -C 5 alkylsulfonylC 1 -C 5 alkyl, C 2 -C 8 alkylideneaminoxyC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylC 1 -C 5 alkyl, C 1 -C 5 alkoxycarbonylC 1 -C 5 alkyl, aminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylaminocarbonylC 1 -C 5 alkyl, C 2 -C 8 dialkylaminocarbonylC 1 -C 5 alkyl, C 1 -C 5 alkylcarbonylaminoC 1 -C 5 alkyl, N—C 1 -C 5 alkylcarbonyl-N—C 1 -C 5 alkylaminoC 1 -C 5 alkyl, C 3 -C 6 trialkylsilylC 1 -C 5 alkyl, phenylC 1 -C 5 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3  alkylsulfonyl, halogen, cyano or by nitro), heteroarylC 1 -C 5 alkyl (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3  alkylsulfonyl, halogen, cyano or by nitro), phenoxyC 1 -C 5 alkyl (wherein the phenyl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3  alkylsulfonyl, halogen, cyano or by nitro), heteroaryloxyC 1 -C 5 alkyl (wherein the heteroaryl may optionally be substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3  alkylsulfonyl, halogen, cyano or by nitro), C 3 -C 5 haloalkenyl, C 3 -C 8 cycloalkyl, phenyl or phenyl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen or by nitro, or heteroaryl, or heteroaryl substituted by C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, cyano or by nitro. 
     In particular, the latentiating group G is a group —C(X a )—R a  or —C(X b )—X c —R b , and the meanings of X a , R a , X b , X c  and R b  are as defined above. 
     It is also preferred that G is hydrogen, an alkali metal or alkaline earth metal, or an ammonium or sulfonium group, where hydrogen is especially preferred. 
     Depending on the nature of the substituents, compounds of formula I may exist in different isomeric forms. When G is hydrogen, for example, compounds of formula I may exist in different tautomeric forms: 
     
       
         
         
             
             
         
       
     
     This invention covers all isomers and tautomers and mixtures thereof in all proportions. Also, when substituents contain double bonds, cis- and trans-isomers can exist. These isomers, too, are within the scope of the claimed compounds of the formula I. 
     The invention relates also to the agriculturally acceptable salts which the compounds of formula I are able to form with transition metal, alkali metal and alkaline earth metal bases, amines, quaternary ammonium bases or tertiary sulfonium bases. 
     Among the transition metal, alkali metal and alkaline earth metal salt formers, special mention should be made of the hydroxides of copper, iron, lithium, sodium, potassium, magnesium and calcium, and preferably the hydroxides, bicarbonates and carbonates of sodium and potassium. 
     Examples of amines suitable for ammonium salt formation include ammonia as well as primary, secondary and tertiary C 1 -C 18 alkylamines, C 1 -C 4 hydroxyalkylamines and C 2 -C 4 alkoxyalkyl-amines, for example methylamine, ethylamine, n-propylamine, propylamine, the four butylamine isomers, n-amylamine, i-amylamine, hexylamine, heptylamine, octylamine, nonylamine, decylamine, pentadecylamine, hexadecylamine, heptadecylamine, octadecylamine, methylethylamine, methylisopropylamine, methylhexylamine, methylnonylamine, methylpentadecylamine, methyloctadecylamine, ethylbutylamine, ethylheptylamine, ethyloctylamine, hexylheptylamine, hexyloctylamine, dimethylamine, diethylamine, di-n-propylamine, di-i-propylamine, di-n-butylamine, di-n-amylamine, di-i-amylamine, dihexylamine, diheptylamine, dioctylamine, ethanolamine, n-propanolamine, i-propanolamine, N,N-diethanolamine, N-ethylpropanolamine, N-butylethanolamine, allylamine, n-but-2-enylamine, n-pent-2-enylamine, 2,3-dimethylbut-2-enylamine, dibut-2-enylamine, n-hex-2-enylamine, propylenediamine, trimethylamine, triethylamine, tri-n-propylamine, tri-i-opropylamine, tri-n-butylamine, tri-i-butylamine, tri-sec-butylamine, tri-n-amylamine, methoxyethylamine and ethoxyethylamine; heterocyclic amines, for example pyridine, quinoline, isoquinoline, morpholine, piperidine, pyrrolidine, indoline, quinuclidine and azepine; primary arylamines, for example anilines, methoxyanilines, ethoxyanilines, o-, m- and p-toluidines, phenylenediamines, benzidines, naphthylamines and o-, m- and p-chloroanilines; but especially triethylamine, i-propylamine and di-i-propylamine. 
     Preferred quaternary ammonium bases suitable for salt formation correspond, for example, to the formula [N(R a1 R b1 R d1 )]OH, wherein R a1 , R b1 , R c1  and R d1  are each independently of the others hydrogen or C 1 -C 4 alkyl. Further suitable tetraalkylammonium bases with other anions can be obtained, for example, by anion exchange reactions. 
     Preferred tertiary sulfonium bases suitable for salt formation correspond, for example, to the formula [SR e1 R f1 R g1 ]OH, wherein R e1 , R f1  and R g1  are each independently of the others C 1 -C 4  alkyl. Trimethylsulfonium hydroxide is especially preferred. Suitable sulfonium bases may be obtained from the reaction of thioethers, in particular dialkylsulfides, with alkylhalides, followed by conversion to a suitable base, for example a hydroxide, by anion exchange reactions. 
     It should be understood that in those compounds of formula I, where G is a metal, ammonium or sulfonium as mentioned above and as such represents a cation, the corresponding negative charge is largely delocalised across the O—C═C—C═O unit. 
     The compounds of formula I according to the invention also include hydrates which may be formed during the salt formation. 
     Preferably, R 1  and R 2 , independently of each other, are hydrogen or C 1-6 alkyl. 
     Preferably, R 1  and R 2 , together with the nitrogen atom to which they are attached form a 5- to 7-membered ring optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur. 
     Preferably, R 3  and R 4 , independently of each other, are hydrogen or C 1-6 alkyl. 
     Preferably, R 3  and R 4 , together with the nitrogen atom to which they are attached form a 5- to 7-membered ring optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur. 
     Preferably, X, Y and Z denote C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 4 alkoxy or halogen, in particular methyl, ethyl, cyclopropyl, methoxy, fluoro, bromo or chloro, when m+n is 1, 2 or 3, in particular, when m+n is 1 or 2. 
     Alternatively, Y and Z, independently of each other, denote C 1 -C 4 alkyl, C 3 -C 6 cycloalkyl, C 1-4 haloalkyl, C 1-4 alkoxy, halogen, phenyl or phenyl substituted by C 1-4 alkyl, C 1-4 haloalkyl or halogen, in particular methyl, ethyl, cyclopropyl, methoxy, fluoro, chloro, bromo, phenyl or phenyl substituted with methyl, trifluoromethyl or halogen, in particular fluoro or chloro, in particular in 4-position, when m+n is 1, 2 or 3, in particular, when m+n is 1 or 2. 
     In a preferred group of compounds of the formula (I), 
     R 1  and R 2 , independently of each other, are hydrogen or C 1-6 alkyl; or 
     R 1  and R 2 , together with the nitrogen atom to which they are attached form a 5- to 6-membered ring optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur; 
     R 3  and R 4 , independently of each other, are hydrogen or C 1-6 alkyl; or 
     R 3  and R 4 , together with the nitrogen atom to which they are attached form a 5- to 6-membered ring optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur; 
     X denotes C 1-4 alkyl, C 1-4 alkoxy or halogen, in particular methyl, ethyl, methoxy, fluoro, bromo or chloro; 
     Y and Z, independently of each other, are C 1-4 alkyl, C 3 -C 6 cycloalkyl, C 1-4 alkoxy, halogen, phenyl or phenyl substituted by C 1-4 alkyl, C 1-4 haloalkyl or halogen, in particular methyl, ethyl, cyclopropyl, methoxy, fluoro, chloro, bromo, phenyl or phenyl substituted with methyl, trifluoromethyl or halogen, in particular fluoro or chloro, in particular in 4-position, when m+n is 1, 2 or 3, in particular, when m+n is 1 or 2; and 
     G has the meanings assigned to it above. 
     In another preferred group of compounds of the formula (I), 
     R 1  and R 2 , independently of each other, are C 1-6 alkyl; or 
     R 1  and R 2 , together with the nitrogen atom to which they are attached form a 5- to 6-membered ring optionally containing oxygen; 
     R 3  and R 4 , independently of each other, are C 1-6 alkyl; or 
     R 3  and R 4 , together with the nitrogen atom to which they are attached form a 5- to 6-membered ring optionally containing oxygen; 
     X is C 1 -C 4 alkyl, C 1 -C 4 alkoxy or halogen; 
     Y and Z, independently of each other, are methyl, ethyl, methoxy, bromo or chloro; 
     G is hydrogen or C 1 -C 6 alkyl-carbonyl or C 1 -C 6 alkoxy-carbonyl; and 
     m+n is 1 or 2. 
     More preferably, R 1  and R 2  are methyl or R 1  and R 2 , together with the nitrogen atom to which they are attached form a 6-membered ring optionally containing oxygen; R 3  and R 4 , are methyl; X, Y and Z are methyl; G is hydrogen or ethoxycarbonyl; and m+n is 2. 
     The invention covers also salts of the compounds of the formula I with amines, alkali metal and alkaline earth metal bases or quaternary ammonium bases. 
     Among the alkali metal and alkaline earth metal hydroxides as salt formers, special mention should be made of the hydroxides of lithium, sodium, potassium, magnesium and calcium, but especially the hydroxides of sodium and potassium. The compounds of formula I according to the invention also include hydrates which may be formed during the salt formation. 
     Examples of amines suitable for ammonium salt formation include ammonia as well as primary, secondary and tertiary C 1 -C 18 alkylamines, C 1 -C 4 hydroxyalkylamines and C 2 -C 4 alkoxyalkylamines, for example methylamine, ethylamine, n-propylamine, isopropylamine, the four butylamine isomers, n-amylamine, isoamylamine, hexylamine, heptylamine, octylamine, nonylamine, decylamine, pentadecylamine, hexadecylamine, heptadecylamine, octadecylamine, methylethylamine, methylisopropylamine, methylhexylamine, methylnonylamine, methylpentadecylamine, methyloctadecylamine, ethylbutylamine, ethylheptylamine, ethyloctylamine, hexylheptylamine, hexyloctylamine, dimethylamine, diethylamine, di-n-propylamine, diisopropylamine, di-n-butylamine, di-n-amylamine, diisoamylamine, dihexylamine, diheptylamine, dioctylamine, ethanolamine, n-propanolamine, isopropanolamine, N,N-diethanolamine, N-ethylpropanolamine, N-butylethanolamine, allylamine, n-but-2-enylamine, n-pent-2-enylamine, 2,3-dimethylbut-2-enylamine, dibut-2-enylamine, n-hex-2-enylamine, propylenediamine, trimethylamine, triethylamine, tri-n-propylamine, triisopropylamine, tri-n-butylamine, triisobutylamine, tri-sec-butylamine, tri-n-amylamine, methoxyethylamine and ethoxyethylamine; heterocyclic amines, for example pyridine, quinoline, isoquinoline, morpholine, piperidine, pyrrolidine, indoline, quinuclidine and azepine; primary arylamines, for example anilines, methoxyanilines, ethoxyanilines, o-, m- and p-toluidines, phenylenediamines, benzidines, naphthylamines and o-, m- and p-chloroanilines; but especially triethylamine, isopropylamine and diisopropylamine. 
     Preferred quaternary ammonium bases suitable for salt formation correspond, for example, to the formula [N(R a1 R b1 R c1 R d1 )]OH wherein R a1 , R b1 , R c1  and R d1  are each independently of the others C 1 -C 4 alkyl. Further suitable tetraalkylammonium bases with other anions can be obtained, for example, by anion exchange reactions. 
     The compounds of the invention may be made by a variety of methods. 
     For example, the compounds of formula I, wherein the substituents have the meanings assigned to them above, can be prepared by means of processes known per se, e.g. by treating compounds of formula II with an alkylating, acylating, phosphorylating or sulfonylating agent G-Q in the presence of at least one equivalent of a base, where G is the alkyl, acyl, phosphoryl or sulfonyl group to be incorporated and Q is a nucleofuge: 
     
       
         
         
             
             
         
       
     
     Compounds of formula I, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above and wherein G is a latentiating group of the formula —C(X a )—R a , C(X b )—X c —R b  or —C(X d )—NR c R d  may be prepared by procedures known in the art. Typically, compounds of formula II, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  areas defined above, are treated with an acylating agent such as an acid halide (especially acid chloride), acid anhydride, haloformate (especially chloroformate), halothioformate (especially chlorothioformate), isocyanate, isothiocycanate, carbamoyl halide (especially carbamoyl chloride) or thiocarbamoyl chloride (especially thiocarbamoyl chloride) in the presence of at least one equivalent of a suitable base, optionally in the presence of a suitable solvent. The base may be inorganic such as an alkali metal carbonate or hydroxide or a metal hydride, or an organic base such as a tertiary amine or metal alkoxide. Examples of suitable inorganic bases include sodium carbonate, sodium or potassium hydroxide, sodium hydride, and suitable organic bases include trialkylamines such as trimethylamine and triethylamine, pyridines or other amine bases such as 1,4-diazobicyclo[2.2.2]octane and 1,8-diazabicyclo[5.4.0]undec-7-ene. Preferred bases include triethylamine and pyridine. Suitable solvents for this reaction are selected to be compatible with the reagents and include ethers such as tetrahydrofuran and 1,2-dimethoxyethane and halogenated solvents such as dichloromethane and chloroform. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. For cases, where the acylating agent is a carboxylic acid, acylation is preferably effected in the presence of a coupling agent such as 2-chloro-1-methylpyridinium iodide, N,N′-dicyclohexycarbodiimide, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and N,N′-carbodiimidazole, and a base such as triethylamine or pyridine in a suitable solvent such as tetrahydrofuran, dichloromethane and acetonitrile. 
     Compounds of formula I, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above and wherein G is a latentiating group of the formula C(X b )—X c —R b  or —C(X d )—NR c R d , may be also be prepared by treating compounds of formula II, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above, with phosgene or a phosgene equivalent, optionally in the presence of a solvent such as toluene or ethyl acetate, and a base and reacting the resultant chloroformate, or equivalent, with an alcohol, thiol or amine under known conditions, as described, for example, in U.S. Pat. No. 6,774,133, U.S. Pat. No. 6,555,567 and U.S. Pat. No. 6,479,489. 
     Compounds of formula I, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above and wherein G is a latentiating group of the formula —P(X e )R f R g , may be prepared from compounds of formula II, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above, using procedures described, for example, in U.S. Pat. No. 6,774,133, U.S. Pat. No. 6,555,567 and U.S. Pat. No. 6,479,489. 
     Compounds of formula I, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above and wherein G is a latentiating group of the formula —SO 2 R e , may be prepared by reaction of compounds of formula II, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above, with an alkyl or aryl sulfonyl halide, preferably in the presence of at least one equivalent of base. 
     Compounds of formula I, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above and wherein G is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 3 -C 6 alkynyl or a latentiating group of the formula CH 2 —X f —R h , may be prepared by treatment of a compound of formula II, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above, with a compound of formula G-Y wherein Y is a halogen (especially bromine or iodine), sulfonate (especially mesylate or tosylate) or a sulfate preferably in the presence of a base, under known conditions. 
     Compounds of formula III, in which X, Y, Z, m, n, R 1 , R 2  and R 4  and G are as defined above, 
                         
can be obtained by catalytic hydrogenation of compounds of formula I, in which X, Y, Z, m, n, R 1 , R 2  and R 4  and G are as defined above and in which R3 is represented by a benzyl group.
 
     
       
         
         
             
             
         
       
     
     Compounds of formula I, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  and G are as defined above, can be obtained by treating compounds of formula III, in which X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  and G are as defined above, with an alkylating agent R 3 -Q, wherein R 3  represents the alkyl group to be incorporated and Q represents a nucleofuge, in the presence of at least one equivalent of a base, and optionally in the presence of a suitable solvent. 
     Compounds of formula II may be prepared via the cyclisation of compounds of formula IV, 
                         
wherein R 14  is C 1-6 alkyl, preferably in the presence of base, and optionally in the presence of a suitable solvent, by known methods described, for example, in WO 09/049,851. X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above.
 
     
       
         
         
             
             
         
       
     
     Compounds of formula IV may be prepared by reacting piperidine-4-carboxylic acid derivatives of formula V with phenylacetyl halides of formula VI, preferably in the presence of base in a suitable solvent by known methods described, for example, in WO 09/049,851. X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  and R 14  are as defined above. The base may be inorganic such as an alkali metal carbonate or hydroxide or a metal hydride, or an organic base such as a tertiary amine or metal alkoxide. Examples of suitable inorganic bases include sodium carbonate, sodium or potassium hydroxide, sodium hydride, and suitable organic bases include trialkylamines such as trimethylamine and triethylamine, pyridines or other amine bases such as 1,4-diazobicyclo[2.2.2]octane and 1,8-diazabicyclo[5.4.0]undec-7-ene. Preferred bases include triethylamine and pyridine. Suitable solvents for this reaction are selected to be compatible with the reagents and include ethers such as tetrahydrofuran and 1,2-dimethoxyethane and halogenated solvents such as dichloromethane and chloroform. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. 
     Phenylacetyl halides of formula VI, wherein Hal is Cl or Br and in which X, Y, Z, m, n are as defined above, are known compounds or can be prepared by known methods, described for example in WO 09/049,851. 
     
       
         
         
             
             
         
       
     
     Piperidine-4-carboxylic acid derivatives of the formula V, wherein R 14  is C 1 -C 6 alkyl, may be prepared by reacting compounds of the formula VII with an alcohol of the formula R 14 OH, wherein R 14  is C 1 -C 6 alkyl, preferably in the presence of a strong acid (especially sulfuric acid or hydrochloric acid), under known conditions. For the particular situation where R 14  is methyl, a compound of the formula VII may also be treated with acetyl chloride in methanol. R 1 , R 2 , R 3  and R 4  are as defined above. 
     Piperidine-4-carboxylic acid derivatives of the formula V, wherein R 14  is C 1 -C 6 alkyl, can also be prepared by known methods from acids of formula VIII. Esterification of VIII with an alcohol of the formula R 14 OH, wherein R 14  is C 1 -C 6 alkyl, under thionyl chloride activation is a typical example for the preparation of esters V. 
     
       
         
         
             
             
         
       
     
     Acids of formula VIII can be prepared from hydrazones of formula X by means of Strecker-type chemistry via nitriles of formula VII. Hydrolysis of nitriles of formula VII into acids of formula VIII is typically performed with water under acidic conditions, for example in presence of hydrochloric acid. Nitriles of formula VII can be prepared from hydrazones of formula X by a number of methods, for example by treatment with hydrocyanic acid. Other sources of cyanide are, for example, potassium or sodium cyanide, possibly in presence of acetic acid (in situ generation of HCN), optionally in presence of ammonium chloride, or trimethylsilyl cyanide, acetone cyanohydrin or diethylaluminum cyanide, optionally in presence of a Lewis acid, like for example, zinc chloride, zinc iodide, titanium chloride, titanium isopropoxide, ytterbium isopropoxide, magnesium bromide, boron trifluoride ethyl etherate, tetrachlorosilane or equivalents thereof. R 1 , R 2 , R 3  and R 4  are as defined above. Of particular interest is the uncatalyzed Strecker-type reaction of the hydrazones X with trimethylsilyl cyanide in polar solvents like for example, but not limited to, water, methanol or ethanol as described by E. Marques-Lopez et al., Eur. J. Org. Chem. 2008, 3457-3460. 
     Hydrazone compounds of formula X, wherein R 1 , R 2 , R 3  and R 4  are as defined above, can be made by methods known per se from ketones Xa and hydrazines Xb. R 1 , R 2 , R 3  and R 4  are as defined above. 
     Compounds of formula Xa, wherein R 3  and R 4  are as defined above, are known or can be obtained, for example, according to methods described in Journal of Medicinal &amp; Pharmaceutical Chemistry, 4, 423-36; 1961. 
     Compounds of formula Xb, wherein R 1  and R 2  are as defined above, are known, or can be obtained by methods known to a person skilled in the art. 
     
       
         
         
             
             
         
       
     
     Alternatively, compounds of formula IV, wherein R 14  is C 1 -C 6 alkyl, may be prepared by subjecting nitrile derivatives of formula XI to alcoholysis with R 14 OH, preferably in acidic media (especially sulfuric acid or hydrochloric acid) by known methods described, for example, in WO 09/049,851. X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  are as defined above. 
     Nitrile compounds of formula XI may be themselves prepared by reacting cyanohydrazines of formula VII with phenylacetyl halides of formula VI, preferably in the presence of base in a suitable solvent by known methods described, for example, in WO 09/049,851. X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  areas defined above. The base may be inorganic such as an alkali metal carbonate or hydroxide or a metal hydride, or an organic base such as a tertiary amine or metal alkoxide. Examples of suitable inorganic bases include sodium carbonate, sodium or potassium hydroxide, sodium hydride, and suitable organic bases include trialkylamines such as trimethylamine and triethylamine, pyridines or other amine bases such as 1,4-diazobicyclo[2.2.2]octane and 1,8-diazabicyclo[5.4.0]undec-7-ene. Preferred bases include triethylamine and pyridine. Suitable solvents for this reaction are selected to be compatible with the reagents and include ethers such as tetrahydrofuran and 1,2-dimethoxyethane and halogenated solvents such as dichloromethane and chloroform. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. 
     Compounds of the formula IV, V, VII, VIII, X and XI, and salts thereof, are novel, have been specifically designed for the synthesis of the compounds of the formula I and as such form a further aspect of the invention. Thus, compounds of the formula IV 
                         
and salts thereof, wherein X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4 have the meanings assigned to them above and R 14  is C 1-6 alkyl;
 
compounds of the formula V
 
                         
and salts thereof, wherein R 1 , R 2 , R 3  and R 4 have the meanings assigned to them above and R 14  is C 1 -C 6 alkyl;
 
compounds of the formula VIII
 
                         
and salts thereof, wherein R 1 , R 2 , R 3  and R 4  have the meanings assigned to them above; compounds of the formula XI
 
                         
and salts thereof, wherein X, Y, Z, m, n, R 1 , R 2 , R 3  and R 4  have the meanings assigned to them above;
 
compounds of the formula VII
 
                         
and salts thereof, wherein R 1 , R 2 , R 3  and R 4  have the meanings assigned to them above; and
 
compounds of the formula X
 
                         
and salts thereof, wherein R 1 , R 2 , R 3  and R 4  have the meanings assigned to them above are novel.
 
     The remaining starting compounds and intermediates of the reaction schemes are known or can be prepared according to methods known to a person skilled in the art. 
     The reactants can be reacted in the presence of a base. Examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines. Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). 
     The reactants can be reacted with each other as such, i.e. without adding a solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture of these. If the reaction is carried out in the presence of a base, bases which are employed in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also act as solvents or diluents. 
     The reaction is advantageously carried out in a temperature range from approximately −80° C. to approximately +140° C., preferably from approximately −30° C. to approximately +100° C., in many cases in the range between ambient temperature and approximately +80° C. 
     The compounds of the formula I, wherein A is sulphur, can be prepared using methods similar to those shown above or methods generally known in the art. 
     A compound I can be converted in a manner known per se into another compound I by replacing one or more substituents of the starting compound I in the customary manner by (an) other substituent(s) according to the invention. 
     Depending on the choice of the reaction conditions and starting materials which are suitable in each case, it is possible, for example, in one reaction step only to replace one substituent by another substituent according to the invention, or a plurality of substituents can be replaced by other substituents according to the invention in the same reaction step. 
     Salts of compounds I can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds I are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent. 
     Salts of compounds I can be converted in the customary manner into the free compounds I, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent. 
     Salts of compounds I can be converted in a manner known per se into other salts of compounds I, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture. 
     Depending on the procedure or the reaction conditions, the compounds I, which have salt-forming properties can be obtained in free form or in the form of salts. 
     The compounds I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case. 
     Diastereomer mixtures or racemate mixtures of compounds I, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography. 
     Enantiomer mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl cellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be set free by the action of suitable agents, for example basic agents. 
     Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry. 
     It is advantageous to isolate or synthesize in each case the biologically more effective isomer, for example enantiomer or diastereomer, or isomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity. 
     The compounds I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form. 
     The compounds according to the following Tables 1 to 60 below can be prepared according to the methods described above. The examples which follow are intended to illustrate the invention and show preferred compounds of formula I. 
     
       
         
           
               
             
               
                 TABLE 1 
               
             
            
               
                   
               
               
                 This table discloses the 132 compounds T1.001 to T1.132 of the 
               
               
                 formula Ia: 
               
            
           
           
               
               
            
               
                   
                 (Ia) 
               
               
                 
                   
                     
                     
                         
                         
                     
                   
                 
                   
               
               
                   
               
            
           
           
               
            
               
                 wherein R 3  is CH 3 , R 4  is CH 3 , A is N(CH 3 ) 2 , G is hydrogen and R a , R b ,  
               
               
                 R c  and R d  are as defined below: 
               
            
           
           
               
               
               
               
               
            
               
                 No. 
                 R a   
                 R b   
                 R c   
                 R d   
               
               
                   
               
               
                 T1.001 
                 Br 
                 H 
                 H 
                 H 
               
               
                 T1.002 
                 Cl 
                 H 
                 H 
                 H 
               
               
                 T1.003 
                 CH 3   
                 H 
                 H 
                 H 
               
               
                 T1.004 
                 CH 2 CH 3   
                 H 
                 H 
                 H 
               
               
                 T1.005 
                 OCH 3   
                 H 
                 H 
                 H 
               
               
                 T1.006 
                 Br 
                 Cl 
                 H 
                 H 
               
               
                 T1.007 
                 Cl 
                 Br 
                 H 
                 H 
               
               
                 T1.008 
                 Cl 
                 Cl 
                 H 
                 H 
               
               
                 T1.009 
                 Cl 
                 CH 3   
                 H 
                 H 
               
               
                 T1.010 
                 CH 3   
                 Cl 
                 H 
                 H 
               
               
                 T1.011 
                 CH 3   
                 CH 3   
                 H 
                 H 
               
               
                 T1.012 
                 Cl 
                 H 
                 Cl 
                 H 
               
               
                 T1.013 
                 Cl 
                 H 
                 CH 3   
                 H 
               
               
                 T1.014 
                 Cl 
                 H 
                 CH 2 CH 3   
                 H 
               
               
                 T1.015 
                 Cl 
                 H 
                 OCH 3   
                 H 
               
               
                 T1.016 
                 CH 3   
                 H 
                 CH 3   
                 H 
               
               
                 T1.017 
                 CH 3   
                 H 
                 CH 2 CH 3   
                 H 
               
               
                 T1.018 
                 CH 3   
                 H 
                 OCH 3   
                 H 
               
               
                 T1.019 
                 CH 2 CH 3   
                 H 
                 CH 2 CH 3   
                 H 
               
               
                 T1.020 
                 CH 2 CH 3   
                 H 
                 OCH 3   
                 H 
               
               
                 T1.021 
                 OCH 3   
                 H 
                 OCH 3   
                 H 
               
               
                 T1.022 
                 Br 
                 H 
                 H 
                 Cl 
               
               
                 T1.023 
                 Br 
                 H 
                 H 
                 CH 3   
               
               
                 T1.024 
                 Br 
                 H 
                 H 
                 4-Cl—C 6 H 4   
               
               
                 T1.025 
                 Cl 
                 H 
                 H 
                 Cl 
               
               
                 T1.026 
                 Cl 
                 H 
                 H 
                 CH 3   
               
               
                 T1.027 
                 Cl 
                 H 
                 H 
                 4-Cl—C 6 H 4   
               
               
                 T1.028 
                 CH 3   
                 H 
                 H 
                 Br 
               
               
                 T1.029 
                 CH 3   
                 H 
                 H 
                 Cl 
               
               
                 T1.030 
                 CH 3   
                 H 
                 H 
                 CH 3   
               
               
                 T1.031 
                 CH 3   
                 H 
                 H 
                 C 6 H 5   
               
               
                 T1.032 
                 CH 3   
                 H 
                 H 
                 4-Cl—C 6 H 4   
               
               
                 T1.033 
                 CH 2 CH 3   
                 H 
                 H 
                 CH 3   
               
               
                 T1.034 
                 CH 2 CH 3   
                 H 
                 H 
                 4-Cl—C 6 H 4   
               
               
                 T1.035 
                 OCH 3   
                 H 
                 H 
                 CH 3   
               
               
                 T1.036 
                 OCH 3   
                 H 
                 H 
                 4-Cl—C 6 H 4   
               
               
                 T1.037 
                 Cl 
                 H 
                 Cl 
                 Br 
               
               
                 T1.038 
                 CH 3   
                 H 
                 CH 3   
                 Br 
               
               
                 T1.039 
                 CH 3   
                 H 
                 CH 3   
                 Cl 
               
               
                 T1.040 
                 CH 3   
                 H 
                 CH 3   
                 4-Cl—C 6 H 4   
               
               
                 T1.041 
                 Br 
                 Cl 
                 H 
                 CH 3   
               
               
                 T1.042 
                 Br 
                 CH 3   
                 H 
                 CH 3   
               
               
                 T1.043 
                 Cl 
                 Cl 
                 H 
                 Cl 
               
               
                 T1.044 
                 Cl 
                 Br 
                 H 
                 CH 3   
               
               
                 T1.045 
                 Cl 
                 Cl 
                 H 
                 CH 3   
               
               
                 T1.046 
                 Cl 
                 CH 3   
                 H 
                 Cl 
               
               
                 T1.047 
                 Cl 
                 CH 3   
                 H 
                 CH 3   
               
               
                 T1.048 
                 CH 3   
                 Br 
                 H 
                 CH 3   
               
               
                 T1.049 
                 CH 3   
                 Cl 
                 H 
                 CH 3   
               
               
                 T1.050 
                 CH 3   
                 CH 3   
                 H 
                 CH 3   
               
               
                 T1.051 
                 CH 3   
                 CH 3   
                 H 
                 4-Cl—C 6 H 4   
               
               
                 T1.052 
                 Br 
                 Br 
                 CH 3   
                 H 
               
               
                 T1.053 
                 Br 
                 Cl 
                 CH 3   
                 H 
               
               
                 T1.054 
                 Br 
                 CH 3   
                 Br 
                 H 
               
               
                 T1.055 
                 Br 
                 CH 3   
                 Cl 
                 H 
               
               
                 T1.056 
                 Cl 
                 Br 
                 CH 3   
                 H 
               
               
                 T1.057 
                 Cl 
                 Cl 
                 Cl 
                 H 
               
               
                 T1.058 
                 Cl 
                 Cl 
                 CH 3   
                 H 
               
               
                 T1.059 
                 Cl 
                 CH 3   
                 Cl 
                 H 
               
               
                 T1.060 
                 Cl 
                 CH 3   
                 CH 2 CH 3   
                 H 
               
               
                 T1.061 
                 Cl 
                 CH 3   
                 OCH 3   
                 H 
               
               
                 T1.062 
                 Cl 
                 4-Cl—C 6 H 4   
                 Cl 
                 H 
               
               
                 T1.063 
                 Cl 
                 4-Cl—C 6 H 4   
                 CH 3   
                 H 
               
               
                 T1.064 
                 Cl 
                 4-Cl—C 6 H 4   
                 CH 2 CH 3   
                 H 
               
               
                 T1.065 
                 Cl 
                 4-Cl—C 6 H 4   
                 OCH 3   
                 H 
               
               
                 T1.066 
                 CH 3   
                 Br 
                 CH 3   
                 H 
               
               
                 T1.067 
                 CH 3   
                 Cl 
                 CH 3   
                 H 
               
               
                 T1.068 
                 CH 3   
                 CH 3   
                 Br 
                 H 
               
               
                 T1.069 
                 CH 3   
                 CH 3   
                 Cl 
                 H 
               
               
                 T1.070 
                 CH 3   
                 CH 3   
                 CH 3   
                 H 
               
               
                 T1.071 
                 CH 3   
                 CH 3   
                 CH 2 CH 3   
                 H 
               
               
                 T1.072 
                 CH 3   
                 CH 3   
                 OCH 3   
                 H 
               
               
                 T1.073 
                 CH 3   
                 4-Cl—C 6 H 4   
                 CH 3   
                 H 
               
               
                 T1.074 
                 CH 3   
                 4-Cl—C 6 H 4   
                 CH 2 CH 3   
                 H 
               
               
                 T1.075 
                 CH 3   
                 4-Cl—C 6 H 4   
                 OCH 3   
                 H 
               
               
                 T1.076 
                 CH 2 CH 3   
                 Br 
                 Br 
                 H 
               
               
                 T1.077 
                 CH 2 CH 3   
                 Br 
                 Cl 
                 H 
               
               
                 T10.78 
                 CH 2 CH 3   
                 Br 
                 CH 3   
                 H 
               
               
                 T1.079 
                 CH 2 CH 3   
                 Br 
                 CH 2 CH 3   
                 H 
               
               
                 T1.080 
                 CH 2 CH 3   
                 Br 
                 OCH 3   
                 H 
               
               
                 T1.081 
                 CH 2 CH 3   
                 Cl 
                 Br 
                 H 
               
               
                 T1.082 
                 CH 2 CH 3   
                 Cl 
                 Cl 
                 H 
               
               
                 T1.083 
                 CH 2 CH 3   
                 Cl 
                 CH 3   
                 H 
               
               
                 T1.084 
                 CH 2 CH 3   
                 Cl 
                 CH 2 CH 3   
                 H 
               
               
                 T1.085 
                 CH 2 CH 3   
                 Cl 
                 OCH 3   
                 H 
               
               
                 T1.086 
                 CH 2 CH 3   
                 CH 3   
                 Br 
                 H 
               
               
                 T1.087 
                 CH 2 CH 3   
                 CH 3   
                 Cl 
                 H 
               
               
                 T1.088 
                 CH 2 CH 3   
                 CH 3   
                 CH 2 CH 3   
                 H 
               
               
                 T1.089 
                 CH 2 CH 3   
                 CH 3   
                 OCH 3   
                 H 
               
               
                 T1.090 
                 CH 2 CH 3   
                 CH 2 CH 3   
                 CH 3   
                 H 
               
               
                 T1.091 
                 CH 2 CH 3   
                 CH 2 CH 3   
                 CH 2 CH 3   
                 H 
               
               
                 T1.092 
                 CH 2 CH 3   
                 4-Cl—C 6 H 4   
                 Br 
                 H 
               
               
                 T1.093 
                 CH 2 CH 3   
                 4-Cl—C 6 H 4   
                 CH 2 CH 3   
                 H 
               
               
                 T1.094 
                 CH 2 CH 3   
                 4-Cl—C 6 H 4   
                 OCH 3   
                 H 
               
               
                 T1.095 
                 OCH 3   
                 Br 
                 CH 3   
                 H 
               
               
                 T1.096 
                 OCH 3   
                 Cl 
                 CH 3   
                 H 
               
               
                 T1.097 
                 OCH 3   
                 CH 3   
                 Br 
                 H 
               
               
                 T1.098 
                 OCH 3   
                 CH 3   
                 Cl 
                 H 
               
               
                 T1.099 
                 OCH 3   
                 CH 3   
                 OCH 3   
                 H 
               
               
                 T1.100 
                 OCH 3   
                 4-Cl—C 6 H 4   
                 OCH 3   
                 H 
               
               
                 T1.101 
                 CH 3   
                 CH 3   
                 CH 3   
                 F 
               
               
                 T1.102 
                 CH 3   
                 CH 3   
                 CH 3   
                 Cl 
               
               
                 T1.103 
                 CH 3   
                 CH 3   
                 CH 3   
                 Br 
               
               
                 T1.104 
                 CH 3   
                 CH 3   
                 CH 3   
                 CH 3   
               
               
                 T1.105 
                 CH 3   
                 CH 3   
                 CH 3   
                 4-Cl—C 6 H 4   
               
               
                 T1.106 
                 Cl 
                 CH 3   
                 CH 3   
                 CH 3   
               
               
                 T1.107 
                 CH 3   
                 Cl 
                 CH 3   
                 CH 3   
               
               
                 T1.108 
                 CH 3   
                 CH 3   
                 Cl 
                 CH 3   
               
               
                 T1.109 
                 CH 2 CH 3   
                 CH 3   
                 CH 3   
                 CH 3   
               
               
                 T1.110 
                 OCH 3   
                 CH 3   
                 CH 3   
                 CH 3   
               
               
                 T1.111 
                 Cylco-C3 
                 CH 3   
                 CH 3   
                 CH 3   
               
               
                 T1.112 
                 CH 3   
                 CH 3   
                 Cyclo-C3 
                 H 
               
               
                 T1.113 
                 CH 3   
                 F 
                 H 
                 Br 
               
               
                 T1.114 
                 CH 3   
                 CH 3   
                 H 
                 Br 
               
               
                 T1.115 
                 CH 2 CH 3   
                 CH 3   
                 H 
                 CH 3   
               
               
                 T1.116 
                 OCH 3   
                 CH 3   
                 H 
                 CH 3   
               
               
                 T1.117 
                 Cyclo-C3 
                 CH 3   
                 H 
                 CH 3   
               
               
                 T1.118 
                 CH 2 CH 3   
                 Cl 
                 H 
                 CH 3   
               
               
                 T1.119 
                 OCH 3   
                 Cl 
                 H 
                 CH 3   
               
               
                 T1.120 
                 Cyclo-C3 
                 Cl 
                 H 
                 CH 3   
               
               
                 T1.121 
                 Cl 
                 H 
                 CH 3   
                 CH 3   
               
               
                 T1.122 
                 CH 3   
                 H 
                 CH 3   
                 CH 3   
               
               
                 T1.123 
                 CH 2 CH 3   
                 H 
                 CH 3   
                 CH 3   
               
               
                 T1.124 
                 OCH 3   
                 H 
                 CH 3   
                 CH 3   
               
               
                 T1.125 
                 Cyclo-C3 
                 H 
                 CH 3   
                 CH 3   
               
               
                 T1.126 
                 F 
                 H 
                 Cl 
                 CH 3   
               
               
                 T1.127 
                 Cl 
                 H 
                 F 
                 CH 3   
               
               
                 T1.128 
                 H 
                 CH 3   
                 CH 3   
                 CH 3   
               
               
                 T1.129 
                 Br 
                 CH 3   
                 CH 3   
                 CH 3   
               
               
                 T1.130 
                 CH 3   
                 H 
                 Cl 
                 CH 3   
               
               
                 T1.131 
                 CH 3   
                 H 
                 Br 
                 CH 3   
               
               
                 T1.132 
                 Br 
                 H 
                 CH 3   
                 CH 3   
               
               
                   
               
               
                 Cyclo-C3 means cyclopropyl. 
               
            
           
         
       
     
     Table 2: This table discloses the 132 compounds T2.001 to T2.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is N(CH 3 ) 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 3: This table discloses the 132 compounds T3.001 to T3.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is N(CH 3 ) 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 4: This table discloses the 132 compounds T4.001 to T4.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is N(CH 3 ) 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 5: This table discloses the 132 compounds T5.001 to T5.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is N(CH 3 ) 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 6: This table discloses the 132 compounds T6.001 to T6.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is N(CH 3 ) 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 7: This table discloses the 132 compounds T7.001 to T7.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is NH 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 8: This table discloses the 132 compounds T8.001 to T8.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is NH 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 9: This table discloses the 132 compounds T9.001 to T9.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is NH 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 10: This table discloses the 132 compounds T10.001 to T10.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is NH 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 11: This table discloses the 132 compounds T11.001 to T11.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is NH 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 12: This table discloses the 132 compounds T12.001 to T12.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is NH 2 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 13: This table discloses the 132 compounds T13.001 to T13.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is morpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 14: This table discloses the 132 compounds T14.001 to T14.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is morpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 15: This table discloses the 132 compounds T15.001 to T15.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is morpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 16: This table discloses the 132 compounds T16.001 to T16.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is morpholin-4-yl, G is hydrogen and R- a , R b , R c  and R d  are as defined in Table 1. 
     Table 17: This table discloses the 132 compounds T17.001 to T17.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is morpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 18: This table discloses the 132 compounds T18.001 to T18.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is morpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 19: This table discloses the 132 compounds T19.001 to T19.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is pyrrol-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 20: This table discloses the 132 compounds T20.001 to T20.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is pyrrol-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 21: This table discloses the 132 compounds T21.001 to T21.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is pyrrol-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 22: This table discloses the 132 compounds T22.001 to T22.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is pyrrol-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 23: This table discloses the 132 compounds T23.001 to T23.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is pyrrol-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 24: This table discloses the 132 compounds T24.001 to T24.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is pyrrol-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 25: This table discloses the 132 compounds T25.001 to T25.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is NHC(O)OCH 2 CH 3 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 26: This table discloses the 132 compounds T26.001 to T26.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is NHC(O)OCH 2 CH 3 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 27: This table discloses the 132 compounds T27.001 to T27.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is NHC(O)OCH 2 CH 3 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 28: This table discloses the 132 compounds T28.001 to T28.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is NHC(O)OCH 2 CH 3 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 29: This table discloses the 132 compounds T29.001 to T29.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is NHC(O)OCH 2 CH 3 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 30: This table discloses the 132 compounds T30.001 to T30.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is NHC(O)OCH 2 CH 3 , G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 31: This table discloses the 132 compounds T31.001 to T31.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is N(CH 3 ) 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 32: This table discloses the 132 compounds T32.001 to T32.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is N(CH 3 ) 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 33: This table discloses the 132 compounds T33.001 to T33.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is N(CH 3 ) 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 34: This table discloses the 132 compounds T34.001 to T34.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is N(CH 3 ) 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 35: This table discloses the 132 compounds T35.001 to T35.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is N(CH 3 ) 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 36: This table discloses the 132 compounds T36.001 to T36.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is N(CH 3 ) 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 37: This table discloses the 132 compounds T37.001 to T37.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is NH 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 38: This table discloses the 132 compounds T38.001 to T38.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is NH 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 39: This table discloses the 132 compounds T39.001 to T39.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is NH 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 40: This table discloses the 132 compounds T40.001 to T40.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is NH 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 41: This table discloses the 132 compounds T41.001 to T41.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is NH 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 42: This table discloses the 132 compounds T42.001 to T42.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is NH 2 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 43: This table discloses the 132 compounds T43.001 to T43.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is morpholin-4-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 44: This table discloses the 132 compounds T44.001 to T44.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is morpholin-4-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 45: This table discloses the 132 compounds T45.001 to T45.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is morpholin-4-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 46: This table discloses the 132 compounds T46.001 to T46.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is morpholin-4-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 47: This table discloses the 132 compounds T47.001 to T47.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is morpholin-4-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 48: This table discloses the 132 compounds T48.001 to T48.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is morpholin-4-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 49: This table discloses the 132 compounds T49.001 to T49.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is pyrrol-1-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 50: This table discloses the 132 compounds T50.001 to T50.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is pyrrol-1-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 51: This table discloses the 132 compounds T51.001 to T51.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is pyrrol-1-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 52: This table discloses the 132 compounds T52.001 to T52.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is pyrrol-1-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 53: This table discloses the 132 compounds T53.001 to T53.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is pyrrol-1-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 54: This table discloses the 132 compounds T54.001 to T54.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is pyrrol-1-yl, G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 55: This table discloses the 132 compounds T55.001 to T55.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is NHC(O)OCH 2 CH 3 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 56: This table discloses the 132 compounds T56.001 to T56.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is NHC(O)OCH 2 CH 3 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 57: This table discloses the 132 compounds T57.001 to T57.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is NHC(O)OCH 2 CH 3 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 58: This table discloses the 132 compounds T58.001 to T58.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is NHC(O)OCH 2 CH 3 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 59: This table discloses the 132 compounds T59.001 to T59.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is NHC(O)OCH 2 CH 3 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 60: This table discloses the 132 compounds T60.001 to T60.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is NHC(O)OCH 2 CH 3 , G is ethoxycarbonyl and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 61: This table discloses the 132 compounds T61.001 to T61.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is 1,1-dioxo-1λ 6 -thiomorpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 62: This table discloses the 132 compounds T62.001 to T62.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is 1,1-dioxo-1λ 6 -thiomorpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 63: This table discloses the 132 compounds T63.001 to T63.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is 1,1-dioxo-1λ 6 -thiomorpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 64: This table discloses the 132 compounds T64.001 to T64.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is 1,1-dioxo-1λ 6 -thiomorpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 65: This table discloses the 132 compounds T65.001 to T65.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is 1,1-dioxo-1λ 6 -thiomorpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 66: This table discloses the 132 compounds T66.001 to T66.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is 1,1-dioxo-1λ 6 -thiomorpholin-4-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 67: This table discloses the 132 compounds T67.001 to T67.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is pyrrolidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 68: This table discloses the 132 compounds T68.001 to T68.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is pyrrolidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 69: This table discloses the 132 compounds T69.001 to T69.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is pyrrolidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 70: This table discloses the 132 compounds T70.001 to T70.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is pyrrolidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 71: This table discloses the 132 compounds T71.001 to T71.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is pyrrolidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 72: This table discloses the 132 compounds T72.001 to T72.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is pyrrolidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 73: This table discloses the 132 compounds T73.001 to T73.132 of the formula Ia, wherein R 3  is CH 3 , R 4  is CH 3 , A is piperidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 74: This table discloses the 132 compounds T74.001 to T74.132 of the formula Ia, wherein R 3  is H, R 4  is H, A is piperidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 75: This table discloses the 132 compounds T75.001 to T75.132 of the formula Ia, wherein R 3  and R 4  together are CH 2 CH 2 OCH 2 CH 2 , A is piperidin-1-yl, G is hydrogen and R- a , R b , R c  and R d  are as defined in Table 1. 
     Table 76: This table discloses the 132 compounds T76.001 to T76.132 of the formula Ia, wherein R 3  and R 4  together are CH═CH—CH═CH, A is piperidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 77: This table discloses the 132 compounds T77.001 to T77.132 of the formula Ia, wherein R 3  is hydrogen, R 4  is ethoxycarbonyl, A is piperidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     Table 78: This table discloses the 132 compounds T78.001 to T78.132 of the formula Ia, wherein R 3  is benzyl, R 4  is benzyl, A is piperidin-1-yl, G is hydrogen and R a , R b , R c  and R d  are as defined in Table 1. 
     The compounds according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants. The active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina. The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i.e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate, a good activity corresponding to a destruction rate (mortality) of at least 50 to 60%. 
     The compounds of formula I can be used to combat and control infestations of insect pests such as Lepidoptera, Diptera, Hemiptera, Thysanoptera, Orthoptera, Dictyoptera, Coleoptera, Siphonaptera, Hymenoptera and Isoptera and also other invertebrate pests, for example, acarine, nematode and mollusc pests. Insects, acarines, nematodes and molluscs are hereinafter collectively referred to as pests. The pests which may be combated and controlled by the use of the invention compounds include those pests associated with agriculture (which term includes the growing of crops for food and fibre products), horticulture and animal husbandry, companion animals, forestry and the storage of products of vegetable origin (such as fruit, grain and timber); those pests associated with the damage of man-made structures and the transmission of diseases of man and animals; and also nuisance pests (such as flies). 
     Examples of pest species which may be controlled by the compounds of formula I include:  Myzus persicae  (aphid),  Aphis gossypii  (aphid),  Aphis fabae  (aphid),  Lygus  spp. (capsids),  Dysdercus  spp. (capsids),  Nilaparvata lugens  (planthopper),  Nephotettixc incticeps  (leafhopper),  Nezara  spp. (stinkbugs),  Euschistus  spp. (stinkbugs),  Leptocorisa  spp. (stinkbugs),  Frankliniella occidentalis  (thrip),  Thrips  spp. (thrips),  Leptinotarsa decemlineata  (Colorado potato beetle),  Anthonomus grandis  (boll weevil),  Aonidiella  spp. (scale insects),  Trialeurodes  spp. (white flies),  Bemisia tabaci  (white fly),  Ostrinia nubilalis  (European corn borer),  Spodoptera littoralis  (cotton leafworm),  Heliothis virescens  (tobacco budworm),  Helicoverpa armigera  (cotton bollworm),  Helicoverpa zea  (cotton bollworm),  Sylepta derogata  (cotton leaf roller),  Pieris brassicae  (white butterfly),  Plutella xylostella  (diamond back moth),  Agrotis  spp. (cutworms),  Chilo suppressalis  (rice stem borer),  Locusta migratoria  (locust),  Chortiocetes terminifera  (locust),  Diabrotica  spp. (rootworms),  Panonychus ulmi  (European red mite),  Panonychus citri  (citrus red mite),  Tetranychus urticae  (two-spotted spider mite),  Tetranychus cinnabarinus  (carmine spider mite),  Phyllocoptruta oleivora  (citrus rust mite),  Polyphagotarsonemus latus  (broad mite),  Brevipalpus  spp. (flat mites),  Boophilus microplus  (cattle tick),  Dermacentor variabilis  (American dog tick),  Ctenocephalides felis  (cat flea),  Liriomyza  spp. (leafminer),  Musca domestica  (housefly),  Aedes aegypti  (mosquito),  Anopheles  spp. (mosquitoes),  Culex  spp. (mosquitoes),  Lucillia  spp. (blowflies),  Blattella germanica  (cockroach),  Periplaneta americana  (cockroach),  Blatta orientalis  (cockroach), termites of the  Mastotermitidae  (for example  Mastotermes  spp.), the  Kalotermitidae  (for example  Neotermes  spp.), the  Rhinotermitidae  (for example  Coptotermes formosanus, Reticulitermes flavipes, R. speratu, R. virginicus, R. hesperus , and  R. santonensis ) and the  Termitidae  (for example  Globitermes sulphureus ),  Solenopsis geminata  (fire ant),  Monomorium pharaonis  (pharaoh&#39;s ant),  Damalinia  spp. and  Linognathus  spp. (biting and sucking lice),  Meloidogyne  spp. (root knot nematodes),  Globodera  spp. and  Heterodera  spp. (cyst nematodes),  Pratylenchus  spp. (lesion nematodes),  Rhodopholus  spp. (banana burrowing nematodes),  Tylenchulus  spp. (citrus nematodes),  Haemonchus contortus  (barber pole worm),  Caenorhabditis elegans  (vinegar eelworm),  Trichostrongylus  spp. (gastro intestinal nematodes) and  Deroceras reticulatum  (slug). 
     Further examples of the above mentioned pests are: 
     from the order Acarina, for example, 
       Acarus siro, Aceria sheldoni, Aculus schlechtendali, Amblyomma  spp.,  Argas  spp.,  Boophilus  spp.,  Brevipalpus  spp.,  Bryobia praetiosa, Calipitrimerus  spp.,  Chorioptes  spp.,  Dermanyssus gallinae, Eotetranychus carpini, Eriophyes  spp.,  Hyalomma  spp.,  Ixodes  spp.,  Olygonychus pratensis, Ornithodoros  spp.,  Panonychus  spp.,  Phyllocoptruta oleivora, Polyphagotarsonemus latus, Psoroptes  spp.,  Rhipicephalus  spp.,  Rhizoglyphus  spp.,  Sarcoptes  spp.,  Tarsonemus  spp. and  Tetranychus  spp.; 
     from the order Anoplura, for example, 
       Haematopinus  spp.,  Linognathus  spp.,  Pediculus  spp.,  Pemphigus  spp. and  Phylloxera  spp.; 
     from the order Coleoptera, for example, 
       Agriotes  spp.,  Anthonomus  spp.,  Atomaria linearis, Chaetocnema tibialis, Cosmopolites  spp.,  Curculio  spp.,  Dermestes  spp.,  Diabrotica  spp.,  Epilachna  spp.,  Eremnus  spp.,  Leptinotarsa decemLineata, Lissorhoptrus  spp.,  Melolontha  spp.,  Orycaephilus  spp.,  Otiorhynchus  spp.,  Phlyctinus  spp.,  Popillia  spp.,  Psylliodes  spp.,  Rhizopertha  spp.,  Scarabeidae, Sitophilus  spp.,  Sitotroga  spp.,  Tenebrio  spp.,  Tribolium  spp. and  Trogoderma  spp.; 
     from the order Diptera, for example, 
       Aedes  spp.,  Antherigona soccata, Bibio hortulanus, Calliphora erythrocephala, Ceratitis  spp.,  Chrysomyia  spp.,  Culex  spp.,  Cuterebra  spp.,  Dacus  spp.,  Drosophila melanogaster, Fannia  spp.,  Gastrophilus  spp.,  Glossina  spp.,  Hypoderma  spp.,  Hyppobosca  spp.,  Liriomyza  spp.,  Lucilia  spp.,  Melanagromyza  spp.,  Musca  spp.,  Oestrus  spp.,  Orseolia  spp.,  Oscinella frit, Pegomyia hyoscyami, Phorbia  spp.,  Rhagoletis pomonella, Sciara  spp.,  Stomoxys  spp.,  Tabanus  spp.,  Tannia  spp. and  Tipula  spp.; 
     from the order Heteroptera, for example, 
       Cimex  spp.,  Distantiella theobroma, Dysdercus  spp.,  Euchistus  spp.,  Eurygaster  spp.,  Leptocorisa  spp.,  Nezara  spp.,  Piesma  spp.,  Rhodnius  spp.,  Sahlbergella singularis, Scotinophara  spp. and  Triatoma  spp.; 
     from the order Homoptera, for example, 
       Aleurothrixus floccosus, Aleyrodes brassicae, Aonidiella  spp.,  Aphididae, Aphis  spp.,  Aspidiotus  spp.,  Bemisia tabaci, Ceroplaster  spp.,  Chrysomphalus aonidium, Chrysomphalus dictyospermi, Coccus hesperidum, Empoasca  spp.,  Eriosoma larigerum, Erythroneura  spp.,  Gascardia  spp.,  Laodelphax  spp.,  Lecanium corni, Lepidosaphes  spp.,  Macrosiphus  spp.,  Myzus  spp.,  Nephotettix  spp.,  Nilaparvata  spp.,  Parlatoria  spp.,  Pemphigus  spp.,  Planococcus  spp.,  Pseudaulacaspis  spp.,  Pseudococcus  spp.,  Psylla  spp.,  Pulvinaria aethiopica, Quadraspidiotus  spp.,  Rhopalosiphum  spp.,  Saissetia  spp.,  Scaphoideus  spp.,  Schizaphis  spp.,  Sitobion  spp.,  Trialeurodes vaporariorum, Trioza erytreae  and  Unaspis citri;    
     from the order Hymenoptera, for example, 
       Acromyrmex, Atta  spp.,  Cephus  spp.,  Diprion  spp.,  Diprionidae, Gilpinia polytoma, Hoplocampa  spp.,  Lasius  spp.,  Monomorium pharaonis, Neodiprion  spp.,  Solenopsis  spp. and  Vespa  spp.; 
     from the order Isoptera, for example, 
       Reticulitermes  spp.; 
     from the order Lepidoptera, for example, 
       Acleris  spp.,  Adoxophyes  spp.,  Aegeria  spp.,  Agrotis  spp.,  Alabama argillaceae, Amylois  spp.,  Anticarsia gemmatalis, Archips  spp.,  Argyrotaenia  spp.,  Autographa  spp.,  Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo  spp.,  Choristoneura  spp.,  Clysia ambiguella, Cnaphalocrocis  spp.,  Cnephasia  spp.,  Cochylis  spp.,  Coleophora  spp.,  Crocidolomia binotalis, Cryptophlebia leucotreta, Cydia  spp.,  Diatraea  spp.,  Diparopsis castanea, Earias  spp.,  Ephestia  spp.,  Eucosma  spp.,  Eupoecilia ambiguella, Euproctis  spp.,  Euxoa  spp.,  Grapholita  spp.,  Hedya nubiferana, Heliothis  spp.,  Hellula undalis, Hyphantria cunea, Keiferia lycopersicella, Leucoptera scitella, Lithocollethis  spp.,  Lobesia botrana, Lymantria  spp.,  Lyonetia  spp.,  Malacosoma  spp.,  Mamestra brassicae, Manduca sexta, Operophtera  spp.,  Ostrinia nubilalis, Pammene  spp.,  Pandemis  spp.,  Panolis flammea, Pectinophora gossypiela, Phthorimaea operculella, Pieris rapae, Pieris  spp.,  Plutella xylostella, Prays  spp.,  Scirpophaga  spp.,  Sesamia  spp.,  Sparganothis  spp.,  Spodoptera  spp.,  Synanthedon  spp.,  Thaumetopoea  spp.,  Tortrix  spp.,  Trichoplusia ni  and  Yponomeuta  spp.; 
     from the order Mallophaga, for example, 
       Damalinea  spp. and  Trichodectes  spp.; 
     from the order Orthoptera, for example, 
       Blatta  spp.,  Blattella  spp.,  Gryllotalpa  spp.,  Leucophaea maderae, Locusta  spp.,  Periplaneta  spp. and  Schistocerca  spp.; 
     from the order Psocoptera, for example, 
       Liposcelis  spp.; 
     from the order Siphonaptera, for example, 
       Ceratophyllus  spp.,  Ctenocephalides  spp. and  Xenopsylla cheopis;    
     from the order Thysanoptera, for example, 
       Frankliniella  spp.,  Hercinothrips  spp.,  Scirtothrips aurantii, Taeniothrips  spp.,  Thrips palmi  and  Thrips tabaci ; and 
     from the order Thysanura, for example, 
     
       Lepisma saccharina.  
     
     The active ingredients according to the invention can be used for controlling, i.e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests. 
     Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum; beet, such as sugar or fodder beet; fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soya; oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts; cucurbits, such as pumpkins, cucumbers or melons; fibre plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruit or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers; Lauraceae, such as avocado, Cinnamonium or camphor; and also tobacco, nuts, coffee, eggplants, sugarcane, tea, pepper, grapevines, hops, the plantain family, latex plants and ornamentals. 
     The term “crops” is to be understood as including also crops that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola). Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®. 
     The term “crops” is also to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus  Bacillus.    
     Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from  Bacillus cereus  or  Bacillus popliae ; or insecticidal proteins from  Bacillus thuringiensis , such as δ-endotoxins, e.g. CryIA(b), CryIA(c), CryIF, CryIF(a2), CryIIA(b), CryIIIA, CryIIIB(b1) or Cry9c, or vegetative insecticidal proteins (VIP), e.g. VIP1, VIP2, VIP3 or VIP3A; or insecticidal proteins of bacteria colonising nematodes, for example  Photorhabdus  spp. or  Xenorhabdus  spp., such as  Photorhabdus luminescens, Xenorhabdus nematophilus ; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsine inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases. 
     In the context of the present invention there are to be understood by δ-endotoxins, for example CryIA(b), CryIA(c), CryIF, CryIF(a2), CryIIA(b), CryIIIA, CryIIIB(b1) or Cry9c, or vegetative insecticidal proteins (VIP), for example VIP1, VIP2, VIP3 or VIP3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated CryIA(b), are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of CryIIIA055, a cathepsin-D-recognition sequence is inserted into a CryIIIA toxin (see WO 03/018810). 
     Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073. 
     The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651. 
     The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera). 
     Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CryIA(b) toxin); YieldGard Rootworm® (maize variety that expresses a CryIIIB(b1) toxin); YieldGard Plus® (maize variety that expresses a CryIA(b) and a CryIIIB(b1) toxin); Starlink® (maize variety that expresses a Cry9(c) toxin); Herculex I® (maize variety that expresses a CryIF(a2) toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CryIA(c) toxin); Bollgard (cotton variety that expresses a CryIA(c) toxin); Bollgard II® (cotton variety that expresses a CryIA(c) and a CryIIA(b) toxin); VIPCOT® (cotton variety that expresses a VIP toxin); NewLeaf® (potato variety that expresses a CryIIIA toxin); Nature-Gard® Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait) and Protecta®. 
     Further examples of such transgenic crops are: 
     1. Bt11 Maize from Syngenta Seeds SAS, Chemin de l&#39;Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified  Zea mays  which has been rendered resistant to attack by the European corn borer ( Ostrinia nubilalis  and  Sesamia nonagrioides ) by transgenic expression of a truncated CryIA(b) toxin. Bt11 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 
     2. Bt176 Maize from Syngenta Seeds SAS, Chemin de l&#39;Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified  Zea mays  which has been rendered resistant to attack by the European corn borer ( Ostrinia nubilalis  and  Sesamia nonagrioides ) by transgenic expression of a CryIA(b) toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 
     3. MIR604 Maize from Syngenta Seeds SAS, Chemin de l&#39;Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified CryIIIA toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-D-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810. 
     4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a CryIIIB(b1) toxin and has resistance to certain Coleoptera insects. 
     5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/ES/96/02. 
     6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium. 
     7. NK603×MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603×MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from  Agrobacterium  sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CryIA(b) toxin obtained from  Bacillus thuringiensis  subsp.  kurstaki  which brings about tolerance to certain Lepidoptera, include the European corn borer. 
     Transgenic crops of insect-resistant plants are also described in BATS (Zentrum für Biosicherheit and Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003. 
     The term “crops” is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called “pathogenesis-related proteins” (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818, and EP-A-0 353 191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. 
     Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1, KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; the so-called “pathogenesis-related proteins” (PRPs; see e.g. EP-A-0 392 225); antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defense (so-called “plant disease resistance genes”, as described in WO 03/000906). 
     Further areas of use of the compounds and compositions according to the invention are the protection of stored goods and storerooms and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type. 
     In the hygiene sector, the compounds and compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas. 
     Examples of such parasites are: 
     Of the order Anoplurida:  Haematopinus  spp.,  Linognathus  spp.,  Pediculus  spp. and  Phtirus  spp.,  Solenopotes  spp. 
     Of the order Mallophagida:  Trimenopon  spp.,  Menopon  spp.,  Trinoton  spp.,  Bovicola  spp.,  Werneckiella  spp.,  Lepikentron  spp.,  Damalina  spp.,  Trichodectes  spp. and  Felicola  spp. 
     Of the order Diptera and the suborders Nematocerina and Brachycerina, for example  Aedes  spp.,  Anopheles  spp.,  Culex  spp.,  Simulium  spp.,  Eusimulium  spp.,  Phlebotomus  spp.,  Lutzomyia  spp.,  Culicoides  spp.,  Chrysops  spp.,  Hybomitra  spp.,  Atylotus  spp.,  Tabanus  spp.,  Haematopota  spp.,  Philipomyia  spp.,  Braula  spp.,  Musca  spp.,  Hydrotaea  spp.,  Stomoxys  spp.,  Haematobia  spp.,  Morellia  spp.,  Fannia  spp.,  Glossina  spp.,  Calliphora  spp.,  Lucilia  spp.,  Chrysomyia  spp.,  Wohlfahrtia  spp.,  Sarcophaga  spp.,  Oestrus  spp.,  Hypoderma  spp.,  Gasterophilus  spp.,  Hippobosca  spp.,  Lipoptena  spp. and  Melophagus  spp. 
     Of the order Siphonapterida, for example  Pulex  spp.,  Ctenocephalides  spp.,  Xenopsylla  spp.,  Ceratophyllus  spp. 
     Of the order Heteropterida, for example  Cimex  spp.,  Triatoma  spp.,  Rhodnius  spp.,  Panstrongylus  spp. 
     Of the order Blattarida, for example  Blatta orientalis, Periplaneta americana, Blattelagermanica  and  Supella  spp. 
     Of the subclass Acaria (Acarida) and the orders Meta- and Meso-stigmata, for example  Argas  spp.,  Ornithodorus  spp.,  Otobius  spp.,  Ixodes  spp.,  Amblyomma  spp.,  Boophilus  spp.,  Dermacentor  spp.,  Haemophysalis  spp.,  Hyalomma  spp.,  Rhipicephalus  spp.,  Dermanyssus  spp.,  Raillietia  spp.,  Pneumonyssus  spp.,  Sternostoma  spp. and  Varroa  spp. 
     Of the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example  Acarapis  spp.,  Cheyletiella  spp.,  Ornithocheyletia  spp.,  Myobia  spp.,  Psorergates  spp.,  Demodex  spp.,  Trombicula  spp.,  Listrophorus  spp.,  Acarus  spp.,  Tyrophagus  spp.,  Caloglyphus  spp.,  Hypodectes  spp.,  Pterolichus  spp.,  Psoroptes  spp.,  Chorioptes  spp.,  Otodectes  spp.,  Sarcoptes  spp.,  Notoedres  spp.,  Knemidocoptes  spp.,  Cytodites  spp. and  Laminosioptes  spp. 
     The compounds and compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings. 
     The compositions according to the invention can be used, for example, against the following pests: beetles such as  Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus  spec.,  Tryptodendron  spec.,  Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon  spec. and  Dinoderus minutus , and also hymenopterans such as  Sirex juvencus, Urocerus gigas, Urocerus gigas taignus  and  Urocerus augur , and termites such as  Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis  and  Coptotermes formosanus , and bristletails such as  Lepisma saccharina.    
     The invention therefore provides a method of combating and controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula I, or a composition containing a compound of formula I, to a pest, a locus of pest, or to a plant susceptible to attack by a pest, The compounds of formula I are preferably used against insects or acarines. 
     The term “plant” as used herein includes seedlings, bushes and trees. 
     The invention therefore also relates to pesticidal compositions such as emulsifiable concentrates, suspension concentrates, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, soluble powders, dispersible powders, wettable powders, dusts, granules or encapsulations in polymeric substances, which comprise—at least—one of the active ingredients according to the invention and which are to be selected to suit the intended aims and the prevailing circumstances. 
     In these compositions, the active ingredient is employed in pure form, a solid active ingredient for example in a specific particle size, or, preferably, together with—at least—one of the auxiliaries conventionally used in the art of formulation, such as extenders, for example solvents or solid carriers, or such as surface-active compounds (surfactants). 
     Examples of suitable solvents are: unhydrogenated or partially hydrogenated aromatic hydrocarbons, preferably the fractions C8 to C12 of alkylbenzenes, such as xylene mixtures, alkylated naphthalenes or tetrahydronaphthalene, aliphatic or cycloaliphatic hydrocarbons, such as paraffins or cyclohexane, alcohols such as ethanol, propanol or butanol, glycols and their ethers and esters such as propylene glycol, dipropylene glycol ether, ethylene glycol or ethylene glycol monomethyl ether or ethylene glycol monoethyl ether, ketones, such as cyclohexanone, isophorone or diacetone alcohol, strongly polar solvents, such as N-methylpyrrolid-2-one, dimethyl sulfoxide or N,N-dimethylformamide, water, unepoxidized or epoxidized vegetable oils, such as unexpodized or epoxidized rapeseed, castor, coconut or soya oil, and silicone oils. 
     Solid carriers which are used for example for dusts and dispersible powders are, as a rule, ground natural minerals such as calcite, talc, kaolin, montmorillonite or attapulgite. To improve the physical properties, it is also possible to add highly disperse silicas or highly disperse absorbtive polymers. Suitable particulate adsorptive carriers for granules are porous types, such as pumice, brick grit, sepiolite or bentonite, and suitable non-sorptive carrier materials are calcite or sand. In addition, a large number of granulated materials of inorganic or organic nature can be used, in particular dolomite or comminuted plant residues. 
     Suitable surface-active compounds are, depending on the type of the active ingredient to be formulated, non-ionic, cationic and/or anionic surfactants or surfactant mixtures which have good emulsifying, dispersing and wetting properties. The surfactants mentioned below are only to be considered as examples; a large number of further surfactants which are conventionally used in the art of formulation and suitable according to the invention are described in the relevant literature. 
     Suitable non-ionic surfactants are, especially, polyglycol ether derivatives of aliphatic or cycloaliphatic alcohols, of saturated or unsaturated fatty acids or of alkyl phenols which may contain approximately 3 to approximately 30 glycol ether groups and approximately 8 to approximately 20 carbon atoms in the (cyclo)aliphatic hydrocarbon radical or approximately 6 to approximately 18 carbon atoms in the alkyl moiety of the alkyl phenols. Also suitable are water-soluble polyethylene oxide adducts with polypropylene glycol, ethylenediaminopolypropylene glycol or alkyl polypropylene glycol having 1 to approximately 10 carbon atoms in the alkyl chain and approximately 20 to approximately 250 ethylene glycol ether groups and approximately 10 to approximately 100 propylene glycol ether groups. Normally, the abovementioned compounds contain 1 to approximately 5 ethylene glycol units per propylene glycol unit. Examples which may be mentioned are nonylphenoxypolyethoxyethanol, castor oil polyglycol ether, polypropylene glycol/polyethylene oxide adducts, tributylphenoxypolyethoxyethanol, polyethylene glycol or octylphenoxypolyethoxyethanol. Also suitable are fatty acid esters of polyoxyethylene sorbitan, such as polyoxyethylene sorbitan trioleate. 
     The cationic surfactants are, especially, quarternary ammonium salts which generally have at least one alkyl radical of approximately 8 to approximately 22 C atoms as substituents and as further substituents (unhalogenated or halogenated) lower alkyl or hydroxyalkyl or benzyl radicals. The salts are preferably in the form of halides, methylsulfates or ethylsulfates. Examples are stearyltrimethylammonium chloride and benzylbis(2-chloroethyl)ethylammonium bromide. 
     Examples of suitable anionic surfactants are water-soluble soaps or water-soluble synthetic surface-active compounds. Examples of suitable soaps are the alkali, alkaline earth or (unsubstituted or substituted) ammonium salts of fatty acids having approximately 10 to approximately 22 C atoms, such as the sodium or potassium salts of oleic or stearic acid, or of natural fatty acid mixtures which are obtainable for example from coconut or tall oil; mention must also be made of the fatty acid methyl taurates. However, synthetic surfactants are used more frequently, in particular fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or alkylaryl sulfonates. As a rule, the fatty sulfonates and fatty sulfates are present as alkali, alkaline earth or (substituted or unsubstituted) ammonium salts and they generally have an alkyl radical of approximately 8 to approximately 22 C atoms, alkyl also to be understood as including the alkyl moiety of acyl radicals; examples which may be mentioned are the sodium or calcium salts of lignosulfonic acid, of the dodecylsulfuric ester or of a fatty alcohol sulfate mixture prepared from natural fatty acids. This group also includes the salts of the sulfuric esters and sulfonic acids of fatty alcohol/ethylene oxide adducts. The sulfonated benzimidazole derivatives preferably contain 2 sulfonyl groups and a fatty acid radical of approximately 8 to approximately 22 C atoms. Examples of alkylarylsulfonates are the sodium, calcium or triethanolammonium salts of decylbenzenesulfonic acid, of dibutylnaphthalenesulfonic acid or of a naphthalenesulfonic acid/formaldehyde condensate. Also possible are, furthermore, suitable phosphates, such as salts of the phosphoric ester of a p-nonylphenol/(4-14)ethylene oxide adduct, or phospholipids. Further suitable phosphates are tris-esters of phosphoric acid with aliphatic or aromatic alcohols and/or bis-esters of alkyl phosphonic acids with aliphatic or aromatic alcohols, which are a high performance oil-type adjuvant. These tris-esters have been described, for example, in WO0147356, WO0056146, EP-A-0579052 or EP-A-1018299 or are commercially available under their chemical name. Preferred tris-esters of phosphoric acid for use in the new compositions are tris-(2-ethylhexyl)phosphate, tris-n-octyl phosphate and tris-butoxyethyl phosphate, where tris-(2-ethylhexyl)phosphate is most preferred. Suitable bis-ester of alkyl phosphonic acids are bis-(2-ethylhexyl)-(2-ethylhexyl)-phosphonate, bis-(2-ethylhexyl)-(n-octyl)-phosphonate, dibutyl-butyl phosphonate and bis(2-ethylhexyl)-tripropylene-phosphonate, where bis-(2-ethylhexyl)-(n-octyl)-phosphonate is particularly preferred. 
     The compositions according to the invention can preferably additionally include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives. The amount of oil additive used in the composition according to the invention is generally from 0.01 to 10%, based on the spray mixture. For example, the oil additive can be added to the spray tank in the desired concentration after the spray mixture has been prepared. Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil such as ADIGOR® and MERO®, olive oil or sunflower oil, emulsified vegetable oil, such as AMIGO® (Rhône-Poulenc Canada Inc.), alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow. A preferred additive contains, for example, as active components essentially 80% by weight alkyl esters of fish oils and 15% by weight methylated rapeseed oil, and also 5% by weight of customary emulsifiers and pH modifiers. Especially preferred oil additives comprise alkyl esters of C 8 -C 22  fatty acids, especially the methyl derivatives of C 12 -C 18  fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid, being important. Those esters are known as methyl laurate (CAS-111-82-0), methyl palmitate (CAS-112-39-0) and methyl oleate (CAS-112-62-9). A preferred fatty acid methyl ester derivative is Emery® 2230 and 2231 (Cognis GmbH). Those and other oil derivatives are also known from the Compendium of Herbicide Adjuvants, 5th Edition, Southern Illinois University, 2000. Also, alkoxylated fatty acids can be used as additives in the inventive compositions as well as polymethylsiloxane based additives, which have been described in WO08/037,373. 
     The application and action of the oil additives can be further improved by combining them with surface-active substances, such as non-ionic, anionic or cationic surfactants. Examples of suitable anionic, non-ionic and cationic surfactants are listed on pages 7 and 8 of WO 97/34485. Preferred surface-active substances are anionic surfactants of the dodecylbenzylsulfonate type, especially the calcium salts thereof, and also non-ionic surfactants of the fatty alcohol ethoxylate type. Special preference is given to ethoxylated C 12 -C 22  fatty alcohols having a degree of ethoxylation of from 5 to 40. Examples of commercially available surfactants are the Genapol types (Clariant AG). Also preferred are silicone surfactants, especially polyalkyl-oxide-modified heptamethyltrisiloxanes, which are commercially available e.g. as Silwet L-77®, and also perfluorinated surfactants. The concentration of surface-active substances in relation to the total additive is generally from 1 to 30% by weight. Examples of oil additives that consist of mixtures of oils or mineral oils or derivatives thereof with surfactants are Edenor ME SU®, Turbocharge® (Syngenta AG, CH) and Actipron® (BP Oil UK Limited, GB). 
     The said surface-active substances may also be used in the formulations alone, that is to say without oil additives. 
     Furthermore, the addition of an organic solvent to the oil additive/surfactant mixture can contribute to a further enhancement of action. Suitable solvents are, for example, Solvesso® (ESSO) and Aromatic Solvent® (Exxon Corporation). The concentration of such solvents can be from 10 to 80% by weight of the total weight. Such oil additives, which may be in admixture with solvents, are described, for example, in U.S. Pat. No. 4,834,908. A commercially available oil additive disclosed therein is known by the name MERGE® (BASF Corporation). A further oil additive that is preferred according to the invention is SCORE® (Syngenta Crop Protection Canada.) 
     In addition to the oil additives listed above, in order to enhance the activity of the compositions according to the invention it is also possible for formulations of alkylpyrrolidones, (e.g. Agrimax®) to be added to the spray mixture. Formulations of synthetic latices, such as, for example, polyacrylamide, polyvinyl compounds or poly-1-p-menthene (e.g. Bond®, Courier® or Emerald®) can also be used. Solutions that contain propionic acid, for example Eurogkem Pen-e-trate®, can also be mixed into the spray mixture as activity-enhancing agents. 
     As a rule, the compositions comprise 0.1 to 99%, especially 0.1 to 95%, of active ingredient of the formula I and 1 to 99.9%, especially 5 to 99.9%, of at least one solid or liquid adjuvant, it being possible as a rule for 0 to 25%, especially 0.1 to 20%, of the composition to be surfactants (% in each case meaning percent by weight). Whereas concentrated compositions tend to be preferred for commercial goods, the end consumer as a rule uses dilute compositions which have substantially lower concentrations of active ingredient. Preferred compositions are composed in particular as follows (%=percent by weight): 
     Emulsifiable Concentrates:
         active ingredient: 1 to 95%, preferably 5 to 50%, more preferably 5 to 20%   surfactant: 1 to 30%, preferably 10 to 20%   solvent: 5 to 98%, preferably 70 to 85%       

     Dusts:
         active ingredient: 0.1 to 10%, preferably 2 to 5%,   solid carrier: 99.9 to 90%, preferably 99.9 to 99%       

     Suspension Concentrates:
         active ingredient: 5 to 75%, preferably 10 to 50%, more preferably 10 to 40%   water: 94 to 24%, preferably 88 to 30%   surfactant: 1 to 40%, preferably 2 to 30%       

     Oil-Based Suspension Concentrates:
         active ingredient: 2 to 75%, preferably 5 to 50%, more preferably 10 to 25%   oil: 94 to 24%, preferably 88 to 30%   surfactant: 1 to 40%, preferably 2 to 30%       

     Wettable Powders:
         active ingredient: 0.5 to 90%, preferably 1 to 80%, more preferably 25 to 75%   surfactant: 0.5 to 20%, preferably 1 to 15%   solid carrier: 5 to 99%, preferably 15 to 98%       

     Granulates:
         active ingredient: 0.5 to 30%, preferably 3 to 25%, more preferably 3 to 15%   solid carrier: 99.5 to 70%, preferably 97 to 85%       

     Preferably, the term “active ingredient” refers to one of the compounds selected from Tables 1 to 60 shown above. It also refers to mixtures of the compound of formula I, in particular a compound selected from said Tables 1 to 60, with other insecticides, fungicides, herbicides, safeners, adjuvants and the like, which mixtures are specifically disclosed below. 
     The compositions can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers; fertilizers, in particular nitrogen containing fertilizers such as ammonium nitrates and urea as described in WO08/017,388, which can enhance the efficacy of the inventive compounds; or other active ingredients for achieving specific effects, for example ammonium or phosphonium salts, in particular halides, (hydrogen)sulphates, nitrates, (hydrogen)carbonates, citrates, tartrates, formiates and acetates, as described in WO07/068,427 and WO07/068,428, which also can enhance the efficacy of the inventive compounds and which can be used in combination with penetration enhancers such as alkoxalated fatty acids; bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides. 
     The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds I for the preparation of these compositions are also a subject of the invention. 
     The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring—which are to be selected to suit the intended aims of the prevailing circumstances—and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha. 
     A preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question. Alternatively, the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field. 
     The compositions according to the invention are also suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type. The propagation material can be treated with the compositions prior to planting, for example seed can be treated prior to sowing. Alternatively, the compositions can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling. These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention. 
     Further methods of application of the compositions according to the invention comprise drip application onto the soil, dipping of parts of plants such as roots bulbs or tubers, drenching the soil, as well as soil injection. These methods are known in the art. 
     In order to apply a compound of formula I as an insecticide, acaricide, nematicide or molluscicide to a pest, a locus of pest, or to a plant susceptible to attack by a pest, a compound of formula I is usually formulated into a composition which includes, in addition to the compound of formula I, a suitable inert diluent or carrier and, optionally, a formulation adjuvant in form of a surface active agent (SFA) as described herein or, for example, in EP-B-1062217. SFAs are chemicals which are able to modify the properties of an interface (for example, liquid/solid, liquid/air or liquid/liquid interfaces) by lowering the interfacial tension and thereby leading to changes in other properties (for example dispersion, emulsification and wetting). It is preferred that all compositions (both solid and liquid formulations) comprise, by weight, 0.0001 to 95%, more preferably 1 to 85%, for example 5 to 60%, of a compound of formula I. The composition is generally used for the control of pests such that a compound of formula I is applied at a rate of from 0.1 g to 10 kg per hectare, preferably from 1 g to 6 kg per hectare, more preferably from 1 g to 1 kg per hectare. When used in a seed dressing, a compound of formula I is used at a rate of 0.0001 g to 10 g (for example 0.001 g or 0.05 g), preferably 0.005 g to 10 g, more preferably 0.005 g to 4 g, per kilogram of seed. 
     In another aspect the present invention provides an insecticidal, acaricidal, nematicidal or molluscicidal composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula I and a suitable carrier or diluent therefor. 
     In a still further aspect the invention provides a method of combating and controlling pests at a locus which comprises treating the pests or the locus of the pests with an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a composition comprising a compound of formula I. 
     The compositions can be chosen from a number of formulation types, including dustable powders (DP), soluble powders (SP), water soluble granules (SG), water dispersible granules (WG), wettable powders (WP), granules (GR) (slow or fast release), soluble concentrates (SL), oil miscible liquids (OL), ultra low volume liquids (UL), emulsifiable concentrates (EC), dispersible concentrates (DC), emulsions (both oil in water (EW) and water in oil (EO)), micro-emulsions (ME), suspension concentrates (SC), oil-based suspension concentrate (OD), aerosols, fogging/smoke formulations, capsule suspensions (CS) and seed treatment formulations. The formulation type chosen in any instance will depend upon the particular purpose en-visaged and the physical, chemical and biological properties of the compound of formula I. 
     Dustable powders (DP) may be prepared by mixing a compound of formula I with one or more solid diluents (for example natural clays, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulphur, lime, flours, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder. 
     Soluble powders (SP) may be prepared by mixing a compound of formula I with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulphate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG). 
     Wettable powders (WP) may be prepared by mixing a compound of formula I with one or more solid diluents or carriers, one or more wetting agents and, preferably, one or more dispersing agents and, optionally, one or more suspending agents to facilitate the dispersion in liquids. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water dispersible granules (WG). 
     Granules (GR) may be formed either by granulating a mixture of a compound of formula I and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of formula I (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller&#39;s earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of formula I (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulphates or phosphates) and drying if necessary. Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils). One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent). 
     Dispersible Concentrates (DC) may be prepared by dissolving a compound of formula I in water or an organic solvent, such as a ketone, alcohol or glycol ether. These solutions may contain a surface active agent (for example to improve water dilution or prevent crystallisation in a spray tank). 
     Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) may be prepared by dissolving a compound of formula I in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl amides of fatty acids (such as C 8 -C 10  fatty acid dimethylamide) and chlorinated hydrocarbons. An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment. Preparation of an EW involves obtaining a compound of formula I either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70° C.) or in solution (by dissolving it in an appropriate solvent) and then emulsifying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents which have a low solubility in water. 
     Microemulsions (ME) may be prepared by mixing water with a blend of one or more solvents with one or more SFAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation. A compound of formula I is present initially in either the water or the solvent/SFA blend. Suitable solvents for use in MEs include those hereinbefore described for use in in ECs or in EWs. An ME may be either an oil-in-water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation. An ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion. 
     Suspension concentrates (SC) may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of formula I. SCs may be prepared by ball or bead milling the solid compound of formula I in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle. Alternatively, a compound of formula I may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product. 
     Oil-based suspension concentrate (OD) may be prepared similarly by suspending finely divided insoluble solid particles of a compound of formula I in an organic fluid (for example at least one mineral oil or vegetable oil). ODs may further comprise at least one penetration promoter (for example an alcohol ethoxylate or a related compound), at least one non-ionic surfactants and/or at least one anionic surfactant, and optionally at least one additive from the group of emulsifiers, foam-inhibiting agents, preservatives, anti-oxidants, dyestuffs, and/or inert filler materials. An OD is intended and suitable for dilution with water before use to produce a spray solution with sufficient stability to allow spray application through appropriate equipment. 
     Aerosol formulations comprise a compound of formula I and a suitable propellant (for example n-butane). A compound of formula I may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n-propanol) to provide compositions for use in non-pressurised, hand-actuated spray pumps. 
     A compound of formula I may be mixed in the dry state with a pyrotechnic mixture to form a composition suitable for generating, in an enclosed space, a smoke containing the compound. 
     Capsule suspensions (CS) may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerisation stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of formula I and, optionally, a carrier or diluent therefor. The polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure. The compositions may provide for controlled release of the compound of formula I and they may be used for seed treatment. A compound of formula I may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound. 
     A compound of formula I may also be formulated for use as a seed treatment, for example as a powder composition, including a powder for dry seed treatment (DS), a water soluble powder (SS) or a water dispersible powder for slurry treatment (WS), or as a liquid composition, including a flowable concentrate (FS), a solution (LS) or a capsule suspension (CS). The preparations of DS, SS, WS, FS and LS compositions are very similar to those of, respectively, DP, SP, WP, SC, OD and DC compositions described above. Compositions for treating seed may include an agent for assisting the adhesion of the composition to the seed (for example a mineral oil or a film-forming barrier). 
     A composition of the present invention may include one or more additives to improve the biological performance of the composition (for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of formula I). Such additives include surface active agents (SFAs), spray additives based on oils, for example certain mineral oils, vegetable oils or natural plant oils (such as soy bean and rape seed oil), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of formula I). Increasing the effect of a compound of formula I may for example be achieved by adding ammonium and/or phosphonium salts, and/or optionally at least one penetration promoter such as fatty alcohol alkoxylates (for example rape oil methyl ester) or vegetable oil esters. 
     Wetting agents, dispersing agents and emulsifying agents may be surface active agents (SFAs) of the cationic, anionic, amphoteric or non-ionic type. 
     Suitable SFAs of the cationic type include quaternary ammonium compounds (for example cetyltrimethyl ammonium bromide), imidazolines and amine salts. 
     Suitable anionic SFAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulphuric acid (for example sodium lauryl sulphate), salts of sulphonated aromatic compounds (for example sodium dodecylbenzenesulphonate, calcium dodecylbenzenesulphonate, butylnaphthalene sulphonate and mixtures of sodium di-isopropyl- and tri-isopropyl-naphthalene sulphonates), ether sulphates, alcohol ether sulphates (for example sodium laureth-3-sulphate), ether carboxylates (for example sodium laureth-3-carboxylate), phosphate esters (products from the reaction between one or more fatty alcohols and phosphoric acid (predominately mono-esters) or phosphorus pentoxide (predominately di-esters), for example the reaction between lauryl alcohol and tetraphosphoric acid; additionally these products may be ethoxylated), sulphosuccinamates, paraffin or olefine sulphonates, taurates and lignosulphonates. 
     Suitable SFAs of the amphoteric type include betaines, propionates and glycinates. 
     Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins. 
     Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite). 
     A compound of formula I may be applied by any of the known means of applying pesticidal compounds. For example, it may be applied, formulated or unformulated, to the pests or to a locus of the pests (such as a habitat of the pests, or a growing plant liable to infestation by the pests) or to any part of the plant, including the foliage, stems, branches or roots, to the seed before it is planted or to other media in which plants are growing or are to be planted (such as soil surrounding the roots, the soil generally, paddy water or hydroponic culture systems), directly or it may be sprayed on, dusted on, applied by dipping, applied as a cream or paste formulation, applied as a vapour or applied through distribution or incorporation of a composition (such as a granular composition or a composition packed in a water-soluble bag) in soil or an aqueous environment. 
     A compound of formula I may also be injected into plants or sprayed onto vegetation using electrodynamic spraying techniques or other low volume methods, or applied by land or aerial irrigation systems. 
     Compositions for use as aqueous preparations (aqueous solutions or dispersions) are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, the concentrate being added to water before use. These concentrates, which may include DCs, SCs, ODs, ECs, EWs, MEs SGs, SPs, WPs, WGs and CSs, are often required to withstand storage for prolonged periods and, after such storage, to be capable of addition to water to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by conventional spray equipment. Such aqueous preparations may contain varying amounts of a compound of formula I (for example 0.0001 to 10%, by weight) depending upon the purpose for which they are to be used. 
     A compound of formula I may be used in mixtures with fertilisers (for example nitrogen-, potassium- or phosphorus-containing fertilisers, and more particularly ammonium nitrate and/or urea fertilizers). Suitable formulation types include granules of fertiliser. The mixtures suitably contain up to 25% by weight of the compound of formula I. 
     The invention therefore also provides a fertiliser composition comprising a fertiliser and a compound of formula I. 
     The compositions of this invention may contain other compounds having biological activity, for example micronutrients or compounds having fungicidal activity or which possess plant growth regulating, herbicidal, safening, insecticidal, nematicidal or acaricidal activity. 
     The compound of formula I may be the sole active ingredient of the composition or it may be admixed with one or more additional active ingredients such as a pesticide (insect, acarine, mollusc and nematode pesticide), fungicide, synergist, herbicide, safener or plant growth regulator where appropriate. The activity of the compositions according to the invention may thereby be broadened considerably and may have surprising advantages which can also be described, in a wider sense, as synergistic activity. An additional active ingredient may: provide a composition having a broader spectrum of activity or increased persistence at a locus; provide a composition demonstrating better plant/crop tolerance by reducing phytotoxicity; provide a composition controlling insects in their different development stages; synergise the activity or complement the activity (for example by increasing the speed of effect or overcoming repellency) of the compound of formula I; or help to overcome or prevent the development of resistance to individual components. The particular additional active ingredient will depend upon the intended utility of the composition. Examples of suitable pesticides include the following: 
     a) Pyrethroids, such as permethrin, cypermethrin, fenvalerate, esfenvalerate, deltamethrin, cyhalothrin (in particular lambda-cyhalothrin), bifenthrin, fenpropathrin, cyfluthrin, tefluthrin, fish safe pyrethroids (for example ethofenprox), natural pyrethrin, tetramethrin, s-bioallethrin, fenfluthrin, prallethrin or 5-benzyl-3-furylmethyl-(E)-(1R,3S)-2,2-dimethyl-3-(2-oxothiolan-3-ylidenemethyl)cyclopropane carboxylate; 
     b) Organophosphates, such as, profenofos, sulprofos, acephate, methyl parathion, azinphos-methyl, demeton-s-methyl, heptenophos, thiometon, fenamiphos, monocrotophos, profenofos, triazophos, methamidophos, dimethoate, phosphamidon, malathion, chlorpyrifos, phosalone, terbufos, fensulfothion, fonofos, phorate, phoxim, pirimiphos-methyl, pirimiphos-ethyl, fenitrothion, fosthiazate or diazinon; 
     c) Carbamates (including aryl carbamates), such as pirimicarb, triazamate, cloethocarb, carbofuran, furathiocarb, ethiofencarb, aldicarb, thiofurox, carbosulfan, bendiocarb, fenobucarb, propoxur, methomyl or oxamyl; 
     d) Benzoyl ureas, such as diflubenzuron, triflumuron, hexaflumuron, flufenoxuron or chlorfluazuron; 
     e) Organic tin compounds, such as cyhexatin, fenbutatin oxide or azocyclotin; 
     f) Pyrazoles, such as tebufenpyrad and fenpyroximate; 
     g) Macrolides, such as avermectins or milbemycins, for example abamectin, emamectin benzoate, ivermectin, milbemycin, or spinosad, spinetoram or azadirachtin; 
     h) Hormones or pheromones; 
     i) Organochlorine compounds such as endosulfan, benzene hexachloride, DDT, chlordane or dieldrin; 
     j) Amidines, such as chlordimeform or amitraz; 
     k) Fumigant agents, such as chloropicrin, dichloropropane, methyl bromide or metam; 
     l) Neonicotinoid compounds such as imidacloprid, thiacloprid, acetamiprid, clothianidin, nitenpyram, dinotefuran or thiamethoxam; 
     m) Diacylhydrazines, such as tebufenozide, chromafenozide or methoxyfenozide; 
     n) Diphenyl ethers, such as diofenolan or pyriproxifen; 
     o) Indoxacarb; 
     p) Chlorfenapyr; 
     q) Pymetrozine or pyrifluquinazon; 
     r) Spirotetramat, spirodiclofen or spiromesifen; 
     s) Flubendiamide, chloranthraliniprole, or cyanthraniliprole; 
     t) Cyenopyrafen or cyflumetofen; or 
     u) Sulfoxaflor. 
     In addition to the major chemical classes of pesticide listed above, other pesticides having particular targets may be employed in the composition, if appropriate for the intended utility of the composition. For instance, selective insecticides for particular crops, for example stemborer specific insecticides (such as cartap) or hopper specific insecticides (such as buprofezin) for use in rice may be employed. Alternatively insecticides or acaricides specific for particular insect species/stages may also be included in the compositions (for example acaricidal ovo-larvicides, such as clofentezine, flubenzimine, hexythiazox or tetradifon; acaricidal motilicides, such as dicofol or propargite; acaricides, such as bromopropylate or chlorobenzilate; or growth regulators, such as hydramethylnon, cyromazine, methoprene, chlorfluazuron or diflubenzuron). 
     The following mixtures of the compounds of formula I with active ingredients are preferred, wherein, preferably, the term “COMPOUND OF FORMULA I” refers to a compound selected from the Tables 1 to 60:
         an adjuvant selected from the group of substances consisting of an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils, and petroleum oils (alternative name) (628)+COMPOUND OF FORMULA I,   an acaricide selected from the group of substances consisting of 1,1-bis(4-chlorophenyl)-2-ethoxyethanol (IUPAC name) (910)+COMPOUND OF FORMULA I, 2,4-dichlorophenyl benzenesulfonate (IUPAC/Chemical Abstracts name) (1059)+COMPOUND OF FORMULA I, 2-fluoro-N-methyl-N-1-naphthylacetamide (IUPAC name) (1295)+COMPOUND OF FORMULA I, 4-chlorophenyl phenyl sulfone (IUPAC name) (981)+COMPOUND OF FORMULA I, abamectin (1)+COMPOUND OF FORMULA I, acequinocyl (3)+COMPOUND OF FORMULA I, acetoprole [CCN]+COMPOUND OF FORMULA I, acrinathrin (9)+COMPOUND OF FORMULA I, aldicarb (16)+COMPOUND OF FORMULA I, aldoxycarb (863)+COMPOUND OF FORMULA I, alphacypermethrin (202)+COMPOUND OF FORMULA I, amidithion (870)+COMPOUND OF FORMULA I, amidoflumet [CCN]+COMPOUND OF FORMULA I, amidothioate (872)+COMPOUND OF FORMULA I, amiton (875)+COMPOUND OF FORMULA I, amiton hydrogen oxalate (875)+COMPOUND OF FORMULA I, amitraz (24)+COMPOUND OF FORMULA I, aramite (881)+COMPOUND OF FORMULA I, arsenous oxide (882)+COMPOUND OF FORMULA I, AVI 382 (compound code)+COMPOUND OF FORMULA I, AZ 60541 (compound code)+COMPOUND OF FORMULA I, azinphos-ethyl (44)+COMPOUND OF FORMULA I, azinphos-methyl (45)+COMPOUND OF FORMULA I, azobenzene (IUPAC name) (888)+COMPOUND OF FORMULA I, azocyclotin (46)+COMPOUND OF FORMULA I, azothoate (889)+COMPOUND OF FORMULA I, benomyl (62)+COMPOUND OF FORMULA I, benoxafos (alternative name) [CCN]+COMPOUND OF FORMULA I, benzoximate (71)+COMPOUND OF FORMULA I, benzyl benzoate (IUPAC name) [CCN]+COMPOUND OF FORMULA I, bifenazate (74)+COMPOUND OF FORMULA I, bifenthrin (76)+COMPOUND OF FORMULA I, binapacryl (907)+COMPOUND OF FORMULA I, brofenvalerate (alternative name)+COMPOUND OF FORMULA I, bromocyclen (918)+COMPOUND OF FORMULA I, bromophos (920)+COMPOUND OF FORMULA I, bromophos-ethyl (921)+COMPOUND OF FORMULA I, bromopropylate (94)+COMPOUND OF FORMULA I, buprofezin (99)+COMPOUND OF FORMULA I, butocarboxim (103)+COMPOUND OF FORMULA I, butoxycarboxim (104)+COMPOUND OF FORMULA I, butylpyridaben (alternative name)+COMPOUND OF FORMULA I, calcium polysulfide (IUPAC name) (111)+COMPOUND OF FORMULA I, camphechlor (941)+COMPOUND OF FORMULA I, carbanolate (943)+COMPOUND OF FORMULA I, carbaryl (115)+COMPOUND OF FORMULA I, carbofuran (118)+COMPOUND OF FORMULA I, carbophenothion (947)+COMPOUND OF FORMULA I, CGA 50′439 (development code) (125)+COMPOUND OF FORMULA I, chinomethionat (126)+COMPOUND OF FORMULA I, chlorbenside (959)+COMPOUND OF FORMULA I, chlordimeform (964)+COMPOUND OF FORMULA I, chlordimeform hydrochloride (964)+COMPOUND OF FORMULA I, chlorfenapyr (130)+COMPOUND OF FORMULA I, chlorfenethol (968)+COMPOUND OF FORMULA I, chlorfenson (970)+COMPOUND OF FORMULA I, chlorfensulphide (971)+COMPOUND OF FORMULA I, chlorfenvinphos (131)+COMPOUND OF FORMULA I, chlorobenzilate (975)+COMPOUND OF FORMULA I, chloromebuform (977)+COMPOUND OF FORMULA I, chloromethiuron (978)+COMPOUND OF FORMULA I, chloropropylate (983)+COMPOUND OF FORMULA I, chlorpyrifos (145)+COMPOUND OF FORMULA I, chlorpyrifos-methyl (146)+COMPOUND OF FORMULA I, chlorthiophos (994)+COMPOUND OF FORMULA I, cinerin I (696)+COMPOUND OF FORMULA I, cinerin II (696)+COMPOUND OF FORMULA I, cinerins (696)+COMPOUND OF FORMULA I, clofentezine (158)+COMPOUND OF FORMULA I, closantel (alternative name) [CCN]+COMPOUND OF FORMULA I, coumaphos (174)+COMPOUND OF FORMULA I, crotamiton (alternative name) [CCN]+COMPOUND OF FORMULA I, crotoxyphos (1010)+COMPOUND OF FORMULA I, cufraneb (1013)+COMPOUND OF FORMULA I, cyanthoate (1020)+COMPOUND OF FORMULA I, cyenopyrafen [CCN]+COMPOUND OF FORMULA I, cyflumetofen (CAS Reg. No.: 400882-07-7)+COMPOUND OF FORMULA I, cyhalothrin (196)+COMPOUND OF FORMULA I, cyhexatin (199)+COMPOUND OF FORMULA I, cypermethrin (201)+COMPOUND OF FORMULA I, DCPM (1032)+COMPOUND OF FORMULA I, DDT (219)+COMPOUND OF FORMULA I, demephion (1037)+COMPOUND OF FORMULA I, demephion-O (1037)+COMPOUND OF FORMULA I, demephion-S (1037)+COMPOUND OF FORMULA I, demeton (1038)+COMPOUND OF FORMULA I, demeton-methyl (224)+COMPOUND OF FORMULA I, demeton-O (1038)+COMPOUND OF FORMULA I, demeton-O-methyl (224)+COMPOUND OF FORMULA I, demeton-S (1038)+COMPOUND OF FORMULA I, demeton-S-methyl (224)+COMPOUND OF FORMULA I, demeton-S-methylsulphon (1039)+COMPOUND OF FORMULA I, diafenthiuron (226)+COMPOUND OF FORMULA I, dialifos (1042)+COMPOUND OF FORMULA I, diazinon (227)+COMPOUND OF FORMULA I, dichlofluanid (230)+COMPOUND OF FORMULA I, dichlorvos (236)+COMPOUND OF FORMULA I, dicliphos (alternative name)+COMPOUND OF FORMULA I, dicofol (242)+COMPOUND OF FORMULA I, dicrotophos (243)+COMPOUND OF FORMULA I, dienochlor (1071)+COMPOUND OF FORMULA I, diflovidazin [CCN]+COMPOUND OF FORMULA I, dimefox (1081)+COMPOUND OF FORMULA I, dimethoate (262)+COMPOUND OF FORMULA I, dinactin (alternative name) (653)+COMPOUND OF FORMULA I, dinex (1089)+COMPOUND OF FORMULA I, dinex-diclexine (1089)+COMPOUND OF FORMULA I, dinobuton (269)+COMPOUND OF FORMULA I, dinocap (270)+COMPOUND OF FORMULA I, dinocap-4 [CCN]+COMPOUND OF FORMULA I, dinocap-6 [CCN]+COMPOUND OF FORMULA I, dinocton (1090)+COMPOUND OF FORMULA I, dinopenton (1092)+COMPOUND OF FORMULA I, dinosulfon (1097)+COMPOUND OF FORMULA I, dinoterbon (1098)+COMPOUND OF FORMULA I, dioxathion (1102)+COMPOUND OF FORMULA I, diphenyl sulfone (IUPAC name) (1103)+COMPOUND OF FORMULA I, disulfuram (alternative name) [CCN]+COMPOUND OF FORMULA I, disulfoton (278)+COMPOUND OF FORMULA I, DNOC (282)+COMPOUND OF FORMULA I, dofenapyn (1113)+COMPOUND OF FORMULA I, doramectin (alternative name) [CCN]+COMPOUND OF FORMULA I, endosulfan (294)+COMPOUND OF FORMULA I, endothion (1121)+COMPOUND OF FORMULA I, EPN (297)+COMPOUND OF FORMULA I, eprinomectin (alternative name) [CCN]+COMPOUND OF FORMULA I, ethion (309)+COMPOUND OF FORMULA I, ethoate-methyl (1134)+COMPOUND OF FORMULA I, etoxazole (320)+COMPOUND OF FORMULA I, etrimfos (1142)+COMPOUND OF FORMULA I, fenazaflor (1147)+COMPOUND OF FORMULA I, fenazaquin (328)+COMPOUND OF FORMULA I, fenbutatin oxide (330)+COMPOUND OF FORMULA I, fenothiocarb (337)+COMPOUND OF FORMULA I, fenpropathrin (342)+COMPOUND OF FORMULA I, fenpyrad (alternative name)+COMPOUND OF FORMULA I, fenpyroximate (345)+COMPOUND OF FORMULA I, fenson (1157)+COMPOUND OF FORMULA I, fentrifanil (1161)+COMPOUND OF FORMULA I, fenvalerate (349)+COMPOUND OF FORMULA I, fipronil (354)+COMPOUND OF FORMULA I, fluacrypyrim (360)+COMPOUND OF FORMULA I, fluazuron (1166)+COMPOUND OF FORMULA I, flubenzimine (1167)+COMPOUND OF FORMULA I, flucycloxuron (366)+COMPOUND OF FORMULA I, flucythrinate (367)+COMPOUND OF FORMULA I, fluenetil (1169)+COMPOUND OF FORMULA I, flufenoxuron (370)+COMPOUND OF FORMULA I, flumethrin (372)+COMPOUND OF FORMULA I, fluorbenside (1174)+COMPOUND OF FORMULA I, fluvalinate (1184)+COMPOUND OF FORMULA I, FMC 1137 (development code) (1185)+COMPOUND OF FORMULA I, formetanate (405)+COMPOUND OF FORMULA I, formetanate hydrochloride (405)+COMPOUND OF FORMULA I, formothion (1192)+COMPOUND OF FORMULA I, formparanate (1193)+COMPOUND OF FORMULA I, gamma-HCH (430)+COMPOUND OF FORMULA I, glyodin (1205)+COMPOUND OF FORMULA I, halfenprox (424)+COMPOUND OF FORMULA I, heptenophos (432)+COMPOUND OF FORMULA I, hexadecyl cyclopropanecarboxylate (IUPAC/Chemical Abstracts name) (1216)+COMPOUND OF FORMULA I, hexythiazox (441)+COMPOUND OF FORMULA I, IKA 2002 (CAS Reg. No.: 211923-74-9)+COMPOUND OF FORMULA I, iodomethane (IUPAC name) (542)+COMPOUND OF FORMULA I, isocarbophos (alternative name) (473)+COMPOUND OF FORMULA I, isopropyl O-(methoxyaminothiophosphoryl)salicylate (IUPAC name) (473)+COMPOUND OF FORMULA I, ivermectin (alternative name) [CCN]+COMPOUND OF FORMULA I, jasmolin I (696)+COMPOUND OF FORMULA I, jasmolin II (696)+COMPOUND OF FORMULA I, jodfenphos (1248)+COMPOUND OF FORMULA I, lindane (430)+COMPOUND OF FORMULA I, lufenuron (490)+COMPOUND OF FORMULA I, malathion (492)+COMPOUND OF FORMULA I, malonoben (1254)+COMPOUND OF FORMULA I, mecarbam (502)+COMPOUND OF FORMULA I, mephosfolan (1261)+COMPOUND OF FORMULA I, mesulfen (alternative name) [CCN]+COMPOUND OF FORMULA I, methacrifos (1266)+COMPOUND OF FORMULA I, methamidophos (527)+COMPOUND OF FORMULA I, methidathion (529)+COMPOUND OF FORMULA I, methiocarb (530)+COMPOUND OF FORMULA I, methomyl (531)+COMPOUND OF FORMULA I, methyl bromide (537)+COMPOUND OF FORMULA I, metolcarb (550)+COMPOUND OF FORMULA I, mevinphos (556)+COMPOUND OF FORMULA I, mexacarbate (1290)+COMPOUND OF FORMULA I, milbemectin (557)+COMPOUND OF FORMULA I, milbemycin oxime (alternative name) [CCN]+COMPOUND OF FORMULA I, mipafox (1293)+COMPOUND OF FORMULA I, monocrotophos (561)+COMPOUND OF FORMULA I, morphothion (1300)+COMPOUND OF FORMULA I, moxidectin (alternative name) [CCN]+COMPOUND OF FORMULA I, naled (567)+COMPOUND OF FORMULA I, NC-184 (compound code)+COMPOUND OF FORMULA I, NC-512 (compound code)+COMPOUND OF FORMULA I, nifluridide (1309)+COMPOUND OF FORMULA I, nikkomycins (alternative name) [CCN]+COMPOUND OF FORMULA I, nitrilacarb (1313)+COMPOUND OF FORMULA I, nitrilacarb 1:1 zinc chloride complex (1313)+COMPOUND OF FORMULA I, NNI-0101 (compound code)+COMPOUND OF FORMULA I, NNI-0250 (compound code)+COMPOUND OF FORMULA I, omethoate (594)+COMPOUND OF FORMULA I, oxamyl (602)+COMPOUND OF FORMULA I, oxydeprofos (1324)+COMPOUND OF FORMULA I, oxydisulfoton (1325)+COMPOUND OF FORMULA I, pp′-DDT (219)+COMPOUND OF FORMULA I, parathion (615)+COMPOUND OF FORMULA I, permethrin (626)+COMPOUND OF FORMULA I, petroleum oils (alternative name) (628)+COMPOUND OF FORMULA I, phenkapton (1330)+COMPOUND OF FORMULA I, phenthoate (631)+COMPOUND OF FORMULA I, phorate (636)+COMPOUND OF FORMULA I, phosalone (637)+COMPOUND OF FORMULA I, phosfolan (1338)+COMPOUND OF FORMULA I, phosmet (638)+COMPOUND OF FORMULA I, phosphamidon (639)+COMPOUND OF FORMULA I, phoxim (642)+COMPOUND OF FORMULA I, pirimiphos-methyl (652)+COMPOUND OF FORMULA I, polychloroterpenes (traditional name) (1347)+COMPOUND OF FORMULA I, polynactins (alternative name) (653)+COMPOUND OF FORMULA I, proclonol (1350)+COMPOUND OF FORMULA I, profenofos (662)+COMPOUND OF FORMULA I, promacyl (1354)+COMPOUND OF FORMULA I, propargite (671)+COMPOUND OF FORMULA I, propetamphos (673)+COMPOUND OF FORMULA I, propoxur (678)+COMPOUND OF FORMULA I, prothidathion (1360)+COMPOUND OF FORMULA I, prothoate (1362)+COMPOUND OF FORMULA I, pyrethrin I (696)+COMPOUND OF FORMULA I, pyrethrin II (696)+COMPOUND OF FORMULA I, pyrethrins (696)+COMPOUND OF FORMULA I, pyridaben (699)+COMPOUND OF FORMULA I, pyridaphenthion (701)+COMPOUND OF FORMULA I, pyrimidifen (706)+COMPOUND OF FORMULA I, pyrimitate (1370)+COMPOUND OF FORMULA I, quinalphos (711)+COMPOUND OF FORMULA I, quintiofos (1381)+COMPOUND OF FORMULA I, R-1492 (development code) (1382)+COMPOUND OF FORMULA I, RA-17 (development code) (1383)+COMPOUND OF FORMULA I, rotenone (722)+COMPOUND OF FORMULA I, schradan (1389)+COMPOUND OF FORMULA I, sebufos (alternative name)+COMPOUND OF FORMULA I, selamectin (alternative name) [CCN]+COMPOUND OF FORMULA I, SI-0009 (compound code)+COMPOUND OF FORMULA I, sophamide (1402)+COMPOUND OF FORMULA I, spirodiclofen (738)+COMPOUND OF FORMULA I, spiromesifen (739)+COMPOUND OF FORMULA I, SSI-121 (development code) (1404)+COMPOUND OF FORMULA I, sulfuram (alternative name) [CCN]+COMPOUND OF FORMULA I, sulfluramid (750)+COMPOUND OF FORMULA I, sulfotep (753)+COMPOUND OF FORMULA I, sulfur (754)+COMPOUND OF FORMULA I, SZI-121 (development code) (757)+COMPOUND OF FORMULA I, tau-fluvalinate (398)+COMPOUND OF FORMULA I, tebufenpyrad (763)+COMPOUND OF FORMULA I, TEPP (1417)+COMPOUND OF FORMULA I, terbam (alternative name)+COMPOUND OF FORMULA I, tetrachlorvinphos (777)+COMPOUND OF FORMULA I, tetradifon (786)+COMPOUND OF FORMULA I, tetranactin (alternative name) (653)+COMPOUND OF FORMULA I, tetrasul (1425)+COMPOUND OF FORMULA I, thiafenox (alternative name)+COMPOUND OF FORMULA I, thiocarboxime (1431)+COMPOUND OF FORMULA I, thiofanox (800)+COMPOUND OF FORMULA I, thiometon (801)+COMPOUND OF FORMULA I, thioquinox (1436)+COMPOUND OF FORMULA I, thuringiensin (alternative name) [CCN]+COMPOUND OF FORMULA I, triamiphos (1441)+COMPOUND OF FORMULA I, triarathene (1443)+COMPOUND OF FORMULA I, triazophos (820)+COMPOUND OF FORMULA I, triazuron (alternative name)+COMPOUND OF FORMULA I, trichlorfon (824)+COMPOUND OF FORMULA I, trifenofos (1455)+COMPOUND OF FORMULA I, trinactin (alternative name) (653)+COMPOUND OF FORMULA I, vamidothion (847)+COMPOUND OF FORMULA I, vaniliprole [CCN] and yl-5302 (compound code)+COMPOUND OF FORMULA I,   an algicide selected from the group of substances consisting of bethoxazin [CCN]+COMPOUND OF FORMULA I, copper dioctanoate (IUPAC name) (170)+COMPOUND OF FORMULA I, copper sulfate (172)+COMPOUND OF FORMULA I, cybutryne [CCN]+COMPOUND OF FORMULA I, dichlone (1052)+COMPOUND OF FORMULA I, dichlorophen (232)+COMPOUND OF FORMULA I, endothal (295)+COMPOUND OF FORMULA I, fentin (347)+COMPOUND OF FORMULA I, hydrated lime [CCN]+COMPOUND OF FORMULA I, nabam (566)+COMPOUND OF FORMULA I, quinoclamine (714)+COMPOUND OF FORMULA I, quinonamid (1379)+COMPOUND OF FORMULA I, simazine (730)+COMPOUND OF FORMULA I, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+COMPOUND OF FORMULA I,   an anthelmintic selected from the group of substances consisting of abamectin (1)+COMPOUND OF FORMULA I, crufomate (1011)+COMPOUND OF FORMULA I, doramectin (alternative name) [CCN]+COMPOUND OF FORMULA I, emamectin (291)+COMPOUND OF FORMULA I, emamectin benzoate (291)+COMPOUND OF FORMULA I, eprinomectin (alternative name) [CCN]+COMPOUND OF FORMULA I, ivermectin (alternative name) [CCN]+COMPOUND OF FORMULA I, milbemycin oxime (alternative name) [CCN]+COMPOUND OF FORMULA I, moxidectin (alternative name) [CCN]+COMPOUND OF FORMULA I, piperazine [CCN]+COMPOUND OF FORMULA I, selamectin (alternative name) [CCN]+COMPOUND OF FORMULA I, spinosad (737) and thiophanate (1435)+COMPOUND OF FORMULA I,   an avicide selected from the group of substances consisting of chloralose (127)+COMPOUND OF FORMULA I, endrin (1122)+COMPOUND OF FORMULA I, fenthion (346)+COMPOUND OF FORMULA I, pyridin-4-amine (IUPAC name) (23) and strychnine (745)+COMPOUND OF FORMULA I,   a bactericide selected from the group of substances consisting of 1-hydroxy-1H-pyridine-2-thione (IUPAC name) (1222)+COMPOUND OF FORMULA I, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748)+COMPOUND OF FORMULA I, 8-hydroxyquinoline sulfate (446)+COMPOUND OF FORMULA I, bronopol (97)+COMPOUND OF FORMULA I, copper dioctanoate (IUPAC name) (170)+COMPOUND OF FORMULA I, copper hydroxide (IUPAC name) (169)+COMPOUND OF FORMULA I, cresol [CCN]+COMPOUND OF FORMULA I, dichlorophen (232)+COMPOUND OF FORMULA I, dipyrithione (1105)+COMPOUND OF FORMULA I, dodicin (1112)+COMPOUND OF FORMULA I, fenaminosulf (1144)+COMPOUND OF FORMULA I, formaldehyde (404)+COMPOUND OF FORMULA I, hydrargaphen (alternative name) [CCN]+COMPOUND OF FORMULA I, kasugamycin (483)+COMPOUND OF FORMULA I, kasugamycin hydrochloride hydrate (483)+COMPOUND OF FORMULA I, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308)+COMPOUND OF FORMULA I, nitrapyrin (580)+COMPOUND OF FORMULA I, octhilinone (590)+COMPOUND OF FORMULA I, oxolinic acid (606)+COMPOUND OF FORMULA I, oxytetracycline (611)+COMPOUND OF FORMULA I, potassium hydroxyquinoline sulfate (446)+COMPOUND OF FORMULA I, probenazole (658)+COMPOUND OF FORMULA I, streptomycin (744)+COMPOUND OF FORMULA I, streptomycin sesquisulfate (744)+COMPOUND OF FORMULA I, tecloftalam (766)+COMPOUND OF FORMULA I, and thiomersal (alternative name) [CCN]+COMPOUND OF FORMULA I,   a biological agent selected from the group of substances consisting of  Adoxophyes orana  GV (alternative name) (12)+COMPOUND OF FORMULA I,  Agrobacterium radiobacter  (alternative name) (13)+COMPOUND OF FORMULA I,  Amblyseius  spp. (alternative name) (19)+COMPOUND OF FORMULA I,  Anagrapha falcifera  NPV (alternative name) (28)+COMPOUND OF FORMULA I,  Anagrus atomus  (alternative name) (29)+COMPOUND OF FORMULA I,  Aphelinus abdominalis  (alternative name) (33)+COMPOUND OF FORMULA I,  Aphidius colemani  (alternative name) (34)+COMPOUND OF FORMULA I,  Aphidoletes aphidimyza  (alternative name) (35)+COMPOUND OF FORMULA I,  Autographa californica  NPV (alternative name) (38)+COMPOUND OF FORMULA I,  Bacillus firmus  (alternative name) (48)+COMPOUND OF FORMULA I,  Bacillus sphaericus  Neide (scientific name) (49)+COMPOUND OF FORMULA I,  Bacillus thuringiensis  Berliner (scientific name) (51)+COMPOUND OF FORMULA I,  Bacillus thuringiensis  subsp.  aizawai  (scientific name) (51)+COMPOUND OF FORMULA I,  Bacillus thuringiensis  subsp.  israelensis  (scientific name) (51)+COMPOUND OF FORMULA I,  Bacillus thuringiensis  subsp.  japonensis  (scientific name) (51)+COMPOUND OF FORMULA I,  Bacillus thuringiensis  subsp.  kurstaki  (scientific name) (51)+COMPOUND OF FORMULA I,  Bacillus thuringiensis  subsp.  tenebrionis  (scientific name) (51)+COMPOUND OF FORMULA I,  Beauveria bassiana  (alternative name) (53)+COMPOUND OF FORMULA I,  Beauveria brongniartii  (alternative name) (54)+COMPOUND OF FORMULA I,  Chrysoperla carnea  (alternative name) (151)+COMPOUND OF FORMULA I,  Cryptolaemus montrouzieri  (alternative name) (178)+COMPOUND OF FORMULA I,  Cydia pomonella  GV (alternative name) (191)+COMPOUND OF FORMULA I,  Dacnusa sibirica  (alternative name) (212)+COMPOUND OF FORMULA I,  Diglyphus isaea  (alternative name) (254)+COMPOUND OF FORMULA I,  Encarsia formosa  (scientific name) (293)+COMPOUND OF FORMULA I,  Eretmocerus eremicus  (alternative name) (300)+COMPOUND OF FORMULA I,  Helicoverpa zea  NPV (alternative name) (431)+COMPOUND OF FORMULA I,  Heterorhabditis bacteriophora  and  H. megidis  (alternative name) (433)+COMPOUND OF FORMULA I,  Hippodamia convergens  (alternative name) (442)+COMPOUND OF FORMULA I,  Leptomastix dactylopii  (alternative name) (488)+COMPOUND OF FORMULA I,  Macrolophus caliginosus  (alternative name) (491)+COMPOUND OF FORMULA I,  Mamestra brassicae  NPV (alternative name) (494)+COMPOUND OF FORMULA I,  Metaphycus helvolus  (alternative name) (522)+COMPOUND OF FORMULA I,  Metarhizium anisopliae  var.  acridum  (scientific name) (523)+COMPOUND OF FORMULA I,  Metarhizium anisopliae  var.  anisopliae  (scientific name) (523)+COMPOUND OF FORMULA I,  Neodiprion sertifer  NPV and  N. lecontei  NPV (alternative name) (575)+COMPOUND OF FORMULA I,  Orius  spp. (alternative name) (596)+COMPOUND OF FORMULA I,  Paecilomyces fumosoroseus  (alternative name) (613)+COMPOUND OF FORMULA I,  Phytoseiulus persimilis  (alternative name) (644)+COMPOUND OF FORMULA I,  Spodoptera exigua  multicapsid nuclear polyhedrosis virus (scientific name) (741)+COMPOUND OF FORMULA I,  Steinernema bibionis  (alternative name) (742)+COMPOUND OF FORMULA I,  Steinernema carpocapsae  (alternative name) (742)+COMPOUND OF FORMULA I,  Steinernema feltiae  (alternative name) (742)+COMPOUND OF FORMULA I,  Steinernema glaseri  (alternative name) (742)+COMPOUND OF FORMULA I,  Steinernema riobrave  (alternative name) (742)+COMPOUND OF FORMULA I,  Steinernema riobravis  (alternative name) (742)+COMPOUND OF FORMULA I,  Steinernema scapterisci  (alternative name) (742)+COMPOUND OF FORMULA I,  Steinernema  spp. (alternative name) (742)+COMPOUND OF FORMULA I,  Trichogramma  spp. (alternative name) (826)+COMPOUND OF FORMULA I,  Typhlodromus occidentalis  (alternative name) (844) and  Verticillium lecanii  (alternative name) (848)+COMPOUND OF FORMULA I,   a soil sterilant selected from the group of substances consisting of iodomethane (IUPAC name) (542) and methyl bromide (537)+COMPOUND OF FORMULA I,   a chemosterilant selected from the group of substances consisting of apholate [CCN]+COMPOUND OF FORMULA I, bisazir (alternative name) [CCN]+COMPOUND OF FORMULA I, busulfan (alternative name) [CCN]+COMPOUND OF FORMULA I, diflubenzuron (250)+COMPOUND OF FORMULA I, dimatif (alternative name) [CCN]+COMPOUND OF FORMULA I, hemel [CCN]+COMPOUND OF FORMULA I, hempa [CCN]+COMPOUND OF FORMULA I, metepa [CCN]+COMPOUND OF FORMULA I, methiotepa [CCN]+COMPOUND OF FORMULA I, methyl apholate [CCN]+COMPOUND OF FORMULA I, morzid [CCN]+COMPOUND OF FORMULA I, penfluoron (alternative name) [CCN]+COMPOUND OF FORMULA I, tepa [CCN]+COMPOUND OF FORMULA I, thiohempa (alternative name) [CCN]+COMPOUND OF FORMULA I, thiotepa (alternative name) [CCN]+COMPOUND OF FORMULA I, tretamine (alternative name) [CCN] and uredepa (alternative name) [CCN]+COMPOUND OF FORMULA I,   an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (IUPAC name) (222)+COMPOUND OF FORMULA I, (E)-tridec-4-en-1-yl acetate (IUPAC name) (829)+COMPOUND OF FORMULA I, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541)+COMPOUND OF FORMULA I, (E,Z)-tetradeca-4,10-dien-1-yl acetate (IUPAC name) (779)+COMPOUND OF FORMULA I, (Z)-dodec-7-en-1-yl acetate (IUPAC name) (285)+COMPOUND OF FORMULA I, (Z)-hexadec-11-enal (IUPAC name) (436)+COMPOUND OF FORMULA I, (Z)-hexadec-11-en-1-yl acetate (IUPAC name) (437)+COMPOUND OF FORMULA I, (Z)-hexadec-13-en-11-yn-1-yl acetate (IUPAC name) (438)+COMPOUND OF FORMULA I, (Z)-icos-13-en-10-one (IUPAC name) (448)+COMPOUND OF FORMULA I, (Z)-tetradec-7-en-1-al (IUPAC name) (782)+COMPOUND OF FORMULA I, (Z)-tetradec-9-en-1-ol (IUPAC name) (783)+COMPOUND OF FORMULA I, (Z)-tetradec-9-en-1-yl acetate (IUPAC name) (784)+COMPOUND OF FORMULA I, (7E,9Z)-dodeca-7,9-dien-1-yl acetate (IUPAC name) (283)+COMPOUND OF FORMULA I, (9Z,11E)-tetradeca-9,11-dien-1-yl acetate (IUPAC name) (780)+COMPOUND OF FORMULA I, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate (IUPAC name) (781)+COMPOUND OF FORMULA I, 14-methyloctadec-1-ene (IUPAC name) (545)+COMPOUND OF FORMULA I, 4-methylnonan-5-ol with 4-methylnonan-5-one (IUPAC name) (544)+COMPOUND OF FORMULA I, alpha-multistriatin (alternative name) [CCN]+COMPOUND OF FORMULA I, brevicomin (alternative name) [CCN]+COMPOUND OF FORMULA I, codlelure (alternative name) [CCN]+COMPOUND OF FORMULA I, codlemone (alternative name) (167)+COMPOUND OF FORMULA I, cuelure (alternative name) (179)+COMPOUND OF FORMULA I, disparlure (277)+COMPOUND OF FORMULA I, dodec-8-en-1-yl acetate (IUPAC name) (286)+COMPOUND OF FORMULA I, dodec-9-en-1-yl acetate (IUPAC name) (287)+COMPOUND OF FORMULA I, dodeca-8+COMPOUND OF FORMULA I, 10-dien-1-yl acetate (IUPAC name) (284)+COMPOUND OF FORMULA I, dominicalure (alternative name) [CCN]+COMPOUND OF FORMULA I, ethyl 4-methyloctanoate (IUPAC name) (317)+COMPOUND OF FORMULA I, eugenol (alternative name) [CCN]+COMPOUND OF FORMULA I, frontalin (alternative name) [CCN]+COMPOUND OF FORMULA I, gossyplure (alternative name) (420)+COMPOUND OF FORMULA I, grandlure (421)+COMPOUND OF FORMULA I, grandlure I (alternative name) (421)+COMPOUND OF FORMULA I, grandlure II (alternative name) (421)+COMPOUND OF FORMULA I, grandlure III (alternative name) (421)+COMPOUND OF FORMULA I, grandlure IV (alternative name) (421)+COMPOUND OF FORMULA I, hexylure [CCN]+COMPOUND OF FORMULA I, ipsdienol (alternative name) [CCN]+COMPOUND OF FORMULA I, ipsenol (alternative name) [CCN]+COMPOUND OF FORMULA I, japonilure (alternative name) (481)+COMPOUND OF FORMULA I, lineatin (alternative name) [CCN]+COMPOUND OF FORMULA I, litlure (alternative name) [CCN]+COMPOUND OF FORMULA I, looplure (alternative name) [CCN]+COMPOUND OF FORMULA I, medlure [CCN]+COMPOUND OF FORMULA I, megatomoic acid (alternative name) [CCN]+COMPOUND OF FORMULA I, methyl eugenol (alternative name) (540)+COMPOUND OF FORMULA I, muscalure (563)+COMPOUND OF FORMULA I, octadeca-2,13-dien-1-yl acetate (IUPAC name) (588)+COMPOUND OF FORMULA I, octadeca-3,13-dien-1-yl acetate (IUPAC name) (589)+COMPOUND OF FORMULA I, orfralure (alternative name) [CCN]+COMPOUND OF FORMULA I, oryctalure (alternative name) (317)+COMPOUND OF FORMULA I, ostramone (alternative name) [CCN]+COMPOUND OF FORMULA I, siglure [CCN]+COMPOUND OF FORMULA I, sordidin (alternative name) (736)+COMPOUND OF FORMULA I, sulcatol (alternative name) [CCN]+COMPOUND OF FORMULA I, tetradec-11-en-1-yl acetate (IUPAC name) (785)+COMPOUND OF FORMULA I, trimedlure (839)+COMPOUND OF FORMULA I, trimedlure A (alternative name) (839)+COMPOUND OF FORMULA I, trimedlure B 1  (alternative name) (839)+COMPOUND OF FORMULA I, trimedlure B 2  (alternative name) (839)+COMPOUND OF FORMULA I, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN]+COMPOUND OF FORMULA I,   an insect repellent selected from the group of substances consisting of 2-(octylthio)-ethanol (IUPAC name) (591)+COMPOUND OF FORMULA I, butopyronoxyl (933)+COMPOUND OF FORMULA I, butoxy(polypropylene glycol) (936)+COMPOUND OF FORMULA I, dibutyl adipate (IUPAC name) (1046)+COMPOUND OF FORMULA I, dibutyl phthalate (1047)+COMPOUND OF FORMULA I, dibutyl succinate (IUPAC name) (1048)+COMPOUND OF FORMULA I, diethyltoluamide [CCN]+COMPOUND OF FORMULA I, dimethyl carbate [CCN]+COMPOUND OF FORMULA I, dimethyl phthalate [CCN]+COMPOUND OF FORMULA I, ethyl hexanediol (1137)+COMPOUND OF FORMULA I, hexamide [CCN]+COMPOUND OF FORMULA I, methoquin-butyl (1276)+COMPOUND OF FORMULA I, methylneodecanamide [CCN]+COMPOUND OF FORMULA I, oxamate [CCN] and picaridin [CCN]+COMPOUND OF FORMULA I,   an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane (IUPAC/Chemical Abstracts name) (1058)+COMPOUND OF FORMULA I, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane (IUPAC name) (1056), +COMPOUND OF FORMULA I, 1,2-dichloropropane (IUPAC/Chemical Abstracts name) (1062)+COMPOUND OF FORMULA I, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063)+COMPOUND OF FORMULA I, 1-bromo-2-chloroethane (IUPAC/Chemical Abstracts name) (916)+COMPOUND OF FORMULA I, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate (IUPAC name) (1451)+COMPOUND OF FORMULA I, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (IUPAC name) (1066)+COMPOUND OF FORMULA I, 2-(1,3-dithiolan-2-yl)phenyl dimethylcarbamate (IUPAC/Chemical Abstracts name) (1109)+COMPOUND OF FORMULA I, 2-(2-butoxyethoxy)ethyl thiocyanate (IUPAC/Chemical Abstracts name) (935)+COMPOUND OF FORMULA I, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenyl methylcarbamate (IUPAC/Chemical Abstracts name) (1084)+COMPOUND OF FORMULA I, 2-(4-chloro-3,5-xylyloxy)ethanol (IUPAC name) (986)+COMPOUND OF FORMULA I, 2-chlorovinyl diethyl phosphate (IUPAC name) (984)+COMPOUND OF FORMULA I, 2-imidazolidone (IUPAC name) (1225)+COMPOUND OF FORMULA I, 2-isovalerylindan-1,3-dione (IUPAC name) (1246)+COMPOUND OF FORMULA I, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (IUPAC name) (1284)+COMPOUND OF FORMULA I, 2-thiocyanatoethyl laurate (IUPAC name) (1433)+COMPOUND OF FORMULA I, 3-bromo-1-chloroprop-1-ene (IUPAC name) (917)+COMPOUND OF FORMULA I, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (IUPAC name) (1283)+COMPOUND OF FORMULA I, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (IUPAC name) (1285)+COMPOUND OF FORMULA I, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate (IUPAC name) (1085)+COMPOUND OF FORMULA I, abamectin (1)+COMPOUND OF FORMULA I, acephate (2)+COMPOUND OF FORMULA I, acetamiprid (4)+COMPOUND OF FORMULA I, acethion (alternative name) [CCN]+COMPOUND OF FORMULA I, acetoprole [CCN]+COMPOUND OF FORMULA I, acrinathrin (9)+COMPOUND OF FORMULA I, acrylonitrile (IUPAC name) (861)+COMPOUND OF FORMULA I, alanycarb (15)+COMPOUND OF FORMULA I, aldicarb (16)+COMPOUND OF FORMULA I, aldoxycarb (863)+COMPOUND OF FORMULA I, aldrin (864)+COMPOUND OF FORMULA I, allethrin (17)+COMPOUND OF FORMULA I, allosamidin (alternative name) [CCN]+COMPOUND OF FORMULA I, allyxycarb (866)+COMPOUND OF FORMULA I, alpha-cypermethrin (202)+COMPOUND OF FORMULA I, alpha-ecdysone (alternative name) [CCN]+COMPOUND OF FORMULA I, alpha-endosulfan [CCN]+COMPOUND OF FORMULA I, aluminium phosphide (640)+COMPOUND OF FORMULA I, amidithion (870)+COMPOUND OF FORMULA I, amidothioate (872)+COMPOUND OF FORMULA I, aminocarb (873)+COMPOUND OF FORMULA I, amiton (875)+COMPOUND OF FORMULA I, amiton hydrogen oxalate (875)+COMPOUND OF FORMULA I, amitraz (24)+COMPOUND OF FORMULA I, anabasine (877)+COMPOUND OF FORMULA I, athidathion (883)+COMPOUND OF FORMULA I, AVI 382 (compound code)+COMPOUND OF FORMULA I, AZ 60541 (compound code)+COMPOUND OF FORMULA I, azadirachtin (alternative name) (41)+COMPOUND OF FORMULA I, azamethiphos (42)+COMPOUND OF FORMULA I, azinphos-ethyl (44)+COMPOUND OF FORMULA I, azinphos-methyl (45)+COMPOUND OF FORMULA I, azothoate (889)+COMPOUND OF FORMULA I,  Bacillus thuringiensis  delta endotoxins (alternative name) (52)+COMPOUND OF FORMULA I, barium hexafluorosilicate (alternative name) [CCN]+COMPOUND OF FORMULA I, barium polysulfide (IUPAC/Chemical Abstracts name) (892)+COMPOUND OF FORMULA I, barthrin [CCN]+COMPOUND OF FORMULA I, Bayer 22/190 (development code) (893)+COMPOUND OF FORMULA I, Bayer 22408 (development code) (894)+COMPOUND OF FORMULA I, bendiocarb (58)+COMPOUND OF FORMULA I, benfuracarb (60)+COMPOUND OF FORMULA I, bensultap (66)+COMPOUND OF FORMULA I, beta-cyfluthrin (194)+COMPOUND OF FORMULA I, beta-cypermethrin (203)+COMPOUND OF FORMULA I, bifenthrin (76)+COMPOUND OF FORMULA I, bioallethrin (78)+COMPOUND OF FORMULA I, bioallethrin S-cyclopentenyl isomer (alternative name) (79)+COMPOUND OF FORMULA I, bioethanomethrin [CCN]+COMPOUND OF FORMULA I, biopermethrin (908)+COMPOUND OF FORMULA I, bioresmethrin (80)+COMPOUND OF FORMULA I, bis(2-chloroethyl)ether (IUPAC name) (909)+COMPOUND OF FORMULA I, bistrifluoron (83)+COMPOUND OF FORMULA I, borax (86)+COMPOUND OF FORMULA I, brofenvalerate (alternative name)+COMPOUND OF FORMULA I, bromfenvinfos (914)+COMPOUND OF FORMULA I, bromocyclen (918)+COMPOUND OF FORMULA I, bromo-DDT (alternative name) [CCN]+COMPOUND OF FORMULA I, bromophos (920)+COMPOUND OF FORMULA I, bromophos-ethyl (921)+COMPOUND OF FORMULA I, bufencarb (924)+COMPOUND OF FORMULA I, buprofezin (99)+COMPOUND OF FORMULA I, butacarb (926)+COMPOUND OF FORMULA I, butathiofos (927)+COMPOUND OF FORMULA I, butocarboxim (103)+COMPOUND OF FORMULA I, butonate (932)+COMPOUND OF FORMULA I, butoxycarboxim (104)+COMPOUND OF FORMULA I, butylpyridaben (alternative name)+COMPOUND OF FORMULA I, BY102960+COMPOUND OF FORMULA I, cadusafos (109)+COMPOUND OF FORMULA I, calcium arsenate [CCN]+COMPOUND OF FORMULA I, calcium cyanide (444)+COMPOUND OF FORMULA I, calcium polysulfide (IUPAC name) (111)+COMPOUND OF FORMULA I, camphechlor (941)+COMPOUND OF FORMULA I, carbanolate (943)+COMPOUND OF FORMULA I, carbaryl (115)+COMPOUND OF FORMULA I, carbofuran (118)+COMPOUND OF FORMULA I, carbon disulfide (IUPAC/Chemical Abstracts name) (945)+COMPOUND OF FORMULA I, carbon tetrachloride (IUPAC name) (946)+COMPOUND OF FORMULA I, carbophenothion (947)+COMPOUND OF FORMULA I, carbosulfan (119)+COMPOUND OF FORMULA I, cartap (123)+COMPOUND OF FORMULA I, cartap hydrochloride (123)+COMPOUND OF FORMULA I, cevadine (alternative name) (725)+COMPOUND OF FORMULA I, chlorantraniliprole [CCN]+COMPOUND OF FORMULA I, chlorbicyclen (960)+COMPOUND OF FORMULA I, chlordane (128)+COMPOUND OF FORMULA I, chlordecone (963)+COMPOUND OF FORMULA I, chlordimeform (964)+COMPOUND OF FORMULA I, chlordimeform hydrochloride (964)+COMPOUND OF FORMULA I, chlorethoxyfos (129)+COMPOUND OF FORMULA I, chlorfenapyr (130)+COMPOUND OF FORMULA I, chlorfenvinphos (131)+COMPOUND OF FORMULA I, chlorfluazuron (132)+COMPOUND OF FORMULA I, chlormephos (136)+COMPOUND OF FORMULA I, chloroform [CCN]+COMPOUND OF FORMULA I, chloropicrin (141)+COMPOUND OF FORMULA I, chlorphoxim (989)+COMPOUND OF FORMULA I, chlorprazophos (990)+COMPOUND OF FORMULA I, chlorpyrifos (145)+COMPOUND OF FORMULA I, chlorpyrifos-methyl (146)+COMPOUND OF FORMULA I, chlorthiophos (994)+COMPOUND OF FORMULA I, chromafenozide (150)+COMPOUND OF FORMULA I, cinerin I (696)+COMPOUND OF FORMULA I, cinerin II (696)+COMPOUND OF FORMULA I, cinerins (696)+COMPOUND OF FORMULA I, cis-resmethrin (alternative name)+COMPOUND OF FORMULA I, cismethrin (80)+COMPOUND OF FORMULA I, clocythrin (alternative name)+COMPOUND OF FORMULA I, cloethocarb (999)+COMPOUND OF FORMULA I, closantel (alternative name) [CCN]+COMPOUND OF FORMULA I, clothianidin (165)+COMPOUND OF FORMULA I, copper acetoarsenite [CCN]+COMPOUND OF FORMULA I, copper arsenate [CCN]+COMPOUND OF FORMULA I, copper oleate [CCN]+COMPOUND OF FORMULA I, coumaphos (174)+COMPOUND OF FORMULA I, coumithoate (1006)+COMPOUND OF FORMULA I, crotamiton (alternative name) [CCN]+COMPOUND OF FORMULA I, crotoxyphos (1010)+COMPOUND OF FORMULA I, crufomate (1011)+COMPOUND OF FORMULA I, cryolite (alternative name) (177)+COMPOUND OF FORMULA I, CS 708 (development code) (1012)+COMPOUND OF FORMULA I, cyanofenphos (1019)+COMPOUND OF FORMULA I, cyanophos (184)+COMPOUND OF FORMULA I, cyanthoate (1020)+COMPOUND OF FORMULA I, cyantraniliprole [CCN]+COMPOUND OF FORMULA I, cyclethrin [CCN]+COMPOUND OF FORMULA I, cycloprothrin (188)+COMPOUND OF FORMULA I, cyfluthrin (193)+COMPOUND OF FORMULA I, cyhalothrin (196)+COMPOUND OF FORMULA I, cypermethrin (201)+COMPOUND OF FORMULA I, cyphenothrin (206)+COMPOUND OF FORMULA I, cyromazine (209)+COMPOUND OF FORMULA I, cythioate (alternative name) [CCN]+COMPOUND OF FORMULA I, d-limonene (alternative name) [CCN]+COMPOUND OF FORMULA I, d-tetramethrin (alternative name) (788)+COMPOUND OF FORMULA I, DAEP (1031)+COMPOUND OF FORMULA I, dazomet (216)+COMPOUND OF FORMULA I, DDT (219)+COMPOUND OF FORMULA I, decarbofuran (1034)+COMPOUND OF FORMULA I, deltamethrin (223)+COMPOUND OF FORMULA I, demephion (1037)+COMPOUND OF FORMULA I, demephion-O (1037)+COMPOUND OF FORMULA I, demephion-S (1037)+COMPOUND OF FORMULA I, demeton (1038)+COMPOUND OF FORMULA I, demeton-methyl (224)+COMPOUND OF FORMULA I, demeton-O (1038)+COMPOUND OF FORMULA I, demeton-O-methyl (224)+COMPOUND OF FORMULA I, demeton-S (1038)+COMPOUND OF FORMULA I, demeton-S-methyl (224)+COMPOUND OF FORMULA I, demeton-S-methylsulphon (1039)+COMPOUND OF FORMULA I, diafenthiuron (226)+COMPOUND OF FORMULA I, dialifos (1042)+COMPOUND OF FORMULA I, diamidafos (1044)+COMPOUND OF FORMULA I, diazinon (227)+COMPOUND OF FORMULA I, dicapthon (1050)+COMPOUND OF FORMULA I, dichlofenthion (1051)+COMPOUND OF FORMULA I, dichlorvos (236)+COMPOUND OF FORMULA I, dicliphos (alternative name)+COMPOUND OF FORMULA I, dicresyl (alternative name) [CCN]+COMPOUND OF FORMULA I, dicrotophos (243)+COMPOUND OF FORMULA I, dicyclanil (244)+COMPOUND OF FORMULA I, dieldrin (1070)+COMPOUND OF FORMULA I, diethyl 5-methylpyrazol-3-yl phosphate (IUPAC name) (1076)+COMPOUND OF FORMULA I, diflubenzuron (250)+COMPOUND OF FORMULA I, dilor (alternative name) [CCN]+COMPOUND OF FORMULA I, dimefluthrin [CCN]+COMPOUND OF FORMULA I, dimefox (1081)+COMPOUND OF FORMULA I, dimetan (1085)+COMPOUND OF FORMULA I, dimethoate (262)+COMPOUND OF FORMULA I, dimethrin (1083)+COMPOUND OF FORMULA I, dimethylvinphos (265)+COMPOUND OF FORMULA I, dimetilan (1086)+COMPOUND OF FORMULA I, dinex (1089)+COMPOUND OF FORMULA I, dinex-diclexine (1089)+COMPOUND OF FORMULA I, dinoprop (1093)+COMPOUND OF FORMULA I, dinosam (1094)+COMPOUND OF FORMULA I, dinoseb (1095)+COMPOUND OF FORMULA I, dinotefuran (271)+COMPOUND OF FORMULA I, diofenolan (1099)+COMPOUND OF FORMULA I, dioxabenzofos (1100)+COMPOUND OF FORMULA I, dioxacarb (1101)+COMPOUND OF FORMULA I, dioxathion (1102)+COMPOUND OF FORMULA I, disulfoton (278)+COMPOUND OF FORMULA I, dithicrofos (1108)+COMPOUND OF FORMULA I, DNOC (282)+COMPOUND OF FORMULA I, doramectin (alternative name) [CCN]+COMPOUND OF FORMULA I, DSP (1115)+COMPOUND OF FORMULA I, ecdysterone (alternative name) [CCN]+COMPOUND OF FORMULA I, E11642 (development code) (1118)+COMPOUND OF FORMULA I, emamectin (291)+COMPOUND OF FORMULA I, emamectin benzoate (291)+COMPOUND OF FORMULA I, EMPC (1120)+COMPOUND OF FORMULA I, empenthrin (292)+COMPOUND OF FORMULA I, endosulfan (294)+COMPOUND OF FORMULA I, endothion (1121)+COMPOUND OF FORMULA I, endrin (1122)+COMPOUND OF FORMULA I, EPBP (1123)+COMPOUND OF FORMULA I, EPN (297)+COMPOUND OF FORMULA I, epofenonane (1124)+COMPOUND OF FORMULA I, eprinomectin (alternative name) [CCN]+COMPOUND OF FORMULA I, esfenvalerate (302)+COMPOUND OF FORMULA I, etaphos (alternative name) [CCN]+COMPOUND OF FORMULA I, ethiofencarb (308)+COMPOUND OF FORMULA I, ethion (309)+COMPOUND OF FORMULA I, ethiprole (310)+COMPOUND OF FORMULA I, ethoate-methyl (1134)+COMPOUND OF FORMULA I, ethoprophos (312)+COMPOUND OF FORMULA I, ethyl formate (IUPAC name) [CCN]+COMPOUND OF FORMULA I, ethyl-DDD (alternative name) (1056)+COMPOUND OF FORMULA I, ethylene dibromide (316)+COMPOUND OF FORMULA I, ethylene dichloride (chemical name) (1136)+COMPOUND OF FORMULA I, ethylene oxide [CCN]+COMPOUND OF FORMULA I, etofenprox (319)+COMPOUND OF FORMULA I, etrimfos (1142)+COMPOUND OF FORMULA I, EXD (1143)+COMPOUND OF FORMULA I, famphur (323)+COMPOUND OF FORMULA I, fenamiphos (326)+COMPOUND OF FORMULA I, fenazaflor (1147)+COMPOUND OF FORMULA I, fenchlorphos (1148)+COMPOUND OF FORMULA I, fenethacarb (1149)+COMPOUND OF FORMULA I, fenfluthrin (1150)+COMPOUND OF FORMULA I, fenitrothion (335)+COMPOUND OF FORMULA I, fenobucarb (336)+COMPOUND OF FORMULA I, fenoxacrim (1153)+COMPOUND OF FORMULA I, fenoxycarb (340)+COMPOUND OF FORMULA I, fenpirithrin (1155)+COMPOUND OF FORMULA I, fenpropathrin (342)+COMPOUND OF FORMULA I, fenpyrad (alternative name)+COMPOUND OF FORMULA I, fensulfothion (1158)+COMPOUND OF FORMULA I, fenthion (346)+COMPOUND OF FORMULA I, fenthion-ethyl [CCN]+COMPOUND OF FORMULA I, fenvalerate (349)+COMPOUND OF FORMULA I, fipronil (354)+COMPOUND OF FORMULA I, flonicamid (358)+COMPOUND OF FORMULA I, flubendiamide (CAS. Reg. No.: 272451-65-7)+COMPOUND OF FORMULA I, flucofuron (1168)+COMPOUND OF FORMULA I, flucycloxuron (366)+COMPOUND OF FORMULA I, flucythrinate (367)+COMPOUND OF FORMULA I, fluenetil (1169)+COMPOUND OF FORMULA I, flufenerim [CCN]+COMPOUND OF FORMULA I, flufenoxuron (370)+COMPOUND OF FORMULA I, flufenprox (1171)+COMPOUND OF FORMULA I, flumethrin (372)+COMPOUND OF FORMULA I, fluvalinate (1184)+COMPOUND OF FORMULA I, FMC 1137 (development code) (1185)+COMPOUND OF FORMULA I, fonofos (1191)+COMPOUND OF FORMULA I, formetanate (405)+COMPOUND OF FORMULA I, formetanate hydrochloride (405)+COMPOUND OF FORMULA I, formothion (1192)+COMPOUND OF FORMULA I, formparanate (1193)+COMPOUND OF FORMULA I, fosmethilan (1194)+COMPOUND OF FORMULA I, fospirate (1195)+COMPOUND OF FORMULA I, fosthiazate (408)+COMPOUND OF FORMULA I, fosthietan (1196)+COMPOUND OF FORMULA I, furathiocarb (412)+COMPOUND OF FORMULA I, furethrin (1200)+COMPOUND OF FORMULA I, gamma-cyhalothrin (197)+COMPOUND OF FORMULA I, gamma-HCH (430)+COMPOUND OF FORMULA I, guazatine (422)+COMPOUND OF FORMULA I, guazatine acetates (422)+COMPOUND OF FORMULA I, GY-81 (development code) (423)+COMPOUND OF FORMULA I, halfenprox (424)+COMPOUND OF FORMULA I, halofenozide (425)+COMPOUND OF FORMULA I, HCH (430)+COMPOUND OF FORMULA I, HEOD (1070)+COMPOUND OF FORMULA I, heptachlor (1211)+COMPOUND OF FORMULA I, heptenophos (432)+COMPOUND OF FORMULA I, heterophos [CCN]+COMPOUND OF FORMULA I, hexaflumuron (439)+COMPOUND OF FORMULA I, HHDN (864)+COMPOUND OF FORMULA I, hydramethylnon (443)+COMPOUND OF FORMULA I, hydrogen cyanide (444)+COMPOUND OF FORMULA I, hydroprene (445)+COMPOUND OF FORMULA I, hyquincarb (1223)+COMPOUND OF FORMULA I, imidacloprid (458)+COMPOUND OF FORMULA I, imiprothrin (460)+COMPOUND OF FORMULA I, indoxacarb (465)+COMPOUND OF FORMULA I, iodomethane (IUPAC name) (542)+COMPOUND OF FORMULA I, IPSP (1229)+COMPOUND OF FORMULA I, isazofos (1231)+COMPOUND OF FORMULA I, isobenzan (1232)+COMPOUND OF FORMULA I, isocarbophos (alternative name) (473)+COMPOUND OF FORMULA I, isodrin (1235)+COMPOUND OF FORMULA I, isofenphos (1236)+COMPOUND OF FORMULA I, isolane (1237)+COMPOUND OF FORMULA I, isoprocarb (472)+COMPOUND OF FORMULA I, isopropyl O-(methoxyaminothiophosphoryl)salicylate (IUPAC name) (473)+COMPOUND OF FORMULA I, isoprothiolane (474)+COMPOUND OF FORMULA I, isothioate (1244)+COMPOUND OF FORMULA I, isoxathion (480)+COMPOUND OF FORMULA I, ivermectin (alternative name) [CCN]+COMPOUND OF FORMULA I, jasmolin I (696)+COMPOUND OF FORMULA I, jasmolin II (696)+COMPOUND OF FORMULA I, jodfenphos (1248)+COMPOUND OF FORMULA I, juvenile hormone I (alternative name) [CCN]+COMPOUND OF FORMULA I, juvenile hormone II (alternative name) [CCN]+COMPOUND OF FORMULA I, juvenile hormone III (alternative name) [CCN]+COMPOUND OF FORMULA I, kelevan (1249)+COMPOUND OF FORMULA I, kinoprene (484)+COMPOUND OF FORMULA I, lambda-cyhalothrin (198)+COMPOUND OF FORMULA I, lead arsenate [CCN]+COMPOUND OF FORMULA I, lepimectin (CCN)+COMPOUND OF FORMULA I, leptophos (1250)+COMPOUND OF FORMULA I, lindane (430)+COMPOUND OF FORMULA I, lirimfos (1251)+COMPOUND OF FORMULA I, lufenuron (490)+COMPOUND OF FORMULA I, lythidathion (1253)+COMPOUND OF FORMULA I, m-cumenyl methylcarbamate (IUPAC name) (1014)+COMPOUND OF FORMULA I, magnesium phosphide (IUPAC name) (640)+COMPOUND OF FORMULA I, malathion (492)+COMPOUND OF FORMULA I, malonoben (1254)+COMPOUND OF FORMULA I, mazidox (1255)+COMPOUND OF FORMULA I, mecarbam (502)+COMPOUND OF FORMULA I, mecarphon (1258)+COMPOUND OF FORMULA I, menazon (1260)+COMPOUND OF FORMULA I, mephosfolan (1261)+COMPOUND OF FORMULA I, mercurous chloride (513)+COMPOUND OF FORMULA I, mesulfenfos (1263)+COMPOUND OF FORMULA I, metaflumizone (CCN)+COMPOUND OF FORMULA I, metam (519)+COMPOUND OF FORMULA I, metam-potassium (alternative name) (519)+COMPOUND OF FORMULA I, metam-sodium (519)+COMPOUND OF FORMULA I, methacrifos (1266)+COMPOUND OF FORMULA I, methamidophos (527)+COMPOUND OF FORMULA I, methanesulfonyl fluoride (IUPAC/Chemical Abstracts name) (1268)+COMPOUND OF FORMULA I, methidathion (529)+COMPOUND OF FORMULA I, methiocarb (530)+COMPOUND OF FORMULA I, methocrotophos (1273)+COMPOUND OF FORMULA I, methomyl (531)+COMPOUND OF FORMULA I, methoprene (532)+COMPOUND OF FORMULA I, methoquin-butyl (1276)+COMPOUND OF FORMULA I, methothrin (alternative name) (533)+COMPOUND OF FORMULA I, methoxychlor (534)+COMPOUND OF FORMULA I, methoxyfenozide (535)+COMPOUND OF FORMULA I, methyl bromide (537)+COMPOUND OF FORMULA I, methyl isothiocyanate (543)+COMPOUND OF FORMULA I, methylchloroform (alternative name) [CCN]+COMPOUND OF FORMULA I, methylene chloride [CCN]+COMPOUND OF FORMULA I, metofluthrin [CCN]+COMPOUND OF FORMULA I, metolcarb (550)+COMPOUND OF FORMULA I, metoxadiazone (1288)+COMPOUND OF FORMULA I, mevinphos (556)+COMPOUND OF FORMULA I, mexacarbate (1290)+COMPOUND OF FORMULA I, milbemectin (557)+COMPOUND OF FORMULA I, milbemycin oxime (alternative name) [CCN]+COMPOUND OF FORMULA I, mipafox (1293)+COMPOUND OF FORMULA I, mirex (1294)+COMPOUND OF FORMULA I, monocrotophos (561)+COMPOUND OF FORMULA I, morphothion (1300)+COMPOUND OF FORMULA I, moxidectin (alternative name) [CCN]+COMPOUND OF FORMULA I, naftalofos (alternative name) [CCN]+COMPOUND OF FORMULA I, naled (567)+COMPOUND OF FORMULA I, naphthalene (IUPAC/Chemical Abstracts name) (1303)+COMPOUND OF FORMULA I, NC-170 (development code) (1306)+COMPOUND OF FORMULA I, NC-184 (compound code)+COMPOUND OF FORMULA I, nicotine (578)+COMPOUND OF FORMULA I, nicotine sulfate (578)+COMPOUND OF FORMULA I, nifluridide (1309)+COMPOUND OF FORMULA I, nitenpyram (579)+COMPOUND OF FORMULA I, nithiazine (1311)+COMPOUND OF FORMULA I, nitrilacarb (1313)+COMPOUND OF FORMULA I, nitrilacarb 1:1 zinc chloride complex (1313)+COMPOUND OF FORMULA I, NNI-0101 (compound code)+COMPOUND OF FORMULA I, NNI-0250 (compound code)+COMPOUND OF FORMULA I, nornicotine (traditional name) (1319)+COMPOUND OF FORMULA I, novaluron (585)+COMPOUND OF FORMULA I, noviflumuron (586)+COMPOUND OF FORMULA I, O-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (IUPAC name) (1057)+COMPOUND OF FORMULA I, O,O-diethyl O-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate (IUPAC name) (1074)+COMPOUND OF FORMULA I, O,O-diethyl O-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (IUPAC name) (1075)+COMPOUND OF FORMULA I, O,O,O′,O′-tetrapropyl dithiopyrophosphate (IUPAC name) (1424)+COMPOUND OF FORMULA I, oleic acid (IUPAC name) (593)+COMPOUND OF FORMULA I, omethoate (594)+COMPOUND OF FORMULA I, oxamyl (602)+COMPOUND OF FORMULA I, oxydemeton-methyl (609)+COMPOUND OF FORMULA I, oxydeprofos (1324)+COMPOUND OF FORMULA I, oxydisulfoton (1325)+COMPOUND OF FORMULA I, pp′-DDT (219)+COMPOUND OF FORMULA I, para-dichlorobenzene [CCN]+COMPOUND OF FORMULA I, parathion (615)+COMPOUND OF FORMULA I, parathion-methyl (616)+COMPOUND OF FORMULA I, penfluoron (alternative name) [CCN]+COMPOUND OF FORMULA I, pentachlorophenol (623)+COMPOUND OF FORMULA I, pentachlorophenyl laurate (IUPAC name) (623)+COMPOUND OF FORMULA I, permethrin (626)+COMPOUND OF FORMULA I, petroleum oils (alternative name) (628)+COMPOUND OF FORMULA I, PH 60-38 (development code) (1328)+COMPOUND OF FORMULA I, phenkapton (1330)+COMPOUND OF FORMULA I, phenothrin (630)+COMPOUND OF FORMULA I, phenthoate (631)+COMPOUND OF FORMULA I, phorate (636)+COMPOUND OF FORMULA I, phosalone (637)+COMPOUND OF FORMULA I, phosfolan (1338)+COMPOUND OF FORMULA I, phosmet (638)+COMPOUND OF FORMULA I, phosnichlor (1339)+COMPOUND OF FORMULA I, phosphamidon (639)+COMPOUND OF FORMULA I, phosphine (IUPAC name) (640)+COMPOUND OF FORMULA I, phoxim (642)+COMPOUND OF FORMULA I, phoxim-methyl (1340)+COMPOUND OF FORMULA I, pirimetaphos (1344)+COMPOUND OF FORMULA I, pirimicarb (651)+COMPOUND OF FORMULA I, pirimiphos-ethyl (1345)+COMPOUND OF FORMULA I, pirimiphos-methyl (652)+COMPOUND OF FORMULA I, polychlorodicyclopentadiene isomers (IUPAC name) (1346)+COMPOUND OF FORMULA I, polychloroterpenes (traditional name) (1347)+COMPOUND OF FORMULA I, potassium arsenite [CCN]+COMPOUND OF FORMULA I, potassium thiocyanate [CCN]+COMPOUND OF FORMULA I, prallethrin (655)+COMPOUND OF FORMULA I, precocene I (alternative name) [CCN]+COMPOUND OF FORMULA I, precocene II (alternative name) [CCN]+COMPOUND OF FORMULA I, precocene Ill (alternative name) [CCN]+COMPOUND OF FORMULA I, primidophos (1349)+COMPOUND OF FORMULA I, profenofos (662)+COMPOUND OF FORMULA I, profluthrin [CCN]+COMPOUND OF FORMULA I, promacyl (1354)+COMPOUND OF FORMULA I, promecarb (1355)+COMPOUND OF FORMULA I, propaphos (1356)+COMPOUND OF FORMULA I, propetamphos (673)+COMPOUND OF FORMULA I, propoxur (678)+COMPOUND OF FORMULA I, prothidathion (1360)+COMPOUND OF FORMULA I, prothiofos (686)+COMPOUND OF FORMULA I, prothoate (1362)+COMPOUND OF FORMULA I, protrifenbute [CCN]+COMPOUND OF FORMULA I, pymetrozine (688)+COMPOUND OF FORMULA I, pyraclofos (689)+COMPOUND OF FORMULA I, pyrafluprole [CCN]+COMPOUND OF FORMULA I, pyrazophos (693)+COMPOUND OF FORMULA I, pyresmethrin (1367)+COMPOUND OF FORMULA I, pyrethrin I (696)+COMPOUND OF FORMULA I, pyrethrin II (696)+COMPOUND OF FORMULA I, pyrethrins (696)+COMPOUND OF FORMULA I, pyridaben (699)+COMPOUND OF FORMULA I, pyridalyl (700)+COMPOUND OF FORMULA I, pyridaphenthion (701)+COMPOUND OF FORMULA I, pyrifluquinazon [CCN]+COMPOUND OF FORMULA I, pyrimidifen (706)+COMPOUND OF FORMULA I, pyrimitate (1370)+COMPOUND OF FORMULA I, pyriprole [CCN]+COMPOUND OF FORMULA I, pyriproxyfen (708)+COMPOUND OF FORMULA I, quassia (alternative name) [CCN]+COMPOUND OF FORMULA I, quinalphos (711)+COMPOUND OF FORMULA I, quinalphos-methyl (1376)+COMPOUND OF FORMULA I, quinothion (1380)+COMPOUND OF FORMULA I, quintiofos (1381)+COMPOUND OF FORMULA I, R-1492 (development code) (1382)+COMPOUND OF FORMULA I, rafoxanide (alternative name) [CCN]+COMPOUND OF FORMULA I, resmethrin (719)+COMPOUND OF FORMULA I, rotenone (722)+COMPOUND OF FORMULA I, RU 15525 (development code) (723)+COMPOUND OF FORMULA I, RU 25475 (development code) (1386)+COMPOUND OF FORMULA I, ryania (alternative name) (1387)+COMPOUND OF FORMULA I, ryanodine (traditional name) (1387)+COMPOUND OF FORMULA I, sabadilla (alternative name) (725)+COMPOUND OF FORMULA I, schradan (1389)+COMPOUND OF FORMULA I, sebufos (alternative name)+COMPOUND OF FORMULA I, selamectin (alternative name) [CCN]+COMPOUND OF FORMULA I, SI-0009 (compound code)+COMPOUND OF FORMULA I, SI-0205 (compound code)+COMPOUND OF FORMULA I, SI-0404 (compound code)+COMPOUND OF FORMULA I, SI-0405 (compound code)+COMPOUND OF FORMULA I, silafluofen (728)+COMPOUND OF FORMULA I, SN 72129 (development code) (1397)+COMPOUND OF FORMULA I, sodium arsenite [CCN]+COMPOUND OF FORMULA I, sodium cyanide (444)+COMPOUND OF FORMULA I, sodium fluoride (IUPAC/Chemical Abstracts name) (1399)+COMPOUND OF FORMULA I, sodium hexafluorosilicate (1400)+COMPOUND OF FORMULA I, sodium pentachlorophenoxide (623)+COMPOUND OF FORMULA I, sodium selenate (IUPAC name) (1401)+COMPOUND OF FORMULA I, sodium thiocyanate [CCN]+COMPOUND OF FORMULA I, sophamide (1402)+COMPOUND OF FORMULA I, spinetoram [CCN]+COMPOUND OF FORMULA I, spinosad (737)+COMPOUND OF FORMULA I, spiromesifen (739)+COMPOUND OF FORMULA I, spirotetramat [CCN]+COMPOUND OF FORMULA I, sulcofuron (746)+COMPOUND OF FORMULA I, sulcofuron-sodium (746)+COMPOUND OF FORMULA I, sulfluramid (750)+COMPOUND OF FORMULA I, sulfotep (753)+COMPOUND OF FORMULA I, sulfoxaflor [CCN]+COMPOUND OF FORMULA I, sulfuryl fluoride (756)+COMPOUND OF FORMULA I, sulprofos (1408)+COMPOUND OF FORMULA I, tar oils (alternative name) (758)+COMPOUND OF FORMULA I, tau-fluvalinate (398)+COMPOUND OF FORMULA I, tazimcarb (1412)+COMPOUND OF FORMULA I, TDE (1414)+COMPOUND OF FORMULA I, tebufenozide (762)+COMPOUND OF FORMULA I, tebufenpyrad (763)+COMPOUND OF FORMULA I, tebupirimfos (764)+COMPOUND OF FORMULA I, teflubenzuron (768)+COMPOUND OF FORMULA I, tefluthrin (769)+COMPOUND OF FORMULA I, temephos (770)+COMPOUND OF FORMULA I, TEPP (1417)+COMPOUND OF FORMULA I, terallethrin (1418)+COMPOUND OF FORMULA I, terbam (alternative name)+COMPOUND OF FORMULA I, terbufos (773)+COMPOUND OF FORMULA I, tetrachloroethane [CCN]+COMPOUND OF FORMULA I, tetrachlorvinphos (777)+COMPOUND OF FORMULA I, tetramethrin (787)+COMPOUND OF FORMULA I, tetramethylfluthrin (CAS. Reg. No.: 84937-88-2)+COMPOUND OF FORMULA I, theta-cypermethrin (204)+COMPOUND OF FORMULA I, thiacloprid (791)+COMPOUND OF FORMULA I, thiafenox (alternative name)+COMPOUND OF FORMULA I, thiamethoxam (792)+COMPOUND OF FORMULA I, thicrofos (1428)+COMPOUND OF FORMULA I, thiocarboxime (1431)+COMPOUND OF FORMULA I, thiocyclam (798)+COMPOUND OF FORMULA I, thiocyclam hydrogen oxalate (798)+COMPOUND OF FORMULA I, thiodicarb (799)+COMPOUND OF FORMULA I, thiofanox (800)+COMPOUND OF FORMULA I, thiometon (801)+COMPOUND OF FORMULA I, thionazin (1434)+COMPOUND OF FORMULA I, thiosultap (803)+COMPOUND OF FORMULA I, thiosultap-sodium (803)+COMPOUND OF FORMULA I, thuringiensin (alternative name) [CCN]+COMPOUND OF FORMULA I, tolfenpyrad (809)+COMPOUND OF FORMULA I, tralomethrin (812)+COMPOUND OF FORMULA I, transfluthrin (813)+COMPOUND OF FORMULA I, transpermethrin (1440)+COMPOUND OF FORMULA I, triamiphos (1441)+COMPOUND OF FORMULA I, triazamate (818)+COMPOUND OF FORMULA I, triazophos (820)+COMPOUND OF FORMULA I, triazuron (alternative name)+COMPOUND OF FORMULA I, trichlorfon (824)+COMPOUND OF FORMULA I, trichlormetaphos-3 (alternative name) [CCN]+COMPOUND OF FORMULA I, trichloronat (1452)+COMPOUND OF FORMULA I, trifenofos (1455)+COMPOUND OF FORMULA I, triflumuron (835)+COMPOUND OF FORMULA I, trimethacarb (840)+COMPOUND OF FORMULA I, triprene (1459)+COMPOUND OF FORMULA I, vamidothion (847)+COMPOUND OF FORMULA I, vaniliprole [CCN]+COMPOUND OF FORMULA I, veratridine (alternative name) (725)+COMPOUND OF FORMULA I, veratrine (alternative name) (725)+COMPOUND OF FORMULA I, XMC (853)+COMPOUND OF FORMULA I, xylylcarb (854)+COMPOUND OF FORMULA I, yl-5302 (compound code)+COMPOUND OF FORMULA I, zeta-cypermethrin (205)+COMPOUND OF FORMULA I, zetamethrin (alternative name)+COMPOUND OF FORMULA I, zinc phosphide (640)+COMPOUND OF FORMULA I, zolaprofos (1469) and ZXI 8901 (development code) (858)+COMPOUND OF FORMULA I,   a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (IUPAC name) (913)+COMPOUND OF FORMULA I, bromoacetamide [CCN]+COMPOUND OF FORMULA I, calcium arsenate [CCN]+COMPOUND OF FORMULA I, cloethocarb (999)+COMPOUND OF FORMULA I, copper acetoarsenite [CCN]+COMPOUND OF FORMULA I, copper sulfate (172)+COMPOUND OF FORMULA I, fentin (347)+COMPOUND OF FORMULA I, ferric phosphate (IUPAC name) (352)+COMPOUND OF FORMULA I, metaldehyde (518)+COMPOUND OF FORMULA I, methiocarb (530)+COMPOUND OF FORMULA I, niclosamide (576)+COMPOUND OF FORMULA I, niclosamide-olamine (576)+COMPOUND OF FORMULA I, pentachlorophenol (623)+COMPOUND OF FORMULA I, sodium pentachlorophenoxide (623)+COMPOUND OF FORMULA I, tazimcarb (1412)+COMPOUND OF FORMULA I, thiodicarb (799)+COMPOUND OF FORMULA I, tralopyril [CCN]+COMPOUND OF FORMULA I, tributyltin oxide (913)+COMPOUND OF FORMULA I, trifenmorph (1454)+COMPOUND OF FORMULA I, trimethacarb (840)+COMPOUND OF FORMULA I, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+COMPOUND OF FORMULA I,   a nematicide selected from the group of substances consisting of AKD-3088 (compound code)+COMPOUND OF FORMULA I, 1,2-dibromo-3-chloropropane (IUPAC/Chemical Abstracts name) (1045)+COMPOUND OF FORMULA I, 1,2-dichloropropane (IUPAC/Chemical Abstracts name) (1062)+COMPOUND OF FORMULA 1,1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063)+COMPOUND OF FORMULA I, 1,3-dichloropropene (233)+COMPOUND OF FORMULA I, 3,4-dichlorotetrahydrothiophene 1,1-dioxide (IUPAC/Chemical Abstracts name) (1065)+COMPOUND OF FORMULA I, 3-(4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980)+COMPOUND OF FORMULA I, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid (IUPAC name) (1286)+COMPOUND OF FORMULA I, 6-isopentenylaminopurine (alternative name) (210)+COMPOUND OF FORMULA I, abamectin (1)+COMPOUND OF FORMULA I, acetoprole [CCN]+COMPOUND OF FORMULA I, alanycarb (15)+COMPOUND OF FORMULA I, aldicarb (16)+COMPOUND OF FORMULA I, aldoxycarb (863)+COMPOUND OF FORMULA I, AZ 60541 (compound code)+COMPOUND OF FORMULA I, benclothiaz [CCN]+COMPOUND OF FORMULA I, benomyl (62)+COMPOUND OF FORMULA I, butylpyridaben (alternative name)+COMPOUND OF FORMULA I, cadusafos (109)+COMPOUND OF FORMULA I, carbofuran (118)+COMPOUND OF FORMULA I, carbon disulfide (945)+COMPOUND OF FORMULA I, carbosulfan (119)+COMPOUND OF FORMULA I, chloropicrin (141)+COMPOUND OF FORMULA I, chlorpyrifos (145)+COMPOUND OF FORMULA I, cloethocarb (999)+COMPOUND OF FORMULA I, cytokinins (alternative name) (210)+COMPOUND OF FORMULA I, dazomet (216)+COMPOUND OF FORMULA I, DBCP (1045)+COMPOUND OF FORMULA I, DCIP (218)+COMPOUND OF FORMULA I, diamidafos (1044)+COMPOUND OF FORMULA I, dichlofenthion (1051)+COMPOUND OF FORMULA I, dicliphos (alternative name)+COMPOUND OF FORMULA I, dimethoate (262)+COMPOUND OF FORMULA I, doramectin (alternative name) [CCN]+COMPOUND OF FORMULA I, emamectin (291)+COMPOUND OF FORMULA I, emamectin benzoate (291)+COMPOUND OF FORMULA I, eprinomectin (alternative name) [CCN]+COMPOUND OF FORMULA I, ethoprophos (312)+COMPOUND OF FORMULA I, ethylene dibromide (316)+COMPOUND OF FORMULA I, fenamiphos (326)+COMPOUND OF FORMULA I, fenpyrad (alternative name)+COMPOUND OF FORMULA I, fensulfothion (1158)+COMPOUND OF FORMULA I, fluensulfone (CAS. Reg. No.: 318290-98-1)+COMPOUND OF FORMULA I, fosthiazate (408)+COMPOUND OF FORMULA I, fosthietan (1196)+COMPOUND OF FORMULA I, furfural (alternative name) [CCN]+COMPOUND OF FORMULA I, GY-81 (development code) (423)+COMPOUND OF FORMULA I, heterophos [CCN]+COMPOUND OF FORMULA I, imicyafos [CCN]+COMPOUND OF FORMULA I, iodomethane (IUPAC name) (542)+COMPOUND OF FORMULA I, isamidofos (1230)+COMPOUND OF FORMULA I, isazofos (1231)+COMPOUND OF FORMULA I, ivermectin (alternative name) [CCN]+COMPOUND OF FORMULA I, kinetin (alternative name) (210)+COMPOUND OF FORMULA I, mecarphon (1258)+COMPOUND OF FORMULA I, metam (519)+COMPOUND OF FORMULA I, metam-potassium (alternative name) (519)+COMPOUND OF FORMULA I, metam-sodium (519)+COMPOUND OF FORMULA I, methyl bromide (537)+COMPOUND OF FORMULA I, methyl isothiocyanate (543)+COMPOUND OF FORMULA I, milbemycin oxime (alternative name) [CCN]+COMPOUND OF FORMULA I, moxidectin (alternative name) [CCN]+COMPOUND OF FORMULA I,  Myrothecium verrucaria  composition (alternative name) (565)+COMPOUND OF FORMULA I, NC-184 (compound code)+COMPOUND OF FORMULA I, oxamyl (602)+COMPOUND OF FORMULA I, phorate (636)+COMPOUND OF FORMULA I, phosphamidon (639)+COMPOUND OF FORMULA I, phosphocarb [CCN]+COMPOUND OF FORMULA I, sebufos (alternative name)+COMPOUND OF FORMULA I, selamectin (alternative name) [CCN]+COMPOUND OF FORMULA I, spinosad (737)+COMPOUND OF FORMULA I, terbam (alternative name)+COMPOUND OF FORMULA I, terbufos (773)+COMPOUND OF FORMULA I, tetrachlorothiophene (IUPAC/Chemical Abstracts name) (1422)+COMPOUND OF FORMULA I, thiafenox (alternative name)+COMPOUND OF FORMULA I, thionazin (1434)+COMPOUND OF FORMULA I, triazophos (820)+COMPOUND OF FORMULA I, triazuron (alternative name)+COMPOUND OF FORMULA I, xylenols [CCN]+COMPOUND OF FORMULA I, yl-5302 (compound code) and zeatin (alternative name) (210)+COMPOUND OF FORMULA I,   a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580)+COMPOUND OF FORMULA I,   a plant activator selected from the group of substances consisting of acibenzolar (6)+COMPOUND OF FORMULA I, acibenzolar-S-methyl (6)+COMPOUND OF FORMULA I, probenazole (658) and  Reynoutria sachalinensis  extract (alternative name) (720)+COMPOUND OF FORMULA I,   a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1,3-dione (IUPAC name) (1246)+COMPOUND OF FORMULA I, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748)+COMPOUND OF FORMULA I, alpha-chlorohydrin [CCN]+COMPOUND OF FORMULA I, aluminium phosphide (640)+COMPOUND OF FORMULA I, antu (880)+COMPOUND OF FORMULA I, arsenous oxide (882)+COMPOUND OF FORMULA I, barium carbonate (891)+COMPOUND OF FORMULA I, bisthiosemi (912)+COMPOUND OF FORMULA I, brodifacoum (89)+COMPOUND OF FORMULA I, bromadiolone (91)+COMPOUND OF FORMULA I, bromethalin (92)+COMPOUND OF FORMULA I, calcium cyanide (444)+COMPOUND OF FORMULA I, chloralose (127)+COMPOUND OF FORMULA I, chlorophacinone (140)+COMPOUND OF FORMULA I, cholecalciferol (alternative name) (850)+COMPOUND OF FORMULA I, coumachlor (1004)+COMPOUND OF FORMULA I, coumafuryl (1005)+COMPOUND OF FORMULA I, coumatetralyl (175)+COMPOUND OF FORMULA I, crimidine (1009)+COMPOUND OF FORMULA I, difenacoum (246)+COMPOUND OF FORMULA I, difethialone (249)+COMPOUND OF FORMULA I, diphacinone (273)+COMPOUND OF FORMULA I, ergocalciferol (301)+COMPOUND OF FORMULA I, flocoumafen (357)+COMPOUND OF FORMULA I, fluoroacetamide (379)+COMPOUND OF FORMULA I, flupropadine (1183)+COMPOUND OF FORMULA I, flupropadine hydrochloride (1183)+COMPOUND OF FORMULA I, gamma-HCH (430)+COMPOUND OF FORMULA I, HCH (430)+COMPOUND OF FORMULA I, hydrogen cyanide (444)+COMPOUND OF FORMULA I, iodomethane (IUPAC name) (542)+COMPOUND OF FORMULA I, lindane (430)+COMPOUND OF FORMULA I, magnesium phosphide (IUPAC name) (640)+COMPOUND OF FORMULA I, methyl bromide (537)+COMPOUND OF FORMULA I, norbormide (1318)+COMPOUND OF FORMULA I, phosacetim (1336)+COMPOUND OF FORMULA I, phosphine (IUPAC name) (640)+COMPOUND OF FORMULA I, phosphorus [CCN]+COMPOUND OF FORMULA I, pindone (1341)+COMPOUND OF FORMULA I, potassium arsenite [CCN]+COMPOUND OF FORMULA I, pyrinuron (1371)+COMPOUND OF FORMULA I, scilliroside (1390)+COMPOUND OF FORMULA I, sodium arsenite [CCN]+COMPOUND OF FORMULA I, sodium cyanide (444)+COMPOUND OF FORMULA I, sodium fluoroacetate (735)+COMPOUND OF FORMULA I, strychnine (745)+COMPOUND OF FORMULA I, thallium sulfate [CCN]+COMPOUND OF FORMULA I, warfarin (851) and zinc phosphide (640)+COMPOUND OF FORMULA I,   a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)-ethyl piperonylate (IUPAC name) (934)+COMPOUND OF FORMULA I, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903)+COMPOUND OF FORMULA I, farnesol with nerolidol (alternative name) (324)+COMPOUND OF FORMULA I, MB-599 (development code) (498)+COMPOUND OF FORMULA I, MGK 264 (development code) (296)+COMPOUND OF FORMULA I, piperonyl butoxide (649)+COMPOUND OF FORMULA I, piprotal (1343)+COMPOUND OF FORMULA I, propyl isomer (1358)+COMPOUND OF FORMULA I, S421 (development code) (724)+COMPOUND OF FORMULA I, sesamex (1393)+COMPOUND OF FORMULA I, sesasmolin (1394) and sulfoxide (1406)+COMPOUND OF FORMULA I,   an animal repellent selected from the group of substances consisting of anthraquinone (32)+COMPOUND OF FORMULA I, chloralose (127)+COMPOUND OF FORMULA I, copper naphthenate [CCN]+COMPOUND OF FORMULA I, copper oxychloride (171)+COMPOUND OF FORMULA I, diazinon (227)+COMPOUND OF FORMULA I, dicyclopentadiene (chemical name) (1069)+COMPOUND OF FORMULA I, guazatine (422)+COMPOUND OF FORMULA I, guazatine acetates (422)+COMPOUND OF FORMULA I, methiocarb (530)+COMPOUND OF FORMULA I, pyridin-4-amine (IUPAC name) (23)+COMPOUND OF FORMULA I, thiram (804)+COMPOUND OF FORMULA I, trimethacarb (840)+COMPOUND OF FORMULA I, zinc naphthenate [CCN] and ziram (856)+COMPOUND OF FORMULA I,   a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN]+COMPOUND OF FORMULA I,   a wound protectant selected from the group of substances consisting of mercuric oxide (512)+COMPOUND OF FORMULA I, octhilinone (590) and thiophanate-methyl (802)+COMPOUND OF FORMULA I,   an insecticide selected from the group consisting of the compound of the formula A-1       

                         
the formula A-2
 
                         
the formula A-3
 
                         
the formula A-4
 
                         
the formula A-5
 
                         
the formula A-6
 
                         
the formula A-7
 
                         
the formula A-8
 
                         
the formula A-9
 
                         
the formula A-10
 
                         
the formula A-11
 
                         
the formula A-12
 
                         
the formula A-13
 
                         
the formula A-14
 
                         
the formula A-15
 
                         
the formula A-16
 
                         
the formula A-17
 
                         
the formula A-18
 
                         
the formula A-19
 
                         
the formula A-20
 
                         
the formula A-21
 
                         
the formula A-22
 
                         
the formula A-23
 
                         
the formula A-24
 
                         
the formula A-25
 
                         
the formula A-26
 
                         
and the formula A-27
 
     
       
         
         
             
             
         
       
         
         
           
             an insecticide selected from the group consisting of the compound of the formula A-28 
           
         
       
    
                         
the formula A-29
 
                         
and the formula A-30
 
     
       
         
         
             
             
         
       
         
         
           
             an insecticide selected from the group consisting of the compound of the formula A-31 
           
         
       
    
                         
the formula A-32
 
                         
and the formula A-33
 
     
       
         
         
             
             
         
       
     
     The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The compounds of the formula A-1 to A-26 are described in WO 03/015518 or in WO 04/067528. The compound of the formula A-27 is described in WO 06/022225 and in WO 07/112,844. The above described mixing partners are known. Where the active ingredients are included in “The Pesticide Manual” [The Pesticide Manual—A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound “abamectin” is described under entry number (1). Where “[CCN]” is added hereinabove to the particular compound, the compound in question is included in the “Compendium of Pesticide Common Names”, which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright© 1995-2004]; for example, the compound “acetoprole” is described under the internet address http://www.alanwood.net/pesticides/acetoprole.htmL. 
     Most of the active ingredients described above are referred to hereinabove by a so-called “common name”, the relevant “ISO common name” or another “common name” being used in individual cases. If the designation is not a “common name”, the nature of the designation used instead is given in round brackets for the particular compound; in that case, the IUPAC name, the IUPAC/Chemical Abstracts name, a “chemical name”, a “traditional name”, a “compound name” or a “development code” is used or, if neither one of those designations nor a “common name” is used, an “alternative name” is employed. “CAS Reg. No” means the Chemical Abstracts Registry Number. 
     The compounds of formula I according to the invention can also be used in combination with one or more fungicides. In particular, in the following mixtures of the compounds of formula I with fungicides, the term COMPOUND OF FORMULA I preferably refers to a compound selected from one of the Tables 1 to 60: 
     COMPOUND OF FORMULA I+(E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamide (SSF-129), COMPOUND OF FORMULA I+4-bromo-2-cyano-N,N-dimethyl-6-trifluoromethylbenzimidazole-1-sulphonamide, COMPOUND OF FORMULA I+α-[N-(3-chloro-2,6-xylyl)-2-methoxyacetamido]-γ-butyrolactone, COMPOUND OF FORMULA I+4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide (IKF-916, cyamidazosulfamid), COMPOUND OF FORMULA I+3-5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-4-methylbenzamide (RH-7281, zoxamide), COMPOUND OF FORMULA I+N-allyl-4,5,-dimethyl-2-trimethylsilylthiophene-3-carboxamide (MON65500), COMPOUND OF FORMULA I+N-(1-cyano-1,2-dimethylpropyl)-2-(2,4-dichlorophenoxy)propionamide (AC382042), COMPOUND OF FORMULA I+N-(2-methoxy-5-pyridyl)-cyclopropane carboxamide, COMPOUND OF FORMULA I+acibenzolar, COMPOUND OF FORMULA I+alanycarb, COMPOUND OF FORMULA I+aldimorph, COMPOUND OF FORMULA I+ametoctradin, COMPOUND OF FORMULA I+amisulbrom, COMPOUND OF FORMULA I+anilazine, COMPOUND OF FORMULA I+azaconazole, COMPOUND OF FORMULA I+azoxystrobin, COMPOUND OF FORMULA I+benalaxyl, COMPOUND OF FORMULA I+benalaxyl-M, COMPOUND OF FORMULA I+benomyl, COMPOUND OF FORMULA I+benthiavalicarb, COMPOUND OF FORMULA I+biloxazol, COMPOUND OF FORMULA I+bitertanol, COMPOUND OF FORMULA I+bixafen, COMPOUND OF FORMULA I+blasticidin S, COMPOUND OF FORMULA I+boscalid, COMPOUND OF FORMULA I+bromuconazole, COMPOUND OF FORMULA I+bupirimate, COMPOUND OF FORMULA I+captafol, COMPOUND OF FORMULA I+captan, COMPOUND OF FORMULA I+carbendazim, COMPOUND OF FORMULA I+carbendazim chlorhydrate, COMPOUND OF FORMULA I+carboxin, COMPOUND OF FORMULA I+carpropamid, carvone, COMPOUND OF FORMULA I+CGA41396, COMPOUND OF FORMULA I+CGA41397, COMPOUND OF FORMULA I+chinomethionate, COMPOUND OF FORMULA I+chlazafenone, COMPOUND OF FORMULA I+chlorothalonil, COMPOUND OF FORMULA I+chlorozolinate, COMPOUND OF FORMULA I+clozylacon, COMPOUND OF FORMULA I+copper containing compounds such as copper oxychloride, copper oxyquinolate, copper sulphate, copper tallate and Bordeaux mixture, COMPOUND OF FORMULA I+cyazofamid, COMPOUND OF FORMULA I+cyflufenamid, COMPOUND OF FORMULA I+cymoxanil, COMPOUND OF FORMULA I+cyproconazole, COMPOUND OF FORMULA I+cyprodinil, COMPOUND OF FORMULA I+debacarb, COMPOUND OF FORMULA I+di-2-pyridyl disulphide 1,1′-dioxide, COMPOUND OF FORMULA I+dichlofluanid, COMPOUND OF FORMULA I+diclomezine, COMPOUND OF FORMULA I+dicloran, COMPOUND OF FORMULA I+diethofencarb, COMPOUND OF FORMULA I+difenoconazole, COMPOUND OF FORMULA I+difenzoquat, COMPOUND OF FORMULA I+diflumetorim, COMPOUND OF FORMULA I+O,O-di-iso-propyl-S-benzyl thiophosphate, COMPOUND OF FORMULA I+dimefluazole, COMPOUND OF FORMULA I+dimetconazole, COMPOUND OF FORMULA I+dimethomorph, COMPOUND OF FORMULA I+dimethirimol, COMPOUND OF FORMULA I+dimoxystrobin, COMPOUND OF FORMULA I+diniconazole, COMPOUND OF FORMULA I+dinocap, COMPOUND OF FORMULA I+dithianon, COMPOUND OF FORMULA I+dodecyl dimethyl ammonium chloride, COMPOUND OF FORMULA I+dodemorph, COMPOUND OF FORMULA I+dodine, COMPOUND OF FORMULA I+doguadine, COMPOUND OF FORMULA I+edifenphos, COMPOUND OF FORMULA I+epoxiconazole, COMPOUND OF FORMULA I+ethirimol, COMPOUND OF FORMULA I+ethyl(Z)-N-benzyl-N([methyl(methyl-thioethylideneaminooxycarbonyl)amino]thio)-β-alaninate, COMPOUND OF FORMULA I+etridiazole, COMPOUND OF FORMULA I+famoxadone, COMPOUND OF FORMULA I+fenamidone (RPA407213), COMPOUND OF FORMULA I+fenarimol, COMPOUND OF FORMULA I+fenbuconazole, COMPOUND OF FORMULA I+fenfuram, COMPOUND OF FORMULA I+fenhexamid (KBR2738), COMPOUND OF FORMULA I+fenoxanil, COMPOUND OF FORMULA I+fenpiclonil, COMPOUND OF FORMULA I+fenpropidin, COMPOUND OF FORMULA I+fenpropimorph, COMPOUND OF FORMULA I+fenpyrazamine/ipfenpyrazolone, COMPOUND OF FORMULA I+fentin acetate, COMPOUND OF FORMULA I+fentin hydroxide, COMPOUND OF FORMULA I+ferbam, COMPOUND OF FORMULA I+ferimzone, COMPOUND OF FORMULA I+fluazinam, COMPOUND OF FORMULA I+fludioxonil, COMPOUND OF FORMULA I+flumetover, COMPOUND OF FORMULA I+flumorph, COMPOUND OF FORMULA I+fluopicolide, COMPOUND OF FORMULA I+fluopyram, COMPOUND OF FORMULA I+fluoxastrobin, COMPOUND OF FORMULA I+fluoroimide, COMPOUND OF FORMULA I+fluquinconazole, COMPOUND OF FORMULA I+flusilazole, COMPOUND OF FORMULA I+flutianil, COMPOUND OF FORMULA I+flutolanil, COMPOUND OF FORMULA I+flutriafol, COMPOUND OF FORMULA I+fluxapyroxad, COMPOUND OF FORMULA I+folpet, COMPOUND OF FORMULA I+fuberidazole, COMPOUND OF FORMULA I+furalaxyl, COMPOUND OF FORMULA I+furametpyr, COMPOUND OF FORMULA I+guazatine, COMPOUND OF FORMULA I+hexaconazole, COMPOUND OF FORMULA I+hydroxyisoxazole, COMPOUND OF FORMULA I+hymexazole, COMPOUND OF FORMULA I+imazalil, COMPOUND OF FORMULA I+imibenconazole, COMPOUND OF FORMULA I+iminoctadine, COMPOUND OF FORMULA I+iminoctadine triacetate, COMPOUND OF FORMULA I+ipconazole, COMPOUND OF FORMULA I+iprobenfos, COMPOUND OF FORMULA I+iprodione, COMPOUND OF FORMULA I+iprovalicarb (SZX0722), COMPOUND OF FORMULA I+isopropanyl butyl carbamate, COMPOUND OF FORMULA I+isoprothiolane, COMPOUND OF FORMULA I+isopyrazam, COMPOUND OF FORMULA I+isotianil, COMPOUND OF FORMULA I+kasugamycin, COMPOUND OF FORMULA I+kresoxim-methyl, COMPOUND OF FORMULA I+LY186054, COMPOUND OF FORMULA I+LY211795, COMPOUND OF FORMULA I+LY248908, COMPOUND OF FORMULA I+mancozeb, COMPOUND OF FORMULA I+mandipropamid, COMPOUND OF FORMULA I+maneb, COMPOUND OF FORMULA I+mefenoxam, COMPOUND OF FORMULA I+mepanipyrim, COMPOUND OF FORMULA I+mepronil, COMPOUND OF FORMULA I+meptyldinocap, COMPOUND OF FORMULA I+metalaxyl, COMPOUND OF FORMULA I+metconazole, COMPOUND OF FORMULA I+metiram, COMPOUND OF FORMULA I+metiram-zinc, COMPOUND OF FORMULA I+metominostrobin, COMPOUND OF FORMULA I+metrafenone, COMPOUND OF FORMULA I+myclobutanil, COMPOUND OF FORMULA I+neoasozin, COMPOUND OF FORMULA I+nickel dimethyldithiocarbamate, COMPOUND OF FORMULA I+nicobifen, COMPOUND OF FORMULA I+nitrothal-isopropyl, COMPOUND OF FORMULA I+nuarimol, COMPOUND OF FORMULA I+ofurace, COMPOUND OF FORMULA I+organomercury compounds, COMPOUND OF FORMULA I+orysastrobin, COMPOUND OF FORMULA I+oxadixyl, COMPOUND OF FORMULA I+oxasulfuron, COMPOUND OF FORMULA I+oxolinic acid, COMPOUND OF FORMULA I+oxpoconazole, COMPOUND OF FORMULA I+oxycarboxin, COMPOUND OF FORMULA I+pefurazoate, COMPOUND OF FORMULA I+penconazole, COMPOUND OF FORMULA I+pencycuron, COMPOUND OF FORMULA I+penflufen, COMPOUND OF FORMULA I+penthiopyrad, COMPOUND OF FORMULA I+phenazin oxide, COMPOUND OF FORMULA I+phosetyl-Al, COMPOUND OF FORMULA I+phosphorus acids, COMPOUND OF FORMULA I+phthalide, COMPOUND OF FORMULA I+picoxystrobin (ZA1963), COMPOUND OF FORMULA I+polyoxin D, COMPOUND OF FORMULA I+polyram, COMPOUND OF FORMULA I+probenazole, COMPOUND OF FORMULA I+prochloraz, COMPOUND OF FORMULA I+procymidone, COMPOUND OF FORMULA I+propamocarb, COMPOUND OF FORMULA I+propiconazole, COMPOUND OF FORMULA I+propineb, COMPOUND OF FORMULA I+propionic acid, COMPOUND OF FORMULA I++proquinazid, COMPOUND OF FORMULA I+prothioconazole, COMPOUND OF FORMULA I+pyraclostrobin, COMPOUND OF FORMULA I+pyrazophos, COMPOUND OF FORMULA I+pyribencarb, COMPOUND OF FORMULA I+pyrifenox, COMPOUND OF FORMULA I+pyrimethanil, COMPOUND OF FORMULA I+pyroquilon, COMPOUND OF FORMULA I+pyroxyfur, COMPOUND OF FORMULA I+pyrrolnitrin, COMPOUND OF FORMULA I+quaternary ammonium compounds, COMPOUND OF FORMULA I+quinomethionate, COMPOUND OF FORMULA I+quinoxyfen, COMPOUND OF FORMULA I+quintozene, COMPOUND OF FORMULA I+sedaxane, COMPOUND OF FORMULA I+sipconazole (F-155), COMPOUND OF FORMULA I+sodium pentachlorophenate, COMPOUND OF FORMULA I+spiroxamine, COMPOUND OF FORMULA I+streptomycin, COMPOUND OF FORMULA I+sulphur, COMPOUND OF FORMULA I+tebuconazole, COMPOUND OF FORMULA I+tecloftalam, COMPOUND OF FORMULA I+tecnazene, COMPOUND OF FORMULA I+terbufloquin, COMPOUND OF FORMULA I+tetraconazole, COMPOUND OF FORMULA I+thiabendazole, COMPOUND OF FORMULA I+thifluzamid, COMPOUND OF FORMULA I+2-(thiocyanomethylthio)benzothiazole, COMPOUND OF FORMULA I+thiophanate-methyl, COMPOUND OF FORMULA I+thiram, COMPOUND OF FORMULA I+tiadinil, COMPOUND OF FORMULA I+timibenconazole, COMPOUND OF FORMULA I+tolclofos-methyl, COMPOUND OF FORMULA I+tolylfluanid, COMPOUND OF FORMULA I+triadimefon, COMPOUND OF FORMULA I+triadimenol, COMPOUND OF FORMULA I+triazbutil, COMPOUND OF FORMULA I+triazoxide, COMPOUND OF FORMULA I+tricyclazole, COMPOUND OF FORMULA I+tridemorph, COMPOUND OF FORMULA I+trifloxystrobin, COMPOUND OF FORMULA I+triforine, COMPOUND OF FORMULA I+triflumizole, COMPOUND OF FORMULA I+triticonazole, COMPOUND OF FORMULA I+validamycin A, COMPOUND OF FORMULA I+valiphenal, COMPOUND OF FORMULA I+vapam, COMPOUND OF FORMULA I+vinclozolin, COMPOUND OF FORMULA I+zineb and COMPOUND OF FORMULA I+ziram. 
     The compounds of formula I may be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases. 
     The compounds of formula I according to the invention can also be used in combination with one or more other synergists. In particular, the following mixtures of the COMPOUND OF FORMULA I, where this term preferably refers to a compound selected from one of the Tables 1 to 60, are important: 
     COMPOUND OF FORMULA I+piperonyl butoxide, COMPOUND OF FORMULA I+sesamex, COMPOUND OF FORMULA I+safroxan and COMPOUND OF FORMULA I+dodecyl imidazole. 
     The compounds of formula I according to the invention can also be used in combination with one or more other herbicides. In particular, the following mixtures of the COMPOUND OF FORMULA I, where this term preferably refers to a compound selected from one of the Tables 1 to 60, are important: 
     COMPOUND OF FORMULA I+acetochlor, COMPOUND OF FORMULA I+acifluorfen, COMPOUND OF FORMULA I+acifluorfen-sodium, COMPOUND OF FORMULA I+aclonifen, COMPOUND OF FORMULA I+acrolein, COMPOUND OF FORMULA I+alachlor, COMPOUND OF FORMULA I+alloxydim, COMPOUND OF FORMULA I+allyl alcohol, COMPOUND OF FORMULA I+ametryn, COMPOUND OF FORMULA I+amicarbazone, COMPOUND OF FORMULA I+amidosulfuron, COMPOUND OF FORMULA I+aminocyclopyrachlor, COMPOUND OF FORMULA I+aminopyralid, COMPOUND OF FORMULA I+amitrole, COMPOUND OF FORMULA I+ammonium sulfamate, COMPOUND OF FORMULA I+anilofos, COMPOUND OF FORMULA I+asulam, COMPOUND OF FORMULA I+atraton, COMPOUND OF FORMULA I+atrazine, COMPOUND OF FORMULA I+azimsulfuron, COMPOUND OF FORMULA I+BCPC, COMPOUND OF FORMULA I+beflubutamid, COMPOUND OF FORMULA I+benazolin, COMPOUND OF FORMULA I+bencarbazone, COMPOUND OF FORMULA I+benfluralin, COMPOUND OF FORMULA I+benfuresate, COMPOUND OF FORMULA I+bensulfuron, COMPOUND OF FORMULA I+bensulfuron-methyl, COMPOUND OF FORMULA I+bensulide, COMPOUND OF FORMULA I+bentazone, COMPOUND OF FORMULA I+benzfendizone, COMPOUND OF FORMULA I+benzobicyclon, COMPOUND OF FORMULA I+benzofenap, COMPOUND OF THE FORMULA I+bicyclopyrone, COMPOUND OF FORMULA I+bifenox, COMPOUND OF FORMULA I+bilanafos, COMPOUND OF FORMULA I+bispyribac, COMPOUND OF FORMULA I+bispyribac-sodium, COMPOUND OF FORMULA I+borax, COMPOUND OF FORMULA I+bromacil, COMPOUND OF FORMULA I+bromobutide, COMPOUND OF FORMULA I+bromoxynil, COMPOUND OF FORMULA I+butachlor, COMPOUND OF FORMULA I+butafenacil, COMPOUND OF FORMULA I+butamifos, COMPOUND OF FORMULA I+butralin, COMPOUND OF FORMULA I+butroxydim, COMPOUND OF FORMULA I+butylate, COMPOUND OF FORMULA I+cacodylic acid, COMPOUND OF FORMULA I+calcium chlorate, COMPOUND OF FORMULA I+cafenstrole, COMPOUND OF FORMULA I+carbetamide, COMPOUND OF FORMULA I+carfentrazone, COMPOUND OF FORMULA I+carfentrazone-ethyl, COMPOUND OF FORMULA I+CDEA, COMPOUND OF FORMULA I+CEPC, COMPOUND OF FORMULA I+chlorflurenol, COMPOUND OF FORMULA I+chlorflurenol-methyl, COMPOUND OF FORMULA I+chloridazon, COMPOUND OF FORMULA I+chlorimuron, COMPOUND OF FORMULA I+chlorimuron-ethyl, COMPOUND OF FORMULA I+chloroacetic acid, COMPOUND OF FORMULA I+chlorotoluron, COMPOUND OF FORMULA I+chlorpropham, COMPOUND OF FORMULA I+chlorsulfuron, COMPOUND OF FORMULA I+chlorthal, COMPOUND OF FORMULA I+chlorthal-dimethyl, COMPOUND OF FORMULA I+cinidon-ethyl, COMPOUND OF FORMULA I+cinmethylin, COMPOUND OF FORMULA I+cinosulfuron, COMPOUND OF FORMULA I+cisanilide, COMPOUND OF FORMULA I+clethodim, COMPOUND OF FORMULA I+clodinafop, COMPOUND OF FORMULA I+clodinafop-propargyl, COMPOUND OF FORMULA I+clomazone, COMPOUND OF FORMULA I+clomeprop, COMPOUND OF FORMULA I+clopyralid, COMPOUND OF FORMULA I+cloransulam, COMPOUND OF FORMULA I+cloransulam-methyl, COMPOUND OF FORMULA I+CMA, COMPOUND OF FORMULA I+4-CPB, COMPOUND OF FORMULA I+CPMF, COMPOUND OF FORMULA I+4-CPP, COMPOUND OF FORMULA I+CPPC, COMPOUND OF FORMULA I+cresol, COMPOUND OF FORMULA I+cumyluron, COMPOUND OF FORMULA I+cyanamide, COMPOUND OF FORMULA I+cyanazine, COMPOUND OF FORMULA I+cycloate, COMPOUND OF FORMULA I+cyclosulfamuron, COMPOUND OF FORMULA I+cycloxydim, COMPOUND OF FORMULA I+cyhalofop, COMPOUND OF FORMULA I+cyhalofop-butyl, COMPOUND OF FORMULA I+2,4-D, COMPOUND OF FORMULA I+3,4-DA, COMPOUND OF FORMULA I+daimuron, COMPOUND OF FORMULA I+dalapon, COMPOUND OF FORMULA I+dazomet, COMPOUND OF FORMULA I+2,4-DB, COMPOUND OF FORMULA I+3,4-DB, COMPOUND OF FORMULA I+2,4-DEB, COMPOUND OF FORMULA I+desmedipham, COMPOUND OF FORMULA I+dicamba, COMPOUND OF FORMULA I+dichlobenil, COMPOUND OF FORMULA I+ortho-dichlorobenzene, COMPOUND OF FORMULA I+para-dichlorobenzene, COMPOUND OF FORMULA I+dichlorprop, COMPOUND OF FORMULA I+dichlorprop-P, COMPOUND OF FORMULA I+diclofop, COMPOUND OF FORMULA I+diclofop-methyl, COMPOUND OF FORMULA I+diclosulam, COMPOUND OF FORMULA I+difenzoquat, COMPOUND OF FORMULA I+difenzoquat metilsulfate, COMPOUND OF FORMULA I+diflufenican, COMPOUND OF FORMULA I+diflufenzopyr, COMPOUND OF FORMULA I+dimefuron, COMPOUND OF FORMULA I+dimepiperate, COMPOUND OF FORMULA I+dimethachlor, COMPOUND OF FORMULA I+dimethametryn, COMPOUND OF FORMULA I+dimethenamid, COMPOUND OF FORMULA I+dimethenamid-P, COMPOUND OF FORMULA I+dimethipin, COMPOUND OF FORMULA I+dimethylarsinic acid, COMPOUND OF FORMULA I+dinitramine, COMPOUND OF FORMULA I+dinoterb, COMPOUND OF FORMULA I+diphenamid, COMPOUND OF FORMULA I+diquat, COMPOUND OF FORMULA I+diquat dibromide, COMPOUND OF FORMULA I+dithiopyr, COMPOUND OF FORMULA I+diuron, COMPOUND OF FORMULA I+DNOC, COMPOUND OF FORMULA I+3,4-DP, COMPOUND OF FORMULA I+DSMA, COMPOUND OF FORMULA I+EBEP, COMPOUND OF FORMULA I+endothal, COMPOUND OF FORMULA I+EPTC, COMPOUND OF FORMULA I+esprocarb, COMPOUND OF FORMULA I+ethalfluralin, COMPOUND OF FORMULA I+ethametsulfuron, COMPOUND OF FORMULA I+ethametsulfuron-methyl, COMPOUND OF FORMULA I+ethofumesate, COMPOUND OF FORMULA I+ethoxyfen, COMPOUND OF FORMULA I+ethoxysulfuron, COMPOUND OF FORMULA I+etobenzanid, COMPOUND OF FORMULA I+fenoxaprop-P, COMPOUND OF FORMULA I+fenoxaprop-P-ethyl, COMPOUND OF FORMULA I+fentrazamide, COMPOUND OF FORMULA I+ferrous sulfate, COMPOUND OF FORMULA I+flamprop-M, COMPOUND OF FORMULA I+flazasulfuron, COMPOUND OF FORMULA I+florasulam, COMPOUND OF FORMULA I+fluazifop, COMPOUND OF FORMULA I+fluazifop-butyl, COMPOUND OF FORMULA I+fluazifop-P, COMPOUND OF FORMULA I+fluazifop-P-butyl, COMPOUND OF FORMULA I+flucarbazone, COMPOUND OF FORMULA I+flucarbazone-sodium, COMPOUND OF FORMULA I+flucetosulfuron, COMPOUND OF FORMULA I+fluchloralin, COMPOUND OF FORMULA I+flufenacet, COMPOUND OF FORMULA I+flufenpyr, COMPOUND OF FORMULA I+flufenpyr-ethyl, COMPOUND OF FORMULA I+flumetsulam, COMPOUND OF FORMULA I+flumiclorac, COMPOUND OF FORMULA I+flumiclorac-pentyl, COMPOUND OF FORMULA I+flumioxazin, COMPOUND OF FORMULA I+fluometuron, COMPOUND OF FORMULA I+fluoroglycofen, COMPOUND OF FORMULA I+fluoroglycofen-ethyl, COMPOUND OF FORMULA I+flupropanate, COMPOUND OF FORMULA I+flupyrsulfuron, COMPOUND OF FORMULA I+flupyrsulfuron-methyl-sodium, COMPOUND OF FORMULA I+flurenol, COMPOUND OF FORMULA I+fluridone, COMPOUND OF FORMULA I+fluorochloridone, COMPOUND OF FORMULA I+fluoroxypyr, COMPOUND OF FORMULA I+flurtamone, COMPOUND OF FORMULA I+fluthiacet, COMPOUND OF FORMULA I+fluthiacet-methyl, COMPOUND OF FORMULA I+fomesafen, COMPOUND OF FORMULA I+foramsulfuron, COMPOUND OF FORMULA I+fosamine, COMPOUND OF FORMULA I+glufosinate, COMPOUND OF FORMULA I+glufosinate-ammonium, COMPOUND OF FORMULA I+glufosinate-P, COMPOUND OF FORMULA I+glyphosate, COMPOUND OF FORMULA I+glyphosate-trimesium, COMPOUND OF FORMULA I+halosulfuron, COMPOUND OF FORMULA I+halosulfuron-methyl, COMPOUND OF FORMULA I+haloxyfop, COMPOUND OF FORMULA I+haloxyfop-P, COMPOUND OF FORMULA I+HC-252, COMPOUND OF FORMULA I+hexazinone, COMPOUND OF FORMULA I+imazamethabenz, COMPOUND OF FORMULA I+imazamethabenz-methyl, COMPOUND OF FORMULA I+imazamox, COMPOUND OF FORMULA I+imazapic, COMPOUND OF FORMULA I+imazapyr, COMPOUND OF FORMULA I+imazaquin, COMPOUND OF FORMULA I+imazethapyr, COMPOUND OF FORMULA I+imazosulfuron, COMPOUND OF FORMULA I+indanofan, COMPOUND OF FORMULA I+indaziflam, COMPOUND OF FORMULA I+iodomethane, COMPOUND OF FORMULA I+iodosulfuron, COMPOUND OF FORMULA I+iodosulfuron-methyl-sodium, COMPOUND OF FORMULA I+ioxynil, COMPOUND OF FORMULA I+ipfencarbazone, COMPOUND OF FORMULA I+isoproturon, COMPOUND OF FORMULA I+isouron, COMPOUND OF FORMULA I+isoxaben, COMPOUND OF FORMULA I+isoxachlortole, COMPOUND OF FORMULA I+isoxaflutole, COMPOUND OF FORMULA I+karbutilate, COMPOUND OF FORMULA I+lactofen, COMPOUND OF FORMULA I+lenacil, COMPOUND OF FORMULA I+linuron, COMPOUND OF FORMULA I+MAA, COMPOUND OF FORMULA I+MAMA, COMPOUND OF FORMULA I+MCPA, COMPOUND OF FORMULA I+MCPA-thioethyl, COMPOUND OF FORMULA I+MCPB, COMPOUND OF FORMULA I+mecoprop, COMPOUND OF FORMULA I+mecoprop-P, COMPOUND OF FORMULA I+mefenacet, COMPOUND OF FORMULA I+mefluidide, COMPOUND OF FORMULA I+mesosulfuron, COMPOUND OF FORMULA I+mesosulfuron-methyl, COMPOUND OF FORMULA I+mesotrione, COMPOUND OF FORMULA I+metam, COMPOUND OF FORMULA I+metamifop, COMPOUND OF FORMULA I+metamitron, COMPOUND OF FORMULA I+metazachlor, COMPOUND OF FORMULA I+methabenzthiazuron, COMPOUND OF FORMULA I+methylarsonic acid, COMPOUND OF FORMULA I+methyldymron, COMPOUND OF FORMULA I+methyl isothiocyanate, COMPOUND OF FORMULA I+metobenzuron, COMPOUND OF FORMULA I+metolachlor, COMPOUND OF FORMULA I+S-metolachlor, COMPOUND OF FORMULA I+metosulam, COMPOUND OF FORMULA I+metoxuron, COMPOUND OF FORMULA I+metribuzin, COMPOUND OF FORMULA I+metsulfuron, COMPOUND OF FORMULA I+metsulfuron-methyl, COMPOUND OF FORMULA I+MK-616, COMPOUND OF FORMULA I+molinate, COMPOUND OF FORMULA I+monolinuron, COMPOUND OF FORMULA I+MSMA, COMPOUND OF FORMULA I+naproanilide, COMPOUND OF FORMULA I+napropamide, COMPOUND OF FORMULA I+naptalam, COMPOUND OF FORMULA I+neburon, COMPOUND OF FORMULA I+nicosulfuron, COMPOUND OF FORMULA I+nonanoic acid, COMPOUND OF FORMULA I+norflurazon, COMPOUND OF FORMULA I+oleic acid (fatty acids), COMPOUND OF FORMULA I+orbencarb, COMPOUND OF FORMULA I+orthosulfamuron, COMPOUND OF FORMULA I+oryzalin, COMPOUND OF FORMULA I+oxadiargyl, COMPOUND OF FORMULA I+oxadiazon, COMPOUND OF FORMULA I+oxasulfuron, COMPOUND OF FORMULA I+oxaziclomefone, COMPOUND OF FORMULA I+oxyfluorfen, COMPOUND OF FORMULA I+paraquat, COMPOUND OF FORMULA I+paraquat dichloride, COMPOUND OF FORMULA I+pebulate, COMPOUND OF FORMULA I+pendimethalin, COMPOUND OF FORMULA I+penoxsulam, COMPOUND OF FORMULA I+pentachlorophenol, COMPOUND OF FORMULA I+pentanochlor, COMPOUND OF FORMULA I+pentoxazone, COMPOUND OF FORMULA I+pethoxamid, COMPOUND OF FORMULA I+petrolium oils, COMPOUND OF FORMULA I+phenmedipham, COMPOUND OF FORMULA I+phenmedipham-ethyl, COMPOUND OF FORMULA I+picloram, COMPOUND OF FORMULA I+picolinafen, COMPOUND OF FORMULA I+pinoxaden, COMPOUND OF FORMULA I+piperophos, COMPOUND OF FORMULA I+potassium arsenite, COMPOUND OF FORMULA I+potassium azide, COMPOUND OF FORMULA I+pretilachlor, COMPOUND OF FORMULA I+primisulfuron, COMPOUND OF FORMULA I+primisulfuron-methyl, COMPOUND OF FORMULA I+prodiamine, COMPOUND OF FORMULA I+profluazol, COMPOUND OF FORMULA I+profoxydim, COMPOUND OF FORMULA I+prometon, COMPOUND OF FORMULA I+prometryn, COMPOUND OF FORMULA I+propachlor, COMPOUND OF FORMULA I+propanil, COMPOUND OF FORMULA I+propaquizafop, COMPOUND OF FORMULA I+propazine, COMPOUND OF FORMULA I+propham, COMPOUND OF FORMULA I+propisochlor, COMPOUND OF FORMULA I+propoxycarbazone, COMPOUND OF FORMULA I+propoxycarbazone-sodium, COMPOUND OF FORMULA I+propyrisulfuron, COMPOUND OF FORMULA I+propyzamide, COMPOUND OF FORMULA I+prosulfocarb, COMPOUND OF FORMULA I+prosulfuron, COMPOUND OF FORMULA I+pyraclonil, COMPOUND OF FORMULA I+pyraflufen, COMPOUND OF FORMULA I+pyraflufen-ethyl, COMPOUND OF FORMULA I+pyrasulfutole, COMPOUND OF FORMULA I+pyrazolynate, COMPOUND OF FORMULA I+pyrazosulfuron, COMPOUND OF FORMULA I+pyrazosulfuron-ethyl, COMPOUND OF FORMULA I+pyrazoxyfen, COMPOUND OF FORMULA I+pyribenzoxim, COMPOUND OF FORMULA I+pyributicarb, COMPOUND OF FORMULA I+pyridafol, COMPOUND OF FORMULA I+pyridate, COMPOUND OF FORMULA I+pyriftalid, COMPOUND OF FORMULA I+pyriminobac, COMPOUND OF FORMULA I+pyriminobac-methyl, COMPOUND OF FORMULA I+pyrimisulfan, COMPOUND OF FORMULA I+pyrithiobac, COMPOUND OF FORMULA I+pyrithiobac-sodium, COMPOUND OF FORMULA I+pyroxsulam, COMPOUND OF FORMULA I+pyroxasulfone, COMPOUND OF FORMULA I+quinclorac, COMPOUND OF FORMULA I+quinmerac, COMPOUND OF FORMULA I+quinoclamine, COMPOUND OF FORMULA I+quizalofop, COMPOUND OF FORMULA I+quizalofop-P, COMPOUND OF FORMULA I+rimsulfuron, COMPOUND OF FORMULA I+saflufenacil, COMPOUND OF FORMULA I+sethoxydim, COMPOUND OF FORMULA I+siduron, COMPOUND OF FORMULA I+simazine, COMPOUND OF FORMULA I+simetryn, COMPOUND OF FORMULA I+SMA, COMPOUND OF FORMULA I+sodium arsenite, COMPOUND OF FORMULA I+sodium azide, COMPOUND OF FORMULA I+sodium chlorate, COMPOUND OF FORMULA I+sulcotrione, COMPOUND OF FORMULA I+sulfentrazone, COMPOUND OF FORMULA I+sulfometuron, COMPOUND OF FORMULA I+sulfometuron-methyl, COMPOUND OF FORMULA I+sulfosate, COMPOUND OF FORMULA I+sulfosulfuron, COMPOUND OF FORMULA I+sulfuric acid, COMPOUND OF FORMULA I+tar oils, COMPOUND OF FORMULA I+2,3,6-TBA, COMPOUND OF FORMULA I+TCA, COMPOUND OF FORMULA I+TCA-sodium, COMPOUND OF FORMULA I+tebuthiuron, COMPOUND OF FORMULA I+tefuryltrione, COMPOUND OF FORMULA I+tembotrione, COMPOUND OF FORMULA I+tepraloxydim, COMPOUND OF FORMULA I+terbacil, COMPOUND OF FORMULA I+terbumeton, COMPOUND OF FORMULA I+terbuthylazine, COMPOUND OF FORMULA I+terbutryn, COMPOUND OF FORMULA I+thenylchlor, COMPOUND OF FORMULA I+thiazopyr, COMPOUND OF FORMULA I+thiencarbazone, COMPOUND OF FORMULA I+thifensulfuron, COMPOUND OF FORMULA I+thifensulfuron-methyl, COMPOUND OF FORMULA I+thiobencarb, COMPOUND OF FORMULA I+tiocarbazil, COMPOUND OF FORMULA I+topramezone, COMPOUND OF FORMULA I+tralkoxydim, COMPOUND OF FORMULA I+tri-allate, COMPOUND OF FORMULA I+triasulfuron, COMPOUND OF FORMULA I+triaziflam, COMPOUND OF FORMULA I+tribenuron, COMPOUND OF FORMULA I+tribenuron-methyl, COMPOUND OF FORMULA I+tricamba, COMPOUND OF FORMULA I+triclopyr, COMPOUND OF FORMULA I+trietazine, COMPOUND OF FORMULA I+trifloxysulfuron, COMPOUND OF FORMULA I+trifloxysulfuron-sodium, COMPOUND OF FORMULA I+trifluralin, COMPOUND OF FORMULA I+triflusulfuron, COMPOUND OF FORMULA I+triflusulfuron-methyl, COMPOUND OF FORMULA I+trihydroxytriazine, COMPOUND OF FORMULA I+tritosulfuron, COMPOUND OF FORMULA I+[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetic acid ethyl ester (CAS RN 353292-31-6), COMPOUND OF FORMULA I+4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo)-1H-1,2,4-triazol-1-ylcarbonylsulfamoyl]-5-methylthiophene-3-carboxylic acid (BAY636), COMPOUND OF FORMULA I+BAY747 (CAS RN 335104-84-2), COMPOUND OF FORMULA I+topramezone (CAS RN 210631-68-8), COMPOUND OF FORMULA I+4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one (CAS RN 352010-68-5), and COMPOUND OF FORMULA I+4-hydroxy-3-[[2-(3-methoxypropyl)-6-(difluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one. 
     The compounds of formula (I) according to the invention can also be used in combination with safeners. Preferably, in these mixtures, the compound of the formula (I) is one of those compounds listed in Tables 1 to 60 above. The following mixtures with safeners, especially, come into consideration: 
     compound of formula (I)+cloquintocet-mexyl, compound of formula (I)+cloquintocet acid and salts thereof, compound of formula (I)+fenchlorazole-ethyl, compound of formula (I)+fenchlorazole acid and salts thereof, compound of formula (I)+mefenpyr-diethyl, compound of formula (I)+mefenpyr diacid, compound of formula (I)+isoxadifen-ethyl, compound of formula (I)+isoxadifen acid, compound of formula (I)+furilazole, compound of formula (I)+furilazole R isomer, compound of formula (I)+benoxacor, compound of formula (I)+dichlormid, compound of formula (I)+AD-67, compound of formula (I)+oxabetrinil, compound of formula (I)+cyometrinil, compound of formula (I)+cyometrinil Z-isomer, compound of formula (I)+fenclorim, compound of formula (I)+cyprosulfamide, compound of formula (I)+naphthalic anhydride, compound of formula (I)+flurazole, compound of formula (I)+N-(2-methoxybenzoyl)-4-[(methylaminocarbonyl)amino]benzenesulfonamide, compound of formula (I)+CL 304,415, compound of formula (I)+dicyclonon, compound of formula (I)+fluxofenim, compound of formula (I)+DKA-24, compound of formula (I)+R-29148 and compound of formula (I)+PPG-1292. A safening effect can also be observed for the mixtures compound of the formula (I)+dymron, compound of the formula (I)+MCPA, compound of the formula (I)+mecopropand compound of the formula (I)+mecoprop-P. 
     The mixing partners of the compound of formula I may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 12th Edition (BCPC), 2000. 
     In the above-mentioned mixtures of compounds of formula I, in particular a compound selected from said Tables 1 to 60, with other insecticides, fungicides, herbicides, safeners, adjuvants and the like, the mixing ratios can vary over a large range and are, preferably 100:1 to 1:6000, especially 50:1 to 1:50, more especially 20:1 to 1:20, even more especially 10:1 to 1:10. Those mixing ratios are understood to include, on the one hand, ratios by weight and also, on other hand, molar ratios. 
     The mixtures can advantageously be used in the above-mentioned formulations (in which case “active ingredient” relates to the respective mixture of compound of formula I with the mixing partner). 
     Some mixtures may comprise active ingredients which have significantly different physical, chemical or biological properties such that they do not easily lend themselves to the same conventional formulation type. In these circumstances other formulation types may be prepared. For example, where one active ingredient is a water insoluble solid and the other a water insoluble liquid, it may nevertheless be possible to disperse each active ingredient in the same continuous aqueous phase by dispersing the solid active ingredient as a suspension (using a preparation analogous to that of an SC) but dispersing the liquid active ingredient as an emulsion (using a preparation analogous to that of an EW). The resultant composition is a suspoemulsion (SE) formulation. 
     The mixtures comprising a compound of formula I selected from Table A and one or more active ingredients as described above can be applied, for example, in a single “ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula I selected from Tables 1 to 60 and the active ingredients as described above is not essential for working the present invention. 
     The invention is illustrated by the following examples. The H-NMR data of certain compounds of this invention shows line broadening at room temperature, suggesting the existence of plural conformational isomers due to, for example keto-enol tautomerism, hindered rotation, ring inversion in the piperidine moiety or nitrogen inversion at the piperidine N—OR center. Broad signals have been labeled with ‘br’ accordingly. 
    
    
     PREPARATION EXAMPLE 1 
     1,8-Bis-dimethylamino-3-(2,4,6-trimethyl-phenyl)-1,8-diaza-spiro[4.5]decane-2,4-dione 
     Step 1: [4-(Dimethyl-hydrazono)-piperidin-1-yl]-dimethyl-amine 
     
       
         
         
             
             
         
       
     
     3.0 g 1-Dimethylamino-piperidin-4-one (prepared as described in Journal of Medicinal &amp; Pharmaceutical Chemistry, 4, 423-36; 1961) is cooled to 0° C., and 3.8 g N,N-dimethylhydrazine is added at such a rate, that the internal temperature does not exceed 15° C. The mixture is stirred at ambient temperature for 3 hours. Then the excess of N,N-dimethylhydrazine is evaporated. Thus, 3.65 g [4-(Dimethyl-hydrazono)-piperidin-1-yl]-dimethyl-amine is obtained.  1 H-NMR (CDCl 3 ): 2.80 ppm (m, 2H), 2.70 ppm (m, 4H), 2.45 ppm (s, 6H), 2.42 ppm (m, 2H), 2.40 ppm (s, 6H). 
     Step 2: 1-Dimethylamino-4-(N′,N′-dimethyl-hydrazino)-piperidine-4-carbonitrile 
     
       
         
         
             
             
         
       
     
     2.25 g [4-(Dimethyl-hydrazono)-piperidin-1-yl]-dimethyl-amine (from Step 1) is dissolved in 25 ml water, cooled in an ice bath, and 3.64 g trimethylsilyl cyanide is added at such a rate, that the internal temperature does not exceed 10° C. Then the mixture is stirred at ambient temperature for 18 hours, extracted with ethyl acetate, the organic layer washed with brine, dried over sodium sulfate, and the solvent evaporated, to give 2.1 g 1-Dimethylamino-4-(N′,N′-dimethyl-hydrazino)-piperidine-4-carbonitrile.  1 H-NMR (CDCl 3 ): 2.74 ppm (m, 2H), 2.50 ppm (m, 2H), 2.40 ppm (s, 6H), 2.35 ppm (s, broad, 1H), 2.24 ppm (s, 6H), 1.95 ppm (m, 2H), 1.60 ppm (m, 2H). 
     Step 3: (2,4,6-Trimethyl-phenyl)-acetic acid N-(4-cyano-1-dimethylamino-piperidin-4-yl)-N′,N′-dimethyl-hydrazide 
     
       
         
         
             
             
         
       
     
     2.50 g 1-Dimethylamino-4-(N′,N′-dimethyl-hydrazino)-piperidine-4-carbonitrile (from Step 2) and 14 mg 4-dimethylaminopyridine are dissolved in 50 ml pyridine and cooled to 5° C. 5.23 g (2,4,6-trimethyl-phenyl)-acetyl chloride is added dropwise, then the mixture is stirred at ambient temperature for 18 hours. Then the solvent is evaporated, the residue is partitioned between water and ethyl acetate, the organic layer washed with brine, dried over sodium sulfate and evaporated. The residue is purified by chromatography on silica gel with cyclohexane/ethyl acetate (1:2) as a solvent. Obtained are 2.20 g (2,4,6-Trimethyl-phenyl)-acetic acid N-(4-cyano-1-dimethylamino-piperidin-4-yl)-N′,N′-dimethyl-hydrazide.  1 H-NMR (CDCl 3 ): 6.84 ppm (s, 2H), 3.72 ppm (s, 2H), 2.98 ppm (m, 2H), 2.94 ppm (s, 6H), 2.72 ppm (m, 2H), 2.52 ppm (m, 2H), 2.40 ppm (s, 6H), 2.25 ppm (s, 3H), 2.22 ppm (s, 6H), 2.13 ppm (m, 2H). 
     Step 4: 1-Dimethylamino-4-{N′,N′-dimethyl-N-[2-(2,4,6-trimethyl-phenyl)-acetyl]-hydrazino}-piperidine-4-carboxylic acid methyl ester 
     
       
         
         
             
             
         
       
     
     2.2 g (2,4,6-Trimethyl-phenyl)-acetic acid N-(4-cyano-1-dimethylamino-piperidin-4-yl)-N′,N′-dimethyl-hydrazide (from Step 3) is dissolved in 35 ml methanol and 8.7 g concentrated sulfuric acid is added dropwise. The mixture is heated to reflux for 18 hours, then cooled to room temperature, most of the solvent evaporated, then poured on ice, the pH adjusted to 7 by the addition of aqueous sodium hydroxide, and made alkaline by the addition of aqueous sodium bicarbonate. The mixture is then extracted with ethyl acetate, the organic layer dried over sodium sulfate and the solvent evaporated. The residue is chromatographed on silica gel with ethyl acetate/acetone (2:1) as a solvent, to give 1.55 g 1-Dimethylamino-4-{N′,N′-dimethyl-N-[2-(2,4,6-trimethyl-phenyl)-acetyl]-hydrazino}-piperidine-4-carboxylic acid methyl ester.  1 H-NMR (CDCl 3 ): 6.84 ppm (s, 2H), 3.70 ppm (s, 2H), 3.65 ppm (s, 3H), 3.05 ppm (s, 6H), 2.25 ppm (s, 3H), 2.21 ppm (s, 6H), 2.10-3.10 ppm (broad multiplets, total of 14H). 
     Step 5: 1,8-Bis-dimethylamino-3-(2,4,6-trimethyl-phenyl)-1,8-diaza-spiro[4.5]decane-2,4-dione 
     
       
         
         
             
             
         
       
     
     Under an atmosphere of argon, a solution of 1.25 g 1-Dimethylamino-4-{N′,N′-dimethyl-N-[2-(2,4,6-trimethyl-phenyl)-acetyl]-hydrazino}-piperidine-4-carboxylic acid methyl ester in 10 ml dry N,N-dimethylformamide is cooled to 5° C., and treated with 1.04 g potassium t-butoxide. The mixture is stirred at ambient temperature for 18 hours, then poured into aqueous ammonium hydroxide, and the pH of the solution adjusted to 4.5 by the addition of aqueous hydrochloric acid. It is extracted three times with ethyl acetate, the organic layer separated, dried over sodium sulfate and evaporated. The residue is purified by chromatography on silica gel with cyclohexane/ethyl acetate (1:3) as a solvent, to yield 377 mg 1,8-Bis-dimethylamino-3-(2,4,6-trimethyl-phenyl)-1,8-diaza-spiro[4.5]decane-2,4-dione as a solid, mp 80-85° C.  1 H-NMR (methanol-d 4 ): 6.91 ppm (s, 2H), 3.18 ppm (m, 2H), 3.08 ppm (m, 2H), 2.93 ppm (s, 6H), 2.48 ppm (s, 6H), 2.35 ppm (m, 2H), 2.29 ppm (s, 3H), 2.14 ppm (s, 6H), 1.40 ppm (m, 2H). 
     PREPARATION EXAMPLE 2 
     Carbonic acid 1,8-bis-dimethylamino-2-oxo-3-(2,4,6-trimethyl-phenyl)-1,8-diaza-spiro[4.5]dec-3-en-4-yl ester ethyl ester 
     
       
         
         
             
             
         
       
     
     150 mg 1,8-Bis-dimethylamino-3-(2,4,6-trimethyl-phenyl)-1,8-diaza-spiro[4.5]decane-2,4-dione (PREPARATION EXAMPLE 1) is dissolved in 3 ml tetrahydrofuran, 75 mg triethylamine is added, and the mixture is cooled to 0° C. 44 mg ethyl chloroformate is added and the resulting suspension stirred for 3 hours, thereby warming to room temperature. Then the mixture is partitioned between water and ethyl acetate, the organic layer separated and washed with brine, dried over anhydrous sodium sulfate, and evaporated. The residue is purified by chromatography on silica gel with ethyl acetate/heptane (1:1) as a solvent. Thus, 145 mg Carbonic acid 1,8-bis-dimethylamino-2-oxo-3-(2,4,6-trimethyl-phenyl)-1,8-diaza-spiro[4.5]dec-3-en-4-yl ester ethyl ester is obtained as a solid, mp 105° C.  1 H-NMR (CDCl 3 ): 6.83 ppm (s, 2H), 4.02 ppm (q, 2H), 3.05 ppm (m, 2H), 2.94 ppm (s, 6H), 2.80 ppm (m, 2H), 2.43 ppm (s, 6H), 2.40 ppm (m, 2H), 2.23 ppm (s, 3H), 2.17 ppm (s, 6H), 1.86 ppm (m, 2H), 1.08 ppm (t, 3H). 
     The compounds according to the following Table A below, and corresponding intermediates listed in the Tables B and C, have been prepared in analogy to the procedures described above. Either one of the following LC-MS methods was used to characterize the compounds: 
     Method A 
     MS: ZQ Mass Spectrometer from Waters (Single quadrupole mass spectrometer); Ionisation method: Electrospray; Polarity: positive/negative ions; Capillary (kV) 3.00, Cone (V) 30.00, Extractor (V) 2.00, Source Temperature (° C.) 100, Desolvation Temperature (° C.) 250, Cone Gas Flow (L/Hr) 50, Desolvation Gas Flow (L/Hr) 400; Mass range: 150 to 1000 or 100 to 900 Da. 
     LC: HP 1100 HPLC from Agilent: solvent degasser, quaternary pump (ZCQ)/binary pump (ZDQ), heated column compartment and diode-array detector. Column: Phenomenex Gemini C18, 3 μm particle size, 110 Angström, 30×3 mm, Temp: 60° C.; DAD Wavelength range (nm): 200 to 500; Solvent gradient: A=water+0.05% v/v HCOOH, B=Acetonitril/Methanol (4:1, v/v)+0.04% v/v HCOOH. 
     
       
         
           
               
               
               
               
               
             
               
                   
                   
               
               
                   
                 Time (min) 
                 A % 
                 B % 
                 Flow (ml/min) 
               
               
                   
                   
               
             
            
               
                   
               
            
           
           
               
               
               
               
               
            
               
                   
                 0.00 
                 95.0 
                 5.0 
                 1.700 
               
               
                   
                 2.00 
                 0.0 
                 100.0 
                 1.700 
               
               
                   
                 2.80 
                 0.0 
                 100.0 
                 1.700 
               
               
                   
                 2.90 
                 95.0 
                 5.0 
                 1.700 
               
               
                   
                 3.00 
                 95.0 
                 5.0 
                 1.700 
               
               
                   
                   
               
            
           
         
       
     
     Method B 
     MS: ZMD Mass Spectrometer from Waters (Single quadrupole mass spectrometer); Ionisation method: Electrospray; Polarity: positive/negative ions; Capillary (kV) 3.80, Cone (V) 30.00, Extractor (V) 3.00, Source Temperature (° C.) 150, Desolvation Temperature (° C.) 350, Cone Gas Flow (L/Hr) OFF, Desolvation Gas Flow (L/Hr) 600; Mass range: 150 to 1000 (100 to 1500 for LowMass) or 100 to 900 Da. 
     LC: HP 1100 HPLC from Agilent: solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Phenomenex Gemini C18, 3 μm particle size, 110 Angström, 30×3 mm, Temp: 60° C.; DAD Wavelength range (nm): 200 to 500; Solvent gradient: A=water+0.05% v/v HCOOH, B=Acetonitril/Methanol (4:1, v:v)+0.04% v/v HCOOH. 
     
       
         
           
               
               
               
               
               
             
               
                   
                   
               
               
                   
                 Time (min) 
                 A % 
                 B % 
                 Flow (ml/min) 
               
               
                   
                   
               
             
            
               
                   
               
            
           
           
               
               
               
               
               
            
               
                   
                 0.00 
                 95.0 
                 5.0 
                 1.700 
               
               
                   
                 2.00 
                 0.0 
                 100.0 
                 1.700 
               
               
                   
                 2.80 
                 0.0 
                 100.0 
                 1.700 
               
               
                   
                 2.90 
                 95.0 
                 5.0 
                 1.700 
               
               
                   
                 3.00 
                 95.0 
                 5.0 
                 1.700 
               
               
                   
                   
               
            
           
         
       
     
     The characteristic values obtained for each compound were the retention time (“R t ”, recorded in minutes) and the molecular ion as listed in Table A, Table B and in Table C. 
     
       
         
           
               
             
               
                 TABLE A 
               
             
            
               
                   
               
               
                 Compounds of formula Ib. 
               
            
           
           
               
               
            
               
                   
                 (Ib) 
               
               
                 
                   
                     
                     
                         
                         
                     
                   
                 
                   
               
               
                   
               
            
           
           
               
            
               
                 wherein R a , R b  and R c  are CH 3 , and R d  is H. 
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                   
                   
                   
                   
                   
                 LC-MS (retention time, 
                   
               
               
                   
                 R1 
                 R2 
                 R3 
                 R4 
                 G 
                 m/e, method) 
                 Mp 
               
               
                   
               
               
                 A1 
                 CH 3   
                 CH 3   
                 CH 3   
                 CH 3   
                 H 
                 1.03 min, m/e = 373 [M + H], 
                  80-85° C. 
               
               
                   
                   
                   
                   
                   
                   
                 ZMD09 
                   
               
               
                 A2 
                 CH 3   
                 CH 3   
                 CH 3   
                 CH 3   
                 CO 2 C 2 H 5   
                 1.31 min, m/e = 445 [M + H], 
                 105° C. 
               
               
                   
                   
                   
                   
                   
                   
                 ZMD09 
                   
               
            
           
           
               
               
               
               
               
               
               
            
               
                 A3 
                 —(CH 2 ) 2 O(CH 2 ) 2 — 
                 CH 3   
                 CH 3   
                 H 
                 1.00 min, m/e = 415 [M + H], 
                 114-116° C. 
               
               
                   
                   
                   
                   
                   
                 ZCQ10 
                   
               
               
                 A4 
                 —(CH 2 ) 2 O(CH 2 ) 2 — 
                 CH 3   
                 CH 3   
                 CO 2 C 2 H 5   
                 1.30 min, m/e = 487 [M + H], 
                  77-79° C. 
               
               
                   
                   
                   
                   
                   
                 ZCQ10 
               
               
                   
               
            
           
         
       
     
     Intermediates of the formula IV or XI from Table B can be prepared by analogous procedures. 
     
       
         
           
               
             
               
                 TABLE B 
               
             
            
               
                   
               
               
                 Physical data of intermediates of formula IV or XI: 
               
            
           
           
               
               
               
               
            
               
                 Compound 
                   
                 Melting 
                   
               
               
                 No. 
                 Structures 
                 Point 
                 MS/NMR 
               
               
                   
               
               
                 B1 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 gum 
                 LC/MS: 372 (M + H) +  R t  = 1.30 min 
               
               
                   
               
               
                 B2 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 gum 
                 LC/MS: 405 (M + H) +  R t  = 1.27 min 
               
               
                   
               
               
                 B3 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 160-162° C. 
                 LC/MS: 414 (M + H) +  R t  = 1.26 min 
               
               
                   
               
               
                 B4 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 gum 
                 LC/MS: 447 (M + H) +  R t  = 1.26 min 
               
               
                   
               
            
           
         
       
     
     Intermediates of the formula V, VII, VIII or X from Table C can be prepared by analogous procedures. 
     
       
         
           
               
             
               
                 TABLE C 
               
             
            
               
                   
               
               
                 Physical data of intermediates of formula V, VII, VIII or X: 
               
            
           
           
               
               
               
               
            
               
                 Compound 
                   
                 Melting 
                   
               
               
                 No. 
                 Structures 
                 Point 
                 MS/NMR 
               
               
                   
               
               
                 C1 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 gum 
                 LC/MS: 212 (M + H) +  R t  = 0.21 min 
               
               
                   
               
               
                 C2 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 oil 
                 GC/MS: 184 (M + ) R t  = 3.79 min 
               
               
                   
               
               
                 C3 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 68- 71° C. 
                 LC/MS: 254 (M + H) +  R t  = 0.23 min 
               
               
                   
               
               
                 C4 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 gum 
                 LC/MS: 227 (M + H) +  R t  = 0.23 min 
               
               
                   
               
            
           
         
       
     
     Biological Examples 
     These examples illustrate the pesticidal/insecticidal properties of compounds of formula I. 
     Example B1 
     Activity Against  Myzus persicae  (Green Peach Aphid) 
     (Mixed Population, Feeding/Residual Contact Activity, Preventive) 
     Sunflower leaf discs are placed on agar in a 24-well microtiter plate and sprayed with test solutions. After drying, the leaf discs are infested with an aphid population of mixed ages. After an incubation period of 6 days, samples are checked for mortality and special effects (e.g. phytotoxicity). 
     In this test, compounds listed in the Table A above show good activity. For example compound A4 shows an activity of over 80% at a concentration of 400 ppm. 
     Example B2 
     Activity Against  Myzus persicae  (Green Peach Aphid) 
     (Mixed Population, Systemic/Feeding Activity, Curative) 
     Roots of pea seedlings, infested with an aphid population of mixed ages, are placed directly in the test solutions. 6 days after introduction, samples are checked for mortality and special effects on the plant. 
     Example B3 
     Activity Against  Thrips tabaci  (Onion Thrips) 
     (Mixed Population, Feeding/Residual Contact Activity, Preventive) 
     Sunflower leaf discs are placed on agar in a 24-well microtiter plate and sprayed with test solutions. After drying, the leaf discs are infested with a thrips population of mixed ages. After an incubation period of 6 days, samples are checked for mortality and special effects (e.g. phytotoxicity). 
     Example B4 
     Activity Against  Tetranychus urticae  (Two-Spotted Spider Mite) 
     (Mixed Population, Feeding/Residual Contact Activity, Preventive) 
     Bean leaf discs on agar in 24-well microtiter plates are sprayed with test solutions. After drying, the leaf discs are infested with mite populations of mixed ages. 8 days later, discs are checked for egg mortality, larval mortality, and adult mortality. 
     In this test, compounds listed in the Table A above show good activity. For example compound A4 shows an activity of over 80% at a concentration of 400 ppm. 
     Example B5 
     Activity Against  Myzus persicae  (Green Peach Aphid) 
     (Mixed Population, Feeding/Residual Contact Activity, Plant Damage Evaluation) 
     Cabbage plants infested with a mixed population of  Myzus persicae  are treated with diluted test solutions of the compounds in a spray chamber. 6 days after treatment, samples are checked for mortality and for plant damage (phytotoxicity), visual assessment being made using a 0-100% rating scale (100%=total damage to plant; 0%=no damage to plant). 
     In this test, compounds listed in the Table A above show good activity against  Myzus persicae  and acceptable plant compatibility. For example compounds A3 and A4 show an activity of greater or equal to 80% against  Myzus persicae  and damage to cabbage plants less or equal to 10% at a concentration of 200 ppm.